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INTRODUCTION 
 
1. Cancer incidence and mortality in Italy 
Cancer is the leading cause of death in economically developed countries and the 
second leading cause of death in developing countries (World Health 
Organization, 2008). The burden of cancer is increasing in economically 
developing countries as a result of population aging and growth as well as, 
increasingly, an adoption of cancer-associated lifestyle choices including 
smoking, physical inactivity, and „„westernized‟‟ diets.  The total number of 
cancer deaths by country are collected annually and are made available by the 
World Health Organization (WHO) (World Health Organization Databank WHO 
Statistical Information System, 2010).   
In the last edition of Cancer Incidence in 5 Continents, the presence of 
population-based cancer registries in European Countries varied widely. In some 
Countries (e.g.Greece) cancer registries were not present, in others they extended 
nationally. In Italy, as in several other Countries (Portugal, Spain, France, 
Belgium, Germany, Poland, Switzerland and The United Kingdom) cancer 
registries have a regional coverage. The Graph1 shows the mean number of 
citizens in each European Country who are observed by cancer registries. The 
United Kingdom ranks first with about 56 million citizens, Italy is second with 
more than 17 million. Italian cancer registries are part of the Italian Network of 
cancer registries – AIRTUM (www.registri-tumori.it). AIRTUM has a common 
centralized data-base where data from all the Italian cancer registries are uploaded 
after quality checks. After the publication of Cancer Incidence in 5 Continents 
vol. IX, cancer registration in Italy has also extended, with the support of 
AIRTUM, to include new registries. Nowadays, the cancer registration in Italy 
involves almost 20 million citizens and several others are under the control of 
Specialized (for age, or type of cancer) ones. In Italy there is no national cancer 
registry, but AIRTUM puts our Country among the European leaders with regard 
to the capacity to provide information on cancer epidemiology. 
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Graph 1: mean number of citizens in each European Country 
 
A cancer incidence rate is the number of new cancers of a specific site/type 
occurring in a specified population during a year, usually expressed as the number 
of cancers per 100,000 population at risk. That is, 
Incidence rate = (New cancers / Population) × 100,000 
The numerator of the incidence rate is the number of new cancers; the 
denominator is the size of the population. The number of new cancers may 
include multiple primary cancers occurring in one patient. The primary site 
reported is the site of origin and not the metastatic site. In general, the incidence 
rate would not include recurrences. 
In the area of the Italian Network of Cancer Registries there were, on yearly 
average during 1998-2002, 783.4 cancer cases diagnosed every 100,000 males 
and 613.1 every 100,000 females. The most frequently diagnosed cancers were 
non-melanoma skin cancers (15.2%), prostate (14.4%), lung (14.2%), urinary 
bladder (9.0%), and colon cancer (7.7%) among males and breast (24.9%), non-
melanoma skin cancer (14.8%), colon (8.2%), lung (4.6%), and stomach cancer 
(4.5%) among females. In Italy, 162,756 new cancers among males and 129,247 
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among females have been estimated to be diagnosed yearly. As regards mortality, 
there were 89,561 cancer deaths among males and 66,471 among females in 2002. 
The cumulative risk (0-74 years) of developing a cancer is 1 case every 3 men and 
1 case every 4 women. 
 
Fig. 1: incidence e mortality for cancer in Italy 
 
1.1 Cancer in enfants 
Recent data coming from AIRTUM Working group about children cancer 
incidence (Epidemiol Prev 2008; 32(2) Suppl 2: 1-112) indicate that there is a 
growth trend of both all new cases of cancer and mean tumor sites at 0-14 years. 
Particularly, there are 168,5 cancer cases diagnosed every 1.000.000 children and 
the most frequently diagnosed are leukemia (52,1) and acute lymphatic leukemia 
(40,5). 
 
Fig. 2: cancer incidence at age 0-14 years (AIRTUM) 
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2. Chemotherapy and radiotherapy 
Two-thirds of women <40 years at diagnosis will have a tumor is >2 cm in size 
and/or involved axillary lymph nodes (stage II or higher) (Rosenberg R. et al., 
2003). Almost all women with stage II tumors and even most with stage I disease 
with a tumor greater than 1 cm in size will be advised to have gonadotoxic 
chemotherapy (Goldhirsch A. et al., 2009). At least two-thirds of women under 40 
will have a hormone receptor positive tumor and in addition to chemotherapy (or 
as a single modality in women with favorable tumors) will be advised to undergo 
5 years of antihormone therapy with a GnRH agonist. Adjuvant treatment is 
selected based on both the risk of recurrence and the biologic characteristics of the 
tumor. The 15-year risk of recurrence and death for women under 50 not receiving 
adjuvant systemic therapy is 53% and 42%, respectively, irrespective of stage or 
biologic characteristics according to Early Breast Cancer Trialists (EBCTCG) 
meta-analyses with the latest major published outcomes in 2005 (EBCTCG, 
2005). These figures dramatically differ by stage and biomarker variables, with a 
12.5% breast cancer mortality rate at 15 years for women under 50 with low-risk 
node-negative tumors, 25% for women with high-risk node-negative tumors, and 
50% for node-positive tumors (EBCTCG, 2005). Biologic characteristics with the 
greatest impact on treatment selection include estrogen and progesterone receptors 
(ER and PR), proliferation (usually measured by Ki-67), and presence of the 
growth factor receptors, such as HER-2 neu (Perou CM et al., 2000).  
 
2.1 Drug effect and their toxicity 
Specifically, anticancer drugs diminish the primordial follicle pool, cause ovarian 
atrophy, and harm the ovarian blood vasculature (Reulen RC et al., 2009). 
Possible mechanisms of damage include follicular apoptosis and cortical fibrosis. 
Recent hypothesis suggests increased activation of follicles from the resting pool, 
resulting in accelerated atresia, and eventually a premature „„burn-out‟‟ of the 
primordial follicle reserve. However, the exact mechanism of injury still remains 
unclear. Importantly, the magnitude of anticancer drug-induced damage is 
variable: in some instances, therapy can be sterilizing, whereas often instead, 
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women suffer from partial ovarian injury. The extent of damage is related to 
patient‟s age, chemotherapeutic agent, and drug regimen used (Critchley HOD et 
al., 2005). When treated with radiation, variable effects are also related to the 
location of the irradiation field. Although achieving a pregnancy years after 
cancer treatment is safe (Wallace WH et al., 2010), exposure to anticancer drug 
therapies may harm the quality of maturing eggs and therefore, concern has been 
raised regarding pregnancy and the health of future offspring conceived with 
oocytes exposed to chemotherapy in a non dormant state. Radiation to the uterus 
can interfere with implantation and uterine growth during pregnancy, resulting in 
poor obstetric outcome (Nicosia S et al., 1985). As cancer treatment improves, the 
number of childhood cancer survivors wishing to have healthy children has 
grown. As a result, it has become imperative to fully understand the mechanisms 
that lead to ovarian damage in the prepubertal and adult state and the impact 
variables such as age and treatment regimen have on the magnitude of injury for 
the physicians to effectively counsel patients in future attempts at successful 
pregnancies. 
 
2.2 Chemotherapy induced ovarian damage 
At birth, the ovary contains a finite number of oocytes that are surrounded by a 
single layer of pregranulosa cells to form primordial follicles (about 2 millions). 
By 5 months of gestational age, the female ovary establishes a fixed number of 
primordial follicles and therefore, the number of primordial follicles is a direct 
indication of fertility reserve. Throughout the life cycle, there is an ongoing 
decline in the number of primordial follicles that is the result of apoptotic cell 
death. Eventually, this loss of primordial follicles results in menopause at an 
average age of 50 to 51 years. In a recent study, the first model of human ovarian 
reserve from conception to menopause that best fits the combined histologic 
evidence has been described (Wallace WH et al., 2010). This model suggests that 
81% of the variance in primordial follicle population is exclusively owing to age 
and analysis showed that 95%of the fluctuation in follicular reserves is owing to 
age alone for ages up to 25 years. When ovarian functioning is disrupted by 
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anticancer drugs, the effects can be devastating. Clinically, patients may suffer 
from complete ovarian failure resulting in amenorrhea, climacteric symptoms, an 
increase in gonadotropins, and low estradiol levels (Meirow D, 2000). Histologic 
studies show that the end stage effects of chemotherapy are ovarian atrophy, a 
depletion of the primordial follicle stockpile, diminished ovarian weight, and 
stromal fibrosis (Nicosia S et al., 1985). Alternatively, chemotherapy‟s effects 
may be partial and patients may experience a reduction in their primordial follicle 
stockpiles, menstrual irregularities, and hormonal disturbances, but may still be 
able to maintain menses post-treatment. In animal studies, chemotherapy has been 
shown to cause a significant loss in both maturing follicles and dormant 
primordial follicles. In mice, chemotherapy causes the destruction of growing 
follicles (Utsunomiya T et al., 2008). Chemotherapy also results in diminished 
primordial follicle stockpiles in mice in a dose-dependent manner (Meirow D et 
al., 1999) and has been correlated to a reduction in primordial follicles in the 
rhesus macaque (Ataya K et al., 1995). Chemotherapy has differential effects on 
primordial, dormant follicles and growing, larger ovarian follicles. Chemotherapy 
targets actively dividing cells, and therefore, destroys mature ovarian follicles 
during treatment, specifically by inducing apoptosis in granulosa cells. Mice 
exposed to combination chemotherapy (Ironotecan HCl) show TUNEL positive 
granulosa cells in large ovarian follicles (Utsunomiya T et al., 2008; Meirow D et 
al., 1999; Ataya K et al., 1995; Philosof-Kalich L et al., 2009).However, the 
effects that chemotherapy has on primordial, dormant follicles are variable and the 
question remains as to whether the same effect is observed in these follicles. 
Clinically, patients exposed to chemotherapy initially stop menses as a result of 
the destruction of growing follicles and resume cycling after a period of recovery. 
Even low doses of chemotherapy can wipe out the population of maturing 
follicles, but partial ovarian reserve remains intact, allowing for the eventual 
resumption of menses. The means by which chemotherapy induces damage to the 
primordial follicle stockpiles, which represent future fertility potential, remains 
unclear. It is therefore, of paramount importance to understand the mechanisms by 
which chemotherapy injures the follicular stockpile to develop ways to improve 
fertility post anticancer drug exposure. 
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2.3 Follicular apoptosis 
Chemotherapy has been suggested to induce damage to primordial follicles by 
inducing apoptosis. Electron microscopy has shown that within hours of 
chemotherapy exposure, primordial follicles become surrounded by abnormally 
thick basal lamina (Familiari G et al., 1993). A substantial body of evidence has 
documented in vitro evidence of primordial follicle apoptosis (Meirow D et al., 
1999) and chemotherapy treatment in vitro has also been shown to cause 
primordial follicle architecture disruption and pregranulosa cell swelling. 
Preliminary in vivo studies using human ovarian xenografts in SCID mice have 
also shown indications of primordial follicle apoptosis (Oktem O et al., 2007). 
More research is needed to verify that primordial follicle apoptosis does indeed 
occur in true in vivo conditions, and whether the oocyte or surrounding granulosa 
cells are the primary target. Alternatively, other mechanisms of damage, such as 
cortical fibrosis and follicular „„burn-out‟‟ have been suggested to explain the 
variable loss of follicular reserves. 
 
2.4 Cortical fibrosis 
It is clear that chemotherapy results in ovarian cortical fibrosis and blood vessel 
damage (Nicosia S et al., 1985). In a study conducted on human ovarian tissue 
exposed to combination chemotherapy in vivo, hyalinization of cortical blood 
vessels, neovascularization, and cortical fibrosis were observed. These modes of 
injury result in local ischemia, thereby affecting the growth and survival of 
primordial follicles. Triangular areas of fibrosis have been observed to coincide 
with a depletion of primordial follicles, indicating that blood vessel damage 
results in primordial follicle injury. This may also impair the processes of new 
vessel formation that are critical for normal follicle growth within the territory of 
the damaged vasculature. If apoptosis had initially led to a diminished need for 
blood vasculature, then a uniform pattern of primordial follicle loss would be 
expected; this however, is not the observed trend (Meirow D et al., 2007).  
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2.5 Follicular “BURN-OUT” hypothesis 
A novel hypothesis to explain the loss of primordial stockpiles is the „„burn-out‟‟ 
mechanism. When exposed to chemotherapy, growing follicles are destroyed and 
therefore, there is a possible decrease in granulosa cell-derived paracrine growth 
factors that inhibit primordial follicle recruitment, such as anti Mullerian hormone 
(AMH). AMH null mice show increased activation of primordial follicles, 
resulting in greater numbers of large follicles that undergo atresia, and eventually 
resulting in a premature „„burn-out‟‟ of the primordial follicle reserve (Durlinger 
ALL et al., 1999). As a result, a possible mechanism by which chemotherapy may 
cause a depletion of primordial follicles is by increasing the recruitment of 
dormant follicles into the pool of actively growing follicles. An expected result of 
chemotherapy would, therefore, be an increase in large follicles and a decrease in 
primordial follicles. When mice were exposed to cyclophosphamide, an increase 
in the ratios of both primary and secondary follicles to primordial follicles was 
observed, thus supporting the „„burn-out‟‟ hypothesis (Philosof-Kalich L et al., 
2009). Premature activation may therefore, contribute to the deleterious effects of 
chemotherapy on the ovary. 
 
Table 1: cytotoxic agents according to degree of gonadotoxicity 
 
2.6 DRUG EFFECT  
There are 6 main classes of chemotherapeutic drug groups: alkylating agents, 
platinum derivatives, antibiotics, antimetabolites, plant alkaloids, and the taxanes. 
The extent of ovarian damage is influenced by the type of drug being 
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administered (Lee SJ et al., 2006). Alkylating agents are often and effectively 
used in combination chemotherapy treatment but they are also associated with 
particularly high levels of premature ovarian failure. Indeed, alkylating agents are 
responsible for the highest age-adjusted odds ratio of ovarian failure rates, 
followed by other drug families (Meirow D., 2000) (Fig. 3).  
 
Fig. 3: age-adjusted odds ratio of ovarian failure rates 
 
There are limited data surrounding the effects the taxane family has on ovarian 
failure rates, however; it has been documented that patients suffer from gonadal 
toxicity and high FSH levels (Anderson RA et al., 2006). In addition, the 
inclusion of paclitaxel, a member of the taxane family, to traditional AC 
(doxorubicin, cyclophosphamide) treatment significantly increases ovarian 
damage after treatment as measured by recovery of regular menstrual cycling 
(Petrek JA et al., 2006). Cancer patients usually undergo combination 
chemotherapy treatment, and a number of studies have reported the effects 
treatment protocols have on ovarian function. In breast cancer patients, 
individuals who underwent combination chemotherapy with regimens containing 
cyclophosphamide, methotrexate, and fluorouracil suffer from the highest 
amenorrhea rates. CAF (cyclophosphamide, doxorubicin, and fluorouracil) 
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treatment also induced high rates of ovarian failure whereas AC (doxorubicin and 
cyclophosphamide) treatment resulted in a greater eventual recovery of ovarian 
function after treatment (Meirow D et al., 2004). In a study of the incidence of 
menstrual bleeding after chemotherapy treatment in breast cancer patients, there 
was a 48% bleeding rate in individuals 1 month after cyclophosphamide, 
methotrexate, and fluorouracil treatment. This rate declined significantly over 
time. Alternatively, patients that underwent AC with or without paclitaxel had an 
initial significant decline of menstrual bleeding, slow recovery, and eventual 
restoration of regular menstrual bleeding in approximately 50% of patients (Petrek 
JA et al., 2006) (Table 2). Patients treated for Hodgkin lymphoma experience 
varying impacts on fertility potential based on the course of their treatment. 
Treatment with protocols containing alkylating agents such as MVPP (Nitrogen 
Mustard, vinblastine, procarbazine, and prednisolone), COPP (cyclophosphamide, 
vincristine, procarbazine, and prednisolone), or ChlVPP (chlorambucil, 
vinblastine, procarbazine, and prednisolone) had relatively high rates of ovarian 
damage, with amenorrhea rates between 38% and 57%. Alternatively, in treatment 
with ABVD chemotherapy, (doxorubicin, bleomycin, vinblastine, and 
dacarbazine) significantly less ovarian damage is reported (Meirow D et al., 2004; 
Brougham MFH et al., 2005). In the study of Hodgkin lymphoma survivors 
attempting to achieve pregnancy, it was found that ABVD treatment did not 
hinder fertility potential, as pregnancy rates were comparable with controls 
(Hodgson DC et al., 2007) (Table 2). Variable results have been reported 
regarding the effects treatment protocols have on non-Hodgkin lymphoma 
patients. Patients treated with a variety of drug regimens have documented 
relatively high ovarian failure rates, with sterilization rates of 44%. Patients 
treated for leukemia have low rates of reproductive failure after treatment and in a 
study of 47 patients, only 15% of the cohort experienced ovarian failure after 
treatment with combinations of the drugs ARA-C, daunorubicin, mitoxantrone, 
and VP-16 (Meirow D et al., 2004). Patients that undergo bone marrow 
transplantation (BMT) have extremely high ovarian failure rates. The risk of 
ovarian failure after treatment with total body irradiation (TBI) as conditioning for 
a bone marrow transplant is significant, but less predictable. In a large study of 
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718 long-term survivors, treated with chemotherapy and/or TBI as conditioning 
treatment before a bone marrow transplant, 532 had received TBI (10 to 15.75 Gy, 
single exposure or fractionated) and 186 chemotherapy, with either 
cyclophosphamide or busulphan. After TBI, 90% developed ovarian failure and 
after cyclophosphamide or busulphan 60% failed. There were 16 spontaneous 
pregnancies to 13 women who had received TBI, 6 of these women were 
prepubertal at the time of their radiotherapy (Sanders JE et al., 1996). In an 
additional study of 63 cancer patients who had undergone BMT, only 5 
individuals did not experience a premature menopause, giving a failure rate of 
92%.3 Additional studies further document this high risk of damage, with BMT 
inducing ovarian failure rates ranging from 72% to 100% (Meirow D. et al., 2004) 
(Table 2). It is clear that chemotherapeutic regimens, drugs, and age all have 
differential impacts on ovarian function. It is important for clinicians to fully 
realize the variable effects treatment can have on a patient‟s ability to resume 
menses after completing therapy to effectively consult patients in fertility 
preserving options, especially in the case of young patients that hope to continue 
building their families in the future. 
Introduction 
 
12 
 
 
Table 2: ovarian failure rates tables 
 
2.7 Radiation induced ovarian damage 
High-dose ionizing radiation is used to treat many types of cancer, and central 
nervous system and hematologic malignancies. Whenever possible, the gonads are 
shielded from radiation, however, this is not possible when the radiation field 
overlaps with the ovaries or when total body irradiation is required as a 
conditioning treatment for bone marrow transplantation. Radiotherapy to the 
pelvis results in ovarian injury and diminished follicle reserve; the extent of 
damage is largely based on patient‟s age, treatment dose, and the irradiation field. 
The location of the radiation field impacts the degree of ovarian damage with total 
body irradiation observed to result in ovarian failure in 90% of patients in long-
term follow-up (Sanders JE et al., 1996). After abdominal radiation, ovarian 
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failure rates may be as high as 97% (Wallace WH et al., 1989). Irradiation dosage 
and patient age also largely determine the degree of follicular loss and the 
likelihood of developing premature menopause. Approximately, half of the total 
number of nongrowing follicles are lost at doses of 2Gy (Wallace WHB et al., 
2003) (LD50). In female cancer survivors, the relative risk of developing 
premature ovarian failure and infertility rates have both been observed to increase 
with increasing doses of abdominal pelvic radiation. In addition, older patients are 
more susceptible to radiation-induced damage. Lower doses of radiation cause 
ovarian failure in older patients whereas young patients are more resilient, and 
succumb to ovarian failure at higher doses. 
 
2.8 Radiation induced Uterine Damage 
In addition to ovarian injury, childhood cancer survivors that were exposed to 
radiotherapy reportedly suffer from uterine damage, resulting in an increase in 
premature deliveries and miscarriage rates. These effects are likely the result of 
disruption to uterine blood vasculature and a decrease in uterine weight and 
length; with the extent of damage related to the radiation field and dose. In 
women who were treated with whole abdominal radiotherapy, the mean uterine 
length of 10 women was 4.1 cm when compared with 7.3 cm found in controls 
(Critchley HOD et al., 1992). Endometrial thickness is diminished in women who 
had earlier undergone abdominal radiation and when treated with exogenous sex 
steroid replacement, no increase in thickness was reported. In a later study, 
women who had undergone total body irradiation did show some improvement in 
endometrial thickness and uterine volume in response to sex steroids (Bath LE et 
al., 1999). It is likely that the high irradiation doses used in abdominal and 
directed uterine irradiation result in irreversible damage to the uterus. This is 
particularly worrisome for women hoping to become pregnant, and even those 
individuals who decide to use oocyte donors as a result of ovarian failure must 
realize the higher risk of miscarriage and premature deliveries. 
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2.9 Determinants of ovarian damages 
The primary determinants of chemotherapy-induced amenorrhea and/or loss of 
fertility are age of the woman at the time of chemotherapy, dose and number of 
cycles of the alkylating agent received, and, to a lesser extent, exposure to 
anthracyclines, taxanes, and platinum analogs (Petrek JA et al., 2006; Walshe JM 
et al., 2006; Gerber B et al., 2008; Hickey M et al., 2009). The aklylating agent, 
cyclophosphamide, is also one of the most potent in reducing ovarian follicular 
reserve. A woman who takes the equivalent of 2.4–3 g/m2 of cyclophsophamide 
over 12–16 weeks can count on adding an approximate 10 years to her ovarian 
reproductive age or 1.5–3.0 years per cycle (Petrek JA et al., 2006; Walshe JM et 
al., 2006; Gerber B et al., 2008; Hickey M et al., 2009). A woman who is 30 at 
chemotherapy initiation may have an equivalent ovarian age of 40 after 4–6 cycles 
of cyclophosphamide containing polychemotherapy. Women with a good 
prognosis breast cancer (stage I node negative) who received either six cycles of 
CMF or four cycles of AC experienced an estimated 33% rate of amenorrhea 
(Goldhirsch A et al., 1990; Bonadonna G et al., 1995; Fisher B et al., 1990; Bines 
J et al., 1996; Jones S et al., 2009). Rates of amenorrhea for more aggressive 
regimens given to women with poorer prognosis tumors such as six cycles of 
fluorouracil plus epirubicin or doxorubicin and cyclophosphamide (FEC or FAC), 
six cycles of AC or four cycles of AC followed by four of docetaxel are higher 
ranging from 50% to 65% (Levine MN et al., 1998; Hortobagyi GN et al., 1986; 
Swain SM et al., 2009; Fornier MN et al., 2005; Tham YL et al., 2007). Fifteen to 
50 percent of women younger than age 40 at diagnosis will recover menses. 
Amenorrhea is likely to be permanent in 90% of women over 40 and in 95% of 
women over 45 (Swain SM et al., 2009; Fornier MN et al., 2005; Tham YL et al., 
2007; Perez-Fidalgo JA et al., 2010). 
 
2.10  Age effect and fertility potential 
Age plays a crucial role in determining how resilient the ovary will be to 
chemotherapy treatment. Older patients are more likely to develop a premature 
menopause after chemotherapy, than are younger individuals. Petrek et al (Petrek 
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JA et al., 2006) found that age correlated to a decrease in the prevalence of 
menstrual bleeding as a result of chemotherapy exposure. Breast cancer patients 
younger than 35 had an approximately 85% recovery in monthly bleeding 
whereas women aged between 35 and 40 ranged from a 45% to 61% recovery rate 
and women over 40 years had an even lower recovery rate, with many individuals 
in this age group never regaining regular menses (Graph. 2). 
 
Graph. 2: recovery in monthly bleeding after chemotherapy as a function of age 
 
In an additional study of 168 individuals, patients who maintained ovarian 
function post treatment were found to be significantly younger (27.4+ 8.3 y) than 
those that lost ovarian function (34.7+ 8 y) (Meirow D et al., 2004). Patients 
treated for Hodgkin lymphoma suffer from significantly less gonadotoxicity when 
under the age of 25 (Brusamolino E et al., 2000). This age effect is mostly owing 
to the strong negative correlation between age and the nongrowing follicle (NGF) 
population, representing ovarian reserve (Wallace WH et al., 2010) (graph. 3). 
Introduction 
 
16 
 
Older women have diminished primordial follicle stockpiles and therefore, the 
effects of chemotherapy seem more marked. 
 
 
Graph. 3: correlation between age and the nongrowing follicle 
 
2.11 Alternative chemotherapy treatment regimens that may reduce 
follicular damage 
Chemotherapy regimens can usually be altered somewhat to reduce 
gonadotoxicity. For example, three cycles of FEC followed by three cycles of 
docetaxel provides similar chemotherapeutic efficacy as six cycles of FEC with 
less ovarian damage due to reduced amount of the alkylating agent (Berliere M et 
al., 2008). For most Her- 2þ tumors, preliminary evidence suggests that taxane 
and carboplatin are as effective as anthracycline, cyclophosphamide, and taxane 
combinations, completely avoid cyclophosphamide, and are probably not as likely 
to result in sterility (Slamon D et al., 2001; Costa RB et al., 2010). Triple negative 
breast cancers (ER-, PR-, Her-2 negative) often have multiple deficits in DNA 
repair pathways, and women with these tumors may selectively benefit from 
treatment with cis- or carboplatin regimens in combination with Poly-(ADP-
ribose) polymerase (PARP) inhibitors (Ismail-Khan R et al., 2010). Trials are 
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ongoing, but again platin-based regimens in combination with PARP are likely to 
be less gonadotoxic than cyclophosphamide-based regimens. 
 
3. Preservation of fertility 
 
3.1 Preserving ovarian tissue and function 
Three core strategies are employed to preserve fertility and to protect ovaries from 
the insults discussed earlier. First, the cryopreservation of immature oocytes, 
mature eggs, or embryos is a favored strategy because high survival rates post-
thawing are becoming commonplace (Saragusty J. et al., 2011). However, this 
strategy can be unavailable as embryo production necessarily requires a partner. 
Further, the production of significant numbers of mature eggs requires time for a 
stimulation cycle, and can require hormonal stimulation that is incompatible with 
treatment (Rodriguez-Wallberg K.A. et al., 2010). Even considering these 
contraindications, freezing eggs and embryos remains the most effective course of 
action, as women who survive their treatment with global reproductive tract 
function intact routinely achieve pregnancy. If these options are unavailable, the 
removal and cryopreservation of ovarian tissue is a reasonable but experimental 
strategy. In the second strategy, ovarian tissue containing primordial and primary 
follicles can be isolated, cryopreserved, and replaced after treatment and recovery. 
Here, it is hoped that the grafted tissue will allow the resumption of ovarian 
function and possible conception. The freezing of whole human ovaries and the 
freezing of small pieces of ovarian cortex, referred to as “cortical strips” are 
considered in more detail later (Table 3). The third strategy involves protecting 
intact ovaries from damage. The most common example of this “ovarian 
transposition,” where an ovary is surgically and mechanically displaced from its 
normal position so as to minimize direct irradiation during treatment (Chargari C 
et al., 2009; Dursun P et al., 2009; Bloemers M C et al., 2010). 
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Table 3: fertility preservation strategies 
 
3.2 Oocyte cryopreservation 
 
3.2.1 Cryobiology 
Historically, interdisciplinary researches networked together with the aim of 
maintaining long-term viability in living cells after cryopreservation. It is well 
known that biological material show a decrease or loss of viability above – 135°C 
because of biochemical reactions; consequentially the temperature that is 
generally used for mammalian cell storage is – 196°C, the same as liquid nitrogen. 
This should prevent reactions from taking place, because water at this temperature 
just exists in a solid state and the only possible alteration may be related to DNA 
damage caused by background reactions. This does not seem to compromise the 
chance of survival and development of human oocytes or embryos, anyhow. As 
cells are alive at 37°C and are almost totally inactive at – 196°C, the difficult steps 
to overcome are related to temperature decrease and the rewarming phase. 
These passages represent the key points responsible for cell survival. Chemically, 
when water is cooled below its freezing point, it solidifies, thus becoming ice. 
This can cause damages to the cells mainly because of intracellular ice crystal 
formation. As ice takes more space inside the cell than liquid water and spreads 
through, it may cause stress and subcellular alterations, eventually, resulting in a 
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loss of viability after rewarming. The main issue to overcome in any 
cryopreservation procedure is to consequentially avoid ice crystal formation. All 
biological systems respond to lowering of the temperature and water solidification 
in a different manner. Mazur in 1984 (Mazur P., 1984) was the first author who 
determined, through specific equations, the kinetics of water exchange in the cell 
and predicted the likelihood of intracellular freezing as a function of the cooling 
rate. This quantitative description can be explained qualitatively considering that, 
by definition, water below its freezing point is supercooled showing higher vapor 
pressure, activity, and chemical potential at a given subzero temperature than that 
of ice or of an ice-water equilibrium solution. As a consequence, as far as the cell 
remains supercooled the vapor pressure or the chemical potential difference will 
allow the water to leave the cell and freeze externally. This causes dehydration 
during cryopreservation with a rate and extent dependent on the permeability of 
the specific cell to water and the cooling rate. Generally speaking the slower is the 
cooling rate the higher extent of dehydration will be obtained. Thus, it is obvious 
that one of the most important points in cryopreservation procedures is to 
dehydrate the cell correctly before or during the freezing procedure to reduce the 
damages caused by intracellular ice formation. If dehydration is inadequate, large, 
intracellular ice crystals may form, which can be lethal to the cells. Although the 
avoidance of intracellular freezing is important to improve survival rates, it is not 
the only aspect to overcome. In fact, ice also forms outside the cell leaving the 
residual unfrozen medium to form channels and increase solute concentration 
causing shrinkage. To overcome these issues, cryoprotectans (CPAs) have been 
introduced in laboratory practices. This family of compounds can be classified 
into two main categories:  
 Permeating agents: can enter the cell and includes glycerol, dimethyl 
sulfoxide (DMSO), ethylene glycol, and 1,2-propanediol (PROH) and 
generally have a molecular weight lower than 100. 
 Nonpermeating agents: cannot enter the cell because of their size and 
polarity. They include large sugar molecules such as sucrose, ficoll, and 
raffinose, and also proteins and lipoproteins. 
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The protective properties of cryoprotectants are related to their ability to lower the 
freezing point of the solution in a concentration-dependent way and to their 
chemical property. They form hydrogen bonds with water molecules eliminating 
ice formation. Moreover, they prevent damages caused by high salt concentration. 
The search for suitable cryoprotectants and their appropriate concentrations has 
been a priority in all the freezing protocols. It seems that low molecular weight 
agents such as glycerol have a protective effect because of their ability to increase 
the unfrozen fraction and reduce cell volume excursion during cooling and 
rewarming procedures. Moreover, they also reduce the toxic effects of high 
concentrations of other compounds (colligative properties). The cryoprotectants 
enter the cells by osmosis while the water leaves. This might cause shrinkage as 
the water rapidly leaves the cells to dilute the high concentration of extracellular 
solutes or more serious issues when cryoprotectants need to be removed. On the 
contrary, high molecular weight cryoprotectants cannot enter the cells and are, 
instead, involved in the stabilization of the plasma membrane by solute-specific 
interactions with the bilayer phospholipids. This is the main reason why in almost 
all the slow freezing protocols the cryoprotectant mixture is made up of a 
penetrating agent and a non penetrating agent. 
 
3.2.2 Slow freezing 
The slow cooling protocol is based on a very slow rate of decreasing temperature 
(< l°C/min) over time (graph 4).  
 
Graph 4: slow freezing curve 
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Freezing solutions are cooled from room temperature (around 20°C) to – 8°C at a 
rate of 2°C/min. Manual seeding within straws is performed at near – 8°C and this 
temperature is maintained for 10 minutes to allow uniform ice propagation. This 
process prevents supercooling and starts the dehydration process. If ice formation 
is not initiated by seeding, the solution will remain unfrozen until a much lower 
subzero temperature is reached, which can be detrimental for oocyte survival. 
After this hold ramp the temperature is decreased to –30°C at a rate of 0.3°C/min 
and then rapidly brought to – 150°C at a rate of 50°C/ min. The straws are then 
directly plunged into liquid nitrogen at – 196°C and are stored. The thawing 
procedure consists of rapid rewarming, subsequent stepwise dilution of the 
cryoprotectants, and finally, return to 37°C for culture. The solutions that are 
commonly used during slow cooling procedures are a mixture of a penetrating 
cryoprotectant (usually PROH) and a nonpenetrating one (usually sucrose). 
 
3.2.3 Vitrification  
Vitrification is a recently developed alternative protocol that might become the 
elective method to freeze oocytes and ovarian tissue. It is based on the concept of 
avoiding ice crystal formation by using higher cryoprotectant concentrations, 
which causes the water to form a glassy state around the cell rather than ice 
crystals.  
Nevertheless, although these higher concentrations of cryoprotectants may 
prevent mechanical damages, they can also be toxic for the cell or create an 
osmotic shock. To design a vitrification protocol the main points to consider are 
the cooling and warming rates, the cryoprotectant concentrations, and the sample 
volume. Reducing the volume and raising the freezing rate requires a lower 
concentration of CPAs in the solution leading to lower side damages. On the 
contrary, if the volume is larger the likelihood of ice nucleation is higher causing 
the entire specimen to freeze instantaneously. Yavin and Arav (Yavin S et al., 
2007) expressed the probability of vitrification as a direct relationship between the 
cooling/warming rate and viscosity and, as an inverse relationship with the 
volume. Increasing the viscosity or the cooling/warming rates or decreasing the 
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volume will raise the probability of vitrification. It is well known that CPAs at 
high concentrations might have toxic consequences. This was, in fact, one of the 
main controversial aspects in vitrification procedures. To improve the outcome 
without using very high concentration of cryoprotectants, it is suitable to lower 
the cooling rate or to reduce the volume of sample storage to a very small drop 
that will prevent ice crystal formation. The cooling rate can be increased using 
liquid nitrogen slush at – 210°C whereas the loading volume can be reduced to 
less than 1 mL using newly developed devices. The cryoprotectants in the 
vitrification procedure are involved in two main actions: they should remove the 
water from the cell and, at the same time, enter the cell to form the amorphous 
state in the cytoplasm and prevent the cell from damage caused by low 
temperature. Initially, only penetrating agents were used in vitrification mixtures 
but, more recently, the protocols have been changed and the solutions are made by 
using both penetrating and nonpenetrating agents, and this has increased the 
survival rate and made significant advancements in the procedure. The general 
methodology involves a 2-step sequential exposure to vitrification solutions 
containing one or more cryoprotectants in increasing concentrations up to 40% 
(vol/vol), loading the cerlls in a minimal volume (<1 mL) of solution onto a 
carrier device (open or closed system), and very rapid cooling by plunging 
directly into liquid nitrogen. The time and temperature of exposure to such 
solutions are critical to avoid toxicity. Conversely, warming rates must also be 
rapid to prevent ice nucleation during the warming process and achieve optimal 
results. After warming, the cells are then moved through at least three solutions 
with decreasing concentrations of sucrose to effectively remove the 
cryoprotectants and rehydrate the cells. Vitrification can be defined as a physical 
process by which a highly concentrated solution of cryoprotectants creates a 
glasslike state during rapid cooling without the formation of ice crystals. This 
glassy state is an extremely viscous supercooled solution. Vitrification shows 
certain advantages over conventional slow freezing because it avoids damages 
caused by intracellular ice crystals and osmotic effects caused by extracellular ice 
formation. Moreover, it is a very fast procedure that does not require any 
electronic equipment and allows the freezing of specimens in a very short time. 
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3.3 Freezing of mature oocytes 
The major issue with the MII oocyte is related to the particular cell characteristics. 
The mature human oocyte is distinguished by the presence of the first polar body 
in the perivitelline space and the meiotic spindle in the cytoplasm. Several studies 
using slow freezing and vitrification protocols have been conducted to analyze the 
possible damages to the subcellular structures such as meiotic spindle, 
mitochondria, or cortical granules. It has been shown that the meiotic spindle is a 
very dynamic and sensitive structure, which is able to disappear and reform 
during cryopreservation and after thawing. This is regulated by fine 
polymerization and depolymerization of the tubulin, a very delicate equilibrium; if 
altered, it can lead to abnormal configuration of the spindle after thawing. The 
chromosomes are aligned on this structure tightly in contact with the 
microfilaments and even when the spindle disassembles, they are not found to be 
dispersed in the cytoplasm. Possible damages to the meiotic spindle are more 
related to abnormal fertilization than chromosomal abnormalities in the embryos. 
Another feature is represented by the zona pellucida and cortical granules, which 
are responsible for the correct oocyte fertilization by preventing multiple sperm 
penetration. Normally, the zona pellucida hardens after penetration of one sperm 
to block polyspermy as a consequence of the release of the cortical granules. The 
sperm, in fact releases a protein that causes an increase in intracellular calcium, 
which leads to the release of the cortical granules. The cryopreservation affects 
the normal process because it causes premature release of the cortical granules 
and zona pellucida hardening, which is why ICSI (intra-cytoplasmatic sperm 
injection) has been used routinely for the insemination of thawed oocytes. 
Although the zona pellucida seems to be compromised by cooling, the membrane 
of mature oocytes show a different lipidic composition compared with immature 
oocytes giving a better resistance to low temperature and cryogenic injuries. The 
cumulus is another feature of the mature oocyte: it is involved in the fine 
communication between the inside and outside of the egg. Even though evidence 
suggested that its maintenance does not improve the freezing outcome, this is still 
under debate. Over the past 10 years several satisfactory results have been 
published, yet there is not a defined, generally accepted approach that guarantees 
Introduction 
 
24 
 
a safe routine application. The first protocol used to cryopreserve oocytes was 
based on a slow cooling/rapid thawing method that had already been applied 
successfully for embryo cryopreservation. Since the first pregnancy in 1986, 
several advancements have been made with the aim of improving the original 
protocol. Most of the studies were focused around the choice of cryoprotectant 
and concentration or the exposure time. The freezing curve designed for the 
programmable freezer is basically unchanged from the original protocol first 
designed by Lassalle et al (Lassalle B et al., 1985) for embryo freezing. The CPAs 
generally used are PROH and sucrose. These two CPAs have been modified in 
concentration and exposure time during freezing/thawing procedure in different 
protocols developed in the last two decades. Clinical outcomes have been 
determined for all the different protocols. As already said the first protocol used 
was exactly the same as formulated for embryo freezing. It is based on 
1.5MPROH (equilibration solution) and 1.5M PROH+0.1M sucrose (loading 
solution) in the freezing mixture and a stepwise dilution of PROH (1.0M to 0.5 
M) with an unvaried 0.2M sucrose concentration in the thawing solutions. This 
protocol applied on 68 patients resulted in poor survival (37%), poor fertilization 
(45.4%), but good cleavage rate (86.3%). The pregnancy rate was relatively high 
(22% per patient) even though the implantation rate per oocyte was only 2.3% 
(Borini A et al., 2004).   
As regards the first report of vitrification in embryology, it was with mouse 
embryos in 1985 (Rall WF et al., 1985), followed by the successful vitrification of 
oocytes in 1991 (Kono T et al., 1991), yet the general application of vitrification 
in assisted reproduction has been rather limited until recently. The use of 
vitrification has been described in the literature for several mammalian species, 
including humans, with varying degrees of success depending upon the wide 
variety of tools and procedures applied (Liebermann J et al., 2002; Kuwayama M 
et al., 2005). Different recent publications have shown outstanding results for 
survival and clinical outcomes using vitrification compared with slow cooling 
(Vajta G et al., 2006). Vitrification methods have been modified over the years to 
optimize results in humans, by using minimal volumes and very rapid cooling 
rates, allowing lower concentrations of cryoprotectants to reduce injuries related 
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to chemical toxicity, osmotic shock, chilling sensitivity, and ice nucleation (Vajta 
G et al., 2006; Kuwayama M et al., 2005). The most widely used vitrification 
protocol involves gradual exposure of oocytes to the equilibration solution [7.5% 
ethylene glycol, 7.5% DMSO, and 20% serum substitute supplement (SSS) in 
HEPES buffered medium 199 (M199- H)] for approximately 8 minutes and then 
in the vitrification solution (15% ethylene glycol, 15% DMSO, 0.5M sucrose, and 
20% SSS in M199-H) for up to 110 seconds. Samples are then loaded onto a 
carrier device and plunged into liquid nitrogen. The thawing solutions are based 
on a series of solutions with decreasing sucrose concentrations (1.0, 0.5, and 0M) 
with 20% of SSS in M199-H. 
 
3.4 Cryopreservation of immature oocytes 
To circumvent issues associated with the MII structures, immature oocyte 
cryopreservation may represent an alternative. Oocytes arrested at prophase I of 
the meiotic process have different features than MII oocytes: they display a 
prominent nucleus called germinal vesicle (GV) that contains the chromosomes 
that are still decondensed even though they are transcriptionally active. Immature 
oocytes do not have microtubules organized in the spindle but rather dispersed 
mainly around the GV; this avoids possible damage during freezing procedures as 
opposed to MII oocytes. The cumulus and granulosa cells play a key role here 
because they are still tightly connected to the egg through transzonal projections 
and the plasma membrane is characterized by a reduced content in cholesterol and 
fatty acids so its permeability to CPAs is very different than that of MII oocytes. 
Immature oocyte cryopreservation may represent an alternative for fertility 
preservation in a selected group of patients who cannot undergo ovarian 
stimulation because of cancer-related issues. Generally speaking, this technique 
has not been extensively used because of the low success rates. This might be 
related either to the difficulties to overcome during freezing procedure that 
probably affect the transzonal projections negatively leading to irreversible 
damages or the poor results obtained with in vitro maturation (IVM) methods after 
freezing/ thawing. The immature oocytes are, in fact, characterized by this strict 
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communication between the cumulus and the egg and consequently, the freezing 
process can cause stress that destroys the tight gap junctions and corresponding 
communication. The penetration of cryoprotectants and any extracellular ice 
formation can result in cumulus-granulosa cell loss. 
 
3.5 Embryo cryopreservation 
The successful cryopreservation of surplus embryos after IVF and resultant 
pregnancy following frozen-thawed embryo transfer (FET) was first reported in 
1983, and the first child after embryo freezing was born in 1984 (Trounson A et 
al., 1983; Zeilmaker GH et al., 1984). For more than two decades, embryo 
cryopreservation (EC) has played an important role in assisted reproduction 
treatment (ART), providing couples with more than one attempt at embryo 
transfer after a single ovarian stimulation cycle with IVF, thus improving 
cumulative pregnancy rates while decreasing exposure to gonadotropins and 
reducing treatment costs. It is estimated that almost one quarter of the children 
born after ART are born following cryopreservation of mostly cleavage-stage 
embryos and, less commonly, blastocysts and oocytes (ICMART, 2008). Most 
recent data from the Society for Assisted Reproductive Technology and the 
European IVF Monitoring Program report a pregnancy rate of 34% following FET 
in women younger than 35 years and an overall pregnancy rate of 19%, 
respectively (Society for Assisted Reproductive Technology, 2009; Nyboe 
Andersen A et al., 2005). Slow-freezing has been the most widely applied 
technique for the cryopreservation of embryos, while vitrification has been used 
more frequently recently. A recent review assessing the medical outcome of ART 
children born after cryopreservation reported reassuring results (Wennerholm UB 
et al., 2009). The rate of preterm birth, birth defects and chromosomal 
abnormalities was not significantly different between children born after transfer 
of fresh or cryopreserved embryos. Similarly, these children demonstrated similar 
growth and mental development (Wennerholm UB et al., 2009). A recent 
systematic review of randomized trials comparing laboratory and clinical outcome 
with SF or vitrification conclude that pregnancy rates were not statistically 
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significantly different between the two methods (odds ratio (OR): 1.66, 95% 
confidence interval (CI): 0.98 –2.79, in favour of vitrification) (Kolibianakis E et 
al., 2009). However, vitrification was associated with significantly higher post-
thawing survival rates, both for cleavage-stage embryos (OR: 6.35, 95% CI: 1.14–
35.26) and for blastocysts (OR: 4.09, 95% CI: 2.45–6.84). Moreover, post-
thawing blastocyst development of embryos cryopreserved at the cleavage stage 
was significantly higher with vitrification than with slow freezing (OR: 1.56, 95% 
CI: 1.07–2.27). Similar to IVF embryos, we achieved higher survival and 
pregnancy rates following vitrification of cleavage stage IVM embryos as 
compared with slow-freezing (Son WY et al., 2009). Although the 
cryopreservation of embryos following a stimulated IVF cycle is considered the 
only established method of fertility preservation for female cancer patients, 
several points raise concern about this option. As reported before, these are: (1) a 
possible delay of two to five weeks in treatment of the primary disease due to 
ovarian stimulation depending on the timing of the first consultation with the 
reproductive endocrinologist in relation to onset of the next menstrual cycle (2) 
exposure to supraphysiologic estrogen levels induced by ovarian stimulation (3) 
the requirement for a male partner or willingness to use donor sperm for embryo 
production (4) legal, ethical, religious issues related to cryopreservation of 
embryos in general.  
 
3.5.1 Is it possible to overcome the limits of IVF-embryo cryopreservation? 
A retrospective study addressing the above question concluded that having a 
reproductive medicine consult and subsequent ovarian stimulation followed by 
oocyte collection did not significantly delay the start of adjuvant chemotherapy in 
young patients with breast cancer (Baynosa J et al., 2009). However, the actual 
time required for completion of the fertility preservation procedure, which starts 
with the initial reproductive medicine consultation and technically ends with 
oocyte collection, depends on the conditions of any particular clinic. Ovarian 
stimulation takes between 2 and 5 weeks, depending on the stimulation protocol 
employed and the timing of the following menstrual cycle of the patient. Studies 
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assessing the effect of the length of time between surgery and the initiation of 
chemotherapy on the survival of women with breast cancer report no detrimental 
effect of a delay in treatment if chemotherapy is started within 12 weeks after 
surgery (Cold S et al., 2005; Jara Sanchez C et al., 2007; Lohrisch C et al., 2006). 
However, it must be emphasized that the external validity of these studies is 
limited to their inclusion criteria, and the potential effect of any delay in oncologic 
treatment due to fertility preservation procedures must be evaluated on a case-by-
case basis together with the treating oncology team. In order to minimize any 
preventable delay, it is prudent to inform patients about the effects of treatment on 
fertility and the options for fertility preservation as early as possible in the course 
of oncologic diagnosis and treatment procedures. The effect of elevated estrogen 
levels on underlying disease. The risk of breast cancer is consistently found to be 
associated with persistently elevated blood estrogen levels (Yager JD et al., 2006). 
Serum estradiol (E2) levels are increased during ovarian stimulation for IVF and 
can reach levels twenty times higher than those of a natural cycle (Cahill DJ et al., 
2000). Although the effect of a temporary increase in serum E2 levels on the risk 
of recurrence of breast cancer is controversial, these facts cause concern among 
both physicians and patients. Such concerns should not be limited to women with 
estrogen receptor positive breast cancer, because recent findings also suggest the 
presence of an indirect mitogenic effect of estrogen on hormone receptor negative 
breast cancer (Gupta PB et al., 2006). Moreover, increased E2 levels can be 
relevant for patients undergoing fertility preservation treatment due to other 
oncologic or non-oncologic diseases considered to be estrogen sensitive, such as 
desmoids tumours, systemic lupus erythematosus or severe endometriosis. In 
order to minimize the rise in estradiol levels in breast cancer patients undergoing 
IVF, Oktay et al. developed an ovarian stimulation protocol involving the 
concomitant use of an aromatase inhibitor, letrozole, with gonadotropins (Azim 
AA et al., 2008). Briefly, letrozole was started at a dose of 5mg/day on the second 
day of the menstrual cycle and gonadotropins were initiated two days later. A 
gonadotropin releasing hormone antagonist was used to prevent premature 
ovulation, and human chorionic gonadotropin (HCG) was administered when at 
least two follicles reached 19mm in diameter. Letrozole was reinitiated on the day 
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of oocyte collection in order to prevent a rebound increase in E2 level. 
Themeanpeak E2 level was 406 pg/ml (range 58 to 1,166 pg/ml) in 79 women 
with breast cancer undergoing ovarian stimulation for embryo or oocyte 
cryopreservation (Azim AA et al., 2008). An average of 10.3±7.75 oocytes were 
retrieved and 5.97±4.97 embryos/oocytes cryopreserved per patient. Compared to 
136 women who opted against ovarian stimulation, the recurrence and relapse-free 
survival rates were similar after a median follow up of 23.4 months after 
definitive surgery. However, it is interesting to note that with the same centre 
63.3% of breast cancer patients referred for REI consultation declined ovarian 
stimulation and IVF due to concerns about delay of chemotherapy, effect of 
ovarian stimulation on cancer or costs associated with treatment. 
 
3.5.2 Ethical and legal issues associated with embryo cryopreservation 
When embryos are cryopreserved in a fertility preservation program, the 
patient/couple should make an advance decision on the fate of these embryos in 
the event that they are not transferred for any reason including the patient‟s failure 
to survive cancer. It should be documented whether the remaining partner is 
entitled to use the embryos for his own reproductive end or whether they are to be 
donated to a third party, used for research or discarded. Considering these issues 
and making such decisions can be particularly difficult for a patient who has been 
recently diagnosed with a life-threatening disease and is facing a demanding 
treatment period. Therefore, patients should be given appropriate counselling 
using a multidisciplinary approach involving a psychologist and a legal advisor. 
 
3.6 Whole ovary and cortical strip freezing 
3.6.1 Whole ovary transplantation  
It has been almost two decades since fresh whole ovary autotransplantation was 
reported in human studies. In those reports, ovaries were removed from their 
pelvic location and immediately transplanted into other sites. The use of 
heterotopic sites for ovarian autotransplantation dates back to 1988, when the first 
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case was reported (Muller G et al., 1988). Whole ovary transplantation with a 
vascular anastomosis was proposed as a mechanism to reduce ischemic time and, 
in theory, prolong the longevity of the graft (Jeremias E et al., 2002). In this 
technique, the whole ovary with its vascular pedicle is removed, cryopreserved, 
thawed, and then transplanted with a microvascular anastomosis into a heterotopic 
or orthotopic site. Transplantation of an intact ovary with vascular anastomosis 
reduces the ischemic interval between transplantation and revascularization by 
allowing immediate revascularization of the transplanted tissue (Jadoul P et al., 
2007). 
 
3.6.2 Whole Fresh Ovary Transplantation 
Fresh whole ovary transplantation with vascular anastomosis has been 
successfully performed experimentally in animal models using a wide variety of 
orthotopic and heterotopic-recipient sites. In addition, a number of vessels have 
been used in a wide variety of animal models. These include pelvic vessels such 
as the ovarian artery and iliac artery, parietal vessels such as the inferior epigastric 
vessels and extrapelvic vessels such as the carotid vessels (Wang X et al., 2002; 
Goding JR, 1966). The revascularization process was compromised in 
approximately 50% of the cases when fresh ovaries were transplanted (Jeremias E 
et al., 2002) . A limited number of human studies with transplantation of fresh 
whole ovaries in orthotopic (Silber SJ et al., 2008; Mhatre P et al., 2005) and 
heterotopic sites (Leporrier M et al., 1987; Hilders CG et al., 2004) have been 
attempted with some success. Silber et al culminated his efforts in ovarian 
transplantation in monozygotic twins discordant for premature ovarian failure 
(POF) by reporting the first full-term pregnancy obtained using orthotopic whole 
fresh ovary transplantation with microvascular anastomosis. A fresh ovary from 
the fertile twin was implanted in her monozygotic twin with POF.  
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3.6.3 Whole Frozen-thawed Ovary Transplantation 
Whole frozen ovary transplantation with microvascular anastomosis was first 
described in rats by Wang et al (Wang X et al., 2002). They described successful 
vascular transplantation of frozen-thawed rat ovaries, which were transplanted 
along with the reproductive tract in 4 of 7 (57%) transplants; these transplants 
survived for Z60 days, were ovulatory and resulted in one pregnancy. Ovarian 
function was restored in 100% of cases when fresh organs were transplanted (Yin 
H et al., 2003). The first report of successful cryopreservation and transplantation 
of an intact ovary in sheep (defined as return of hormonal functions) occurred 
with a vascular anastomosis using the inferior epigastric vessels in 2003 (Bedaiwy 
MA et al., 2003). Successful pregnancy and delivery of a lamb in sheep was 
reported by Imhof et al in 2006 after autotransplantation of whole cryopreserved 
ovaries with microanastomosis of the ovarian vascular pedicle. The challenge of 
whole ovary cryopreservation and transplantation technology is not only the 
surgical technique but the cryopreservation protocol for an entire organ. Such a 
protocol should ensure that the cryoprotectant(s) evenly diffuses throughout the 
entire ovary. In addition, the frozen ovary should survive the thawing process and 
maintain functionality after transplantation. We have found evidence of 
endothelial cell damage caused by the freeze-thaw process or by the ischemic time 
until successful reanastomosis. Imhof et al reported that 18 months after 
transplantation, the follicular survival rate was less than an 8%. Other authors 
reported an even lower follicular survival rate (6%) and the depletion of the entire 
follicular population after whole ovary cryopreservation and transplantation 
(Courbiere B et al., 2009). Although ovarian vessel thrombosis is a potential 
complication of a vascular anastomosis, its incidence may be higher with different 
freezing techniques such as vitrification. Similarly, in a more recent study in 
ewes, it was shown that immediate vascular patency was achieved in all ewes and 
maintained in 7 of 8 cryopreserved and 3 of 4 control grafts. Functional corpora 
lutea were identified in 3 ewes (1 control and 2 cryopreserved) 18 to 25 weeks 
after grafting. In addition, inhibin-A levels indicated resumption of follicular 
development in 4 cryopreserved and 1 control ewes, however, castrate 
gonadotrophin levels persisted in 5 cryopreserved and 2 control ewes. The main 
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prominent feature of this whole ovary transplantation experiment is the fact that 
primordial follicle density was significantly reduced after grafting in both 
cryopreserved and nonfrozen ovaries (Onions VJ et al., 2009). Although 
transplantation of whole cryopreserved-thawed ovary was not performed in 
humans, cryopreservation of a whole ovary using a slow freezing protocol has 
been successfully attempted (Bedaiwy MA et al., 2006). The results showed both 
vascular and follicular integrity after freezing and thawing. More recently, a 
multigradient freezing device was recently used with promising results (Bromer 
JG et al., 2008). In that study, a high follicular viability, normal histologic 
architecture, and preserved vessel integrity were reported, supporting the potential 
for vascular reanastomosis. Martinez-Madrid et al in 2007 evaluated apoptosis by 
the terminal deoxynucleotidyl transferase-mediated biotinylated deoxyuridine 
triphosphates nick endlabeling method and by immunohistochemistry for active 
caspase-3 in fresh ovaries, after whole ovary freezing. Ultrastructure was also 
assessed by transmission electron microscopy in the thawed tissue. They found 
that primordial or primary follicles were not positive for either terminal 
deoxynucleotidyl transferase-mediated biotinylated deoxyuridine triphosphates 
nick end-labeling or active caspase-3 after whole ovary freezing indicating the 
feasibility of whole ovary freezing. 
 
3.6.4 Potential Techniques 
An intact human ovarian autotransplantation was reported in 38-year-old 
monozygotic twins discordant for POF (Silber SJ et al., 2008). The donor ovary 
was removed laparoscopically from the fertile sister by dividing the 
infundibulopelvic ligament at its base to maximize the length. Using 
minilaparotomy, the donor‟s ovarian veins (3.0 mm in diameter) were 
anastomosed to the recipient‟s ovarian veins with 9-0 nylon sutures, and the 
donor‟s ovarian arteries (0.5mm in diameter) were anastomosed to the recipient‟s 
ovarian arteries with 10-0 nylon interrupted sutures. A normal- appearing blood 
flow through the ovarian vessels of the transplanted ovary was observed after an 
ischemic period of 100 minutes. Subsequently, the recipient twin had 11 regular 
menstrual cycles. At days 427 after transplantation, she became pregnant and gave 
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birth to a normal healthy baby girl. This case showed the feasibility of using 
whole-ovary transplantation between monozygotic twins who are discordant for 
POF to restore fertility in the affected twin. Should intact human ovary 
cryopreservation be optimized, the same approach could be adopted for 
autotransplantation of intact cryopreserved-thawed ovary with a vascular pedicle. 
Although the likelihood of whole ovary cryopreservation and later reimplantation 
into a patient continues to increase, whole ovary freezing has two critical 
challenges to overcome. First, vascular re-anastomosis of the ovarian arteries in 
particular makes for very challenging surgery. Thus, an elevated risk of ischemia 
during reintroduction of the ovaries post-thaw is inherent in the procedure. 
Second, and most importantly, whole ovary handling means that there is only one 
chance for every step to go optimally. If handling, cryopreservation, or thawing 
and reimplantation are compromised at any step, the entire organ could be lost. 
For these reasons, whole ovary freezing and transplantation should be viewed as 
an experimental strategy for the time being. By comparison, the removal and 
storage of ovarian cortex (“cortical strips”) has several advantages. 
 
3.6.5 Prevention of Post transplantation Ischemic Ovarian Damage 
Many strategies have been devised to minimize the initial post transplantation 
ovarian ischemia However, the majority of them lack standardization, 
reproducibility, and long-term success. 
 
MECHANICALLY INDUCED NEOANGIOGENESIS 
Surgically induced tissue injury is associated with neoangiogenesis and 
inflammation. Consequently, transplantation in the context of an inflammatory 
reaction could expedite the revascularization of ovarian grafts. This approach was 
tested by Donnez et al in 2004 who used a multistep process to create a peritoneal 
pocket 1 week before transplantation. Similarly, this hypothesis was further 
supported by the early perfusion of ovarian cortical strips upon their 
transplantation into granulation tissue (Israely T et al., 2006). 
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THE USE OF ANITOXIDANTS 
Reactive oxygen species (ROS) are produced as a result of the ischemia perfusion 
process. They have the potential to damage cell membranes, endothelial 
membranes, and mitochondrial function (Kupiec-Weglinski JW et al., 2005). The 
use of antioxidants may reduce ROS-associated tissue damage and follicular loss 
after transplantation. The use of exogenous antioxidants to augment ovarian 
transplant resistance to ROS-associated damage has been evaluated by many 
investigators. In various animal models, a wide variety of antioxidants were 
attempted including ascorbic acid, mannitol (Sagsoz N et al., 2002), 
oxytetracycline (Sapmaz E et al., 2003), and vitamin E (Nugent D et al., 1998) 
with variable successes. In a human in-vitro model, Kim et al in 2004 found that 
incubating ovarian tissue with ascorbic acid for up to a maximum of 24 hours 
reduced apoptosis. 
 
GROWTH FACTORS-INDUCED NEOANGIOGENESIS 
Neoangiogenesis is an integral part in the establishment of graft function. 
Therefore, it is expected that neoangiogenic growth factors such as fibroblast 
growth factor, transforming growth factor, and vascular endothelial growth factor 
(VEGF) somehow aid in the establishment of graft function. In lower animals, it 
was shown that the invasion of the rat cortex by vessels was associated with a 
significant increase in the expression of mRNA in the outer cortex for both 
transforming growth factor and VEGF.11 However, systemically administered 
VEGF was not associated with improved graft function in an animal model 
(Schnorr J et al., 2002). Local administration at the transplant site may be more 
beneficial. 
 
HORMONAL TREATMENT 
Data from several animal experiments showed that pretreating the graft recipient 
and/or the donor with gonadotrophin stimulation before and after transplantation 
may have a positive effect on the viable growth follicle rate (Nugent D et al., 
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1998; Imthurn B et al., 2000; Wang X et al., 2002). However, the impact of such 
treatments on long-term ovarian function and fertility is still questionable and 
needs further investigation. 
 
3.7 Ovarian cortex and ovarian follicles 
The transplantation of pieces of ovaries and ovarian cortex (which can contain 
thousands of immature follicles) has been performed successfully in different 
mammals since early in the last century (Lamond DR, 1959; Simmer HH et RT 
Morris, 1970). Use of the sheep, whose ovaries are anatomically similar to the 
human, resulted in important proof-concept studies (Gosden RG et al.; Baird DT 
et al., 1999) that later would be applied to the human. That work showed that 
pieces of sheep ovarian cortex could be removed, optionally cryopreserved, and 
then reintroduced surgically to the surface of a recipient‟s ovary. Strikingly, 
ovarian function resumed long-term in graft recipients, and pregnancies, 
ostensibly from oocytes in graft tissue, were achieved. Grafting human ovarian 
cortex back to the ovary has been similarly successful. The first notable example 
of this was shown in a patient treated for Hodgkin‟s lymphoma who had ovarian 
cortex removed and stored prior to treatment. After recovery, the patient‟s cortical 
strips were thawed and grafted orthotopically, after which recovery of regular 
ovulatory cycles occurred. This patient later became pregnant, resulting in a live 
birth (Donnez, J et al., 2004). A second similar resumption of ovarian function 
using frozen/thawed autografts was seen in a patient treated with chemotherapy 
for sickle cell anemia (Donnez J et al., 2006). More recently, this technique was 
applied to cases of premature ovarian failure (POF) (Silber S et al., 2010). Nine 
women with POF received ovarian tissue donated by their monozygotic twin 
sisters whose ovaries were still functional. Ovarian function resumed in all nine 
women, and eight live births are obtained. Although the effectiveness of such 
grafts are unquestionable, there are situations where this approach would not be 
appropriate. If there is any chance of reintroducing cancer or another malignancy, 
ovarian cortex (or indeed, whole ovary) cryopreservation and grafting should be 
avoided (Shaw  JM et al., 1996; Shaw J. et A. Trounson, 1997; Dolmans MM et 
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al., 2010). For such cases, the experimental strategy of maturing ovarian follicles 
in vitro, in hopes of producing mature eggs, offers promise. 
 
3.8 In vitro culture techniques 
In vitro mammalian ovarian follicle culture has been performed successfully for 
more than 15 years. Multiple groups have cultured mouse preantral follicles to an 
ovulatory state, produced mature eggs, and subsequently, embyros and offspring. 
Originally, follicles were isolated and cultured in plastic culture dishes (Cortvrindt 
R et al., 1996; Smitz J et al., 1996) (Fig. 4 ). To improve the morphological 
characteristics of cultured follicles and the efficiency of development to maturity, 
new approaches making use of bioengineered materials have been developed. 
Embedding follicles in a three-dimensional matrix can improve follicle growth 
performance in vitro (Fig. 4). 
..
 
Fig. 4: 2D and 3D in vitro culture of follicles 
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Particularly, the use of alginate matrices (West ER et al., 2007) has resulted in 
promising follicle development in vitro, up to large antral stages. Such matrices 
are thought to provide an improved mechanical environment better approximating 
growth in vivo. In combination with cryopreservation, this technique holds 
striking promise for cancer survivors at risk for reintroduction of the disease (if 
orthotopic transplantation was performed) (Xu M et al., 2009). The growth of 
frozen/thawed follicles and their cytoskeletal properties approximated those seen 
in non-cryopreserved follicles (Barrett SL et al., 2010). One day, a patient might 
have the entire continuum of oocyte development, from the primordial oocyte to 
the mature MII egg, take place in vitro, with only an embryo transferred back for 
attempted pregnancy. An interesting technique where cortical strips are 
(optionally cryopreserved) cultured in vitro first, and then maturing follicles are 
isolated for further culture (Fig. 4 ), has also been developed. Telfer et al in 2008 
have shown that a two-step procedure can result in the generation of large antral 
follicles. Cortical strips are first cultured intact, and then growing follicles are 
mechanically isolated and cultured singly potentially within a matrix as discussed 
earlier. This technique has the benefit of allowing follicles to grow surrounded by 
native ovarian tissue, potentially more like conditions in vivo. Further, it is likely 
that many of the growing follicles isolated will have started their growth in the 
primordial follicle stage. Primordial follicles are notoriously difficult to 
mechanically isolate, and their growth, first within the cortical strip, would help 
address this problem. Given the need for in vitro methodologies, we turn to recent 
advances in our understanding of the molecular control of follicle growth. If we 
can understand the mechanisms that control follicle growth to maturity, we will be 
able to optimize the above in vitro culture techniques. 
 
3.9 Potential applications of cryopreserved ovarian tissue 
 
3.9.1 Xenotransplantation 
At present, xenotransplantation of the ovarian tissue is the only grafting option 
described for endangered species. It has often been combined with ovarian tissue 
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cryopreservation, and in all models tested so far, good post-thaw survival of the 
graft and its primordial follicles were reported (Paris et al., 2004; Paris and 
Schlatt, 2007). Independent of the species-specific differences, host environment 
can support, in most tested cases, the resumption of ovarian function and 
subsequent follicular development. In a wide range of species, including 
wallabies, wombats, elephants, cats, dogs, pigs, cows and marmoset monkeys, the 
formation of antral-sized follicles has been reported and the oocytes looked 
morphologically healthy (reviewed by Paris et al., 2004). What is unknown is 
whether the oocytes following development in such a different host environment 
are still normal from a functional point of view, and further studies are needed to 
answer this question. Another limiting factor is that, at present, it is possible to 
grow antral follicles from a certain species within an immunocompromised host 
but not mature and fertilize them in the in vivo host environment. The oocyte is 
thus rescued, and then IVM and IVF are still needed before an embryo is available 
for transfer. This is a problem, as for many endangered species, IVM, IVF and 
embryo transfer technologies have not been yet developed and significant hurdles 
are currently still envisioned. In species where IVM and IVF are well-established 
procedures, the next step is to obtain live offspring following ovarian tissue 
xenotransplantation. At present, this has only been done bridging the concordant 
xenogenetic barrier from rats to mice (Snow et al., 2002). Ovarian 
xenotransplantation has other limitations given the only successful recipients that 
have been immunocompromised are rats and mice (Snow et al., 2002), which 
have to be housed under sterile, pathogen free conditions: the overall procedure 
(until the harvest of an antral follicle) is expensive and technically demanding. 
Moreover, since follicles from larger animals do not develop up to their normal 
size in small hosts (Nottola et al., 2008), such as immunodeficient mice, we do not 
know if they could have a healthy oocyte capable of fertilization. Other available 
approaches for ovarian transplantation, such as allotransplantation, have so far 
received little consideration for animal conservation. However, this may change if 
developments in the area of tolerance induction take place. In practice, this would 
mean that if a genetically valuable animal dies, the ovaries could be rescued and 
grafted to several young recipients, and offspring from this specific female 
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germline could be indirectly produced. Thus, close collaborations between zoo 
workers and researchers are needed to bridge these gaps in time. 
 
3.9.2 Fine control of human ovarian follicle development in vivo and in vitro 
There are two key features of follicle development relevant to fertility 
preservation: primordial follicle growth activation and subsequent growth and 
survival. Ensuring that a subset of the many primordial follicles in a given piece 
of ovarian cortex productively grow, and that a subset of growing follicles go on 
to survive and reach the preovulatory stage, will be required to treat patients in 
need. 
 
3.9.3 Follicular growth arrest 
New information is available about the mechanisms that enforce growth arrest 
within primordial follicles. In 2003, Castrillon et al. made a striking initial 
observation that knockout of the FoxO3a gene in mice results in the simultaneous 
growth activation of all primordial follicles. Thus began several studies to 
determine how the process is controlled by signals upstream of FoxO3a. The 
mTOR signaling pathway (Hay N et al., 2005; Wullschleger S et al., 2006) was 
then implicated as a critical regulator of the growth activation of primordial 
follicles (Liu L et al., 2007; Adhikari D et al., 2009; Adhikari D et al., 2010; 
Reddy P et al., 2010; Li  J et al., 2010) (Fig. 5). Increased mTOR activity is 
associated with protein translation, an active cell cycle, and tissue growth. When 
mTOR activity was increased specifically in the oocyte by using a tissue-specific 
knockout of its negative regulators Tsc1 or Tsc2, the entire pool of primordial 
follicles growth-activated around puberty. This resulted in nearly complete follicle 
loss by early adulthood, and thus POF. The importance of mTOR signaling in the 
control of primordial follicle growth activation was further confirmed by Li et al. 
Those investigators targeted the Phosphatase with TENsin homology deleted in 
chromosome 10 (PTEN) phosphatase, known to act as a negative regulator of 
mTOR signaling. Inhibition of PTEN, resulted in increased primordial follicle 
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growth activation in mouse and human ovarian grafts. This was consistent with 
the initial result with FoxO3a knockout mice (Castrillon DH et al., 2003), as 
PTEN inhibition was found to result in Fox03a export from the nucleus. 
Interestingly, the mTOR pathway has also been implicated in the control of the 
follicle growth and survival to preovulatory stages. 
 
Fig. 5: mTORC1 signaling 
 
3.9.4 Follicle growth and granulosa cell proliferation 
Signaling agents that control ovarian follicle growth, including follicle stimulating 
hormone (FSH) and members of the TGF- signaling family (Elvin JA et al., 2000; 
Chang H et al., 2001), are well known. Until recently, how the information from 
growth-stimulatory (and in some cases, growth inhibitory) factors is integrated 
within granulose cells was less clear. The mTOR pathway was an attractive 
candidate due to its function downstream of many growth factors, and the use of 
the mTOR specific inhibitor Rapamycin (red rectangle, Fig. 5) was found to 
antagonize mouse follicle growth in vitro at an accepted bioactive concentration, 
100nM (Yaba A et al., 2008). As these follicles were cultured in the presence of 
FSH, this suggests that mTOR may act downstream of known follicle growth 
factors to foster growth and maturation. Because mTOR has been shown to be a 
positive regulator of the cell cycle (Fig. 5) via interactions with aurora B kinase 
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(Song J et al., 2007), granulosa cell cycle control by mTOR could underlie the 
control of follicle growth. Interestingly, culture in highly dilute (0.01pM) 
Rapamycin resulted in enhanced follicle growth. Whether such treatment can 
enhance human follicle growth in vitro remains to be seen. 
 
4. Hydrogels: biomaterials mimicking the extracellular matrix 
Cells and tissues are routinely cultured in vitro on 2D substrates (Ni Y et Chen R, 
2009; Porro D et al., 2005; Zhang X et al., 2009). However, it has been 
demonstrated that cells or tissues cultured on 2D substrates (e.g., tissue culture 
plates or flasks) do not mimic cell growth in vivo, and fail to express certain 
tissue-specific genes and proteins at levels comparable to those found in vivo. For 
instance, it has been found that cell–drug interactions in a 2D culture system do 
not represent the actual working mechanism in vivo. Thus, 2D culture is not 
appropriate to be used in in vitro drug testing models. This is due to the fact that 
cells and tissues in vivo are immersed within a 3D network constituting a complex 
extracellular environment with a highly porous nanotopography, while a 2D 
culture system is too simple to mimic the native environment.  
 
Graph. 5: development of tissue engineering and hydrogels 
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From a tissue engineering (TE) standpoint, constructing a culture environment 
that closely mimicks the native tissue, which is composed of the extracellular 
matrix (ECM), soluble bioactive factors, and products of homo- and hetero-typical 
cell–cell interactions, is desirable to replicate tissue functions in vitro. However, 
this remains as one of the major challenges in TE, given the complexity of cell–
ECM interactions as well as multicellular architectural features such as repeating 
tissue units and proper vascular structure. Cells commit to their fate by deriving a 
vast amount of information from this environment. As a part of the cell 
environment, ECM has been the most emulated component in TE studies. In 
native tissue, ECM is mainly a mixture of two classes of macromolecules, 
glycosaminoglycans and fibrous proteins (e.g., collagen, elastin, fibronectin and 
laminin), which self-assemble into nanofibrillar supramolecular networks that fill 
the extracellular space between cells (Baker EL et al., 2009). ECM is a dynamic 
structure, which provides structural and anchoring support to the cells to improve 
tissue architecture. It also contributes to signaling, directing cell fate and function 
through cell–matrix interactions. In addition, the ECM is constantly remodeled by 
cells during development, homeostasis and wound healing by balancing its 
synthesis and degradation by a variety of enzymes (e.g., matrix 
metalloproteinases) (Hong H et al., 2007; Tibbitt MW et al., 2009). Significant 
advances in the design of artificial matrices have led to an evolution from a simple 
supporting scaffold to a more complex dynamic biomaterial environment. Ideally, 
the artificial matrices should: support cell growth and maintenance; provide 
appropriate mechanical, chemical and biological characteristics mimicking native 
ECM; and facilitate effective nutrient transfer, gas exchange (i.e., O2 and CO2), 
metabolic waste removal and signal transduction. Scaffolds in various forms, such 
as, hydrogel and nanofibers, have been studied and employed for different tissue 
regeneration purposes. A significant growth of interest in hydrogels started around 
the 1990s, partly due to the rapid emergence of the TE field, as hydrogels possess 
characteristics of native ECM (Du Y et al., 2008; Ling Y et al., 2007; Liu Tsang V 
et al., 2007; Khademhosseini A et al., 2007; Lutolf MP, 2009; Baroli B, 2007; 
Federovich NE et al., 2007; Jabbarzadeh E et al., 2008; Jay SM et Saltzman WM, 
2009; Peppas NA et al., 2006), paving the way for functional tissues (graph. 5) 
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(Burdick JA et Vunjak-Novakovic G, 2009; Mano JF et al., 2007; Seunarine K et 
al., 2006). The biocompatibility of various hydrogels (e.g., collagen, agarose and 
polyethylene glycol) is well characterized and the state-of-the-art nano- and 
microfabrication technologies (e.g., lithography, nano- and micro-fluidics, 
micromolding and biopatterning) provide the techniques to engineer scaffolds 
with intricate structures (Kopecek J, 2007; Saunders BR et al., 2009; Lee WH et 
al., 2009; Seidlits SK et al., 2008, Rodriguez-Cabello JC et al., 2006; 
Madurantakam PA et al., 2009). However, challenges remain when it comes to 
engineering functional tissues. Hydrogel-based cell-encapsulating constructs with 
embedded microchannels have recently been investigated, and became a 
promising tool to generate active tissue mimics by improving nutrient and gas 
transport. Such cell-encapsulating hydrogel platforms could be employed for other 
applications, such as in vitro models for drug testing and toxicological assays. 
Given the intricate nature of the problem, the ultimate success of all these 
applications requires an interdisciplinary approach involving engineering, 
chemistry, materials science and cell biology. 
 
4.1 Engineered hydrogel scaffolds as ECM mimics 
The efforts to engineer a cell microenvironment that mimics the dynamic native 
ECM have been driven by the clinical demand for tissue (or organ) repair and 
replacement (Slaughter BV et al., 2009). Construction of functional tissues relies 
on the structural environment, cell–biomaterial interactions and incorporated 
biological signals (e.g., growth factors encapsulated in hydrogels) (Kim BS et al., 
1998). Thus, the scaffolds must offer properties (i.e., mechanical and chemical) 
that lead to cellular function in a native manner. In this sense, hydrogels have 
advantages when utilized as scaffolds for TE as one can easily adjust their 
physico-chemical (electrical charge and pore size) (Schneider GB et al., 2004; 
Ford MC et al., 2006; Dadsetan M et al., 2008; Bryant SJ et al., 2007; Singh M et 
al., 2008), and mechanical (stiffness, tensile strength) (Anseth KS et al., 1996; 
Wenger MP et al., 2007) properties to levels that are desirable for tissue scaffolds 
(Choi NW et al., 2007; Tu C et al., 2003), cell encapsulation (Nicodemus GD et 
Introduction 
 
44 
 
Bryant SJ, 2008; Mcguigan AP et al., 2008; Tan W-H et Takeuchi S, 2007; Moon 
S et al., 2010), immobilization (Liu J et al., 2009) and drug delivery (Gao D et al., 
2008; Qiu Y et Park K, 2001; Soppimath KS et al., 2002; Kretlow JD et al., 2007). 
Hydrogels are 3D cross-linked insoluble, hydrophilic networks of polymers that 
partially resemble the physical characteristics of native ECM. Polymers in 
hydrogel format can absorb a large amount of water or biological fluid (up to 
99%) due to the presence of interconnected microscopic pores. Some hydrogels 
possess features of fluid transport and stimulus responsive characteristics (e.g., 
pH, temperature and light) (Bettinger CJ et al., 2005). Another appealing feature 
of hydrogels as scaffolds for TE is their biomechanical similarity to native ECM. 
The limitation of hydrogel mechanical properties is well known (Burdick JA, 
2009). A hydrogel with the desired mechanical properties (in terms of stiffness 
and tensile strength) can be achieved by adjusting various parameters including 
the type of polymers used, their concentrations and the crosslinking density. 
Biocompatible hydrogel scaffolds can be obtained by selecting biocompatible 
synthetic or natural polymers and crosslinkers (Rivest C et al., 2007). A variety of 
natural and synthetic polymers have been used to fabricate hydrogels. Collagen 
(Gillette BM et al., 2008), hyaluronic acid (Sahoo S et al., 2008), chondroitin 
sulfate (Li Q et al., 2004), fibrin (Eyrich D et al., 2007), fibronectin (Fukuda J et 
al., 2006), alginate (Smidsrod O et Skjak-Braek G, 1990), agarose, chitosan (Azab 
AK et al., 2006) and silk (Kim HJ et al., 2008) have been the most commonly 
used natural polymers for TE and regenerative medicine applications. Among all 
these natural polymers, collagen has been the most widely investigated since it is 
the most abundant structural protein of ECM in multiple tissues (Black LD et al., 
2008), including bladder (Bolland F et al., 2007), heart valve (Schenke-Layland K 
et al., 2003), blood vessel (Uchimura E et al., 2003), skin (Chen RN et al., 2004) 
and the liver (Lin P et al., 2004). Synthetic biodegradable polymers, such as 
poly(ethylene oxide) (PEO), poly(vinyl alcohol) (PVA), poly(acrylic acid) (PAA), 
poly(propylene furmarate-co-ethylene glycol) (P(PF-co-EG)), poly(ethylene 
glycol) (PEG) (Park Y et al., 2004), poly(lactic acid) (PLA), poly(glycolic acid) 
(PGA) (Hiraoka Y et al., 2003), and a copolymer poly(lactic-glycolic) acid 
(Uematsu K et al., 2005) have also been used for engineered scaffolds. To 
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increase the biological (e.g., hydrophilicity, cell-adhesiveness, degradability), 
biophysical (e.g., porosity, branched vasculature) and mechanical (e.g., stiffness, 
viscoelasticity) properties of tissue scaffolds, combinations of natural or synthetic 
hydrogels (i.e., hybrid hydrogels) have also been utilized (Chen GP et al., 2004). 
Such „bioartificial‟ scaffolds possess desirable mechanical properties and 
biocompatibility due to the coexistence of both synthetic and biological 
components. The biological properties of such scaffolds can further be improved 
by surface chemistry as the biomaterial composition makes them amenable to 
surface modification and biomimetic coatings (Savina IN et al., 2009; Teo WE et 
al., 2006; Hasirci V et al., 2006). Several approaches have been utilized to 
examine the mechanical (e.g., tension, compression, indentation, swelling) 
(Ahearne M et al., 2008; Ahearne M et al., 2005) and physicochemical (e.g., 
porosity, interconnectivity) properties of both natural and synthetic hydrogels, 
including extensiometry (Drury JL et Mooney DJ, 2003), compression test (Awad 
HA et al., 2004) and bulge test. However, these techniques are invasive and 
destructive. They are not appropriate to characterize mechanical properties of cell 
encapsulating hydrogels during culture. To overcome these specific problems, two 
techniques involving spherical indentation have been developed (Ahearne M et 
al., 2009); long focal microscopybased spherical microindentation and optical-
coherence tomography-based spherical microindentation techniques. Both 
monitoring techniques can be utilized to determine the mechanical properties of 
cell-encapsulating hydrogels for in vitro engineering of soft tissues. While the 
former involves the central indention of a circumferentially suspended hydrogel 
using a sphere of a known weight and measurement of the resulting central 
deformation displacement, the latter is a noninvasive imaging technique based on 
Hertz contact theory, where the depth of indentation of a sphere into a hydrogel 
resting on a substrate can be used to calculate the mechanical properties of the 
hydrogel.  
 
 
 
Introduction 
 
46 
 
4.2 Properties of hydrogels 
 
4.2.1 Synthetic materials   
Synthetic hydrogels are appealing for tissue engineering because their chemistry 
and properties are controllable and reproducible. For example, synthetic polymers 
can be reproducibly produced with specific molecular weights, block structures, 
degradable linkages, and crosslinking modes. These properties in turn, determine 
gel formation dynamics, crosslinking density, and material mechanical and 
degradation properties. PEO is currently FDA approved for several medical 
applications and is one of the most commonly applied synthetic hydrogel 
polymers for tissue engineering. PEO and the chemically similar poly(ethylene 
glycol) (PEG) are hydrophilic polymers, that can be photocrosslinked by 
modifying each end of the polymer with either acrylates or methacrylates (Cruise 
GM et al., 1998; West JL et Hubbell JA, 1999; Mann BK et al., 2001). Hydrogels 
are then formed when the modified PEO or PEG is mixed with the appropriate 
photoinitiator and crosslinked via UV exposure (Bryant SJ et Anseth KS, 2001). 
Thermally reversible hydrogels have also been formed from block copolymers of 
PEO and poly(l-lactic acid) (PLLA) (Jeong B et al., 1997) and PEG and PLLA 
(Huh KM et Bae YH, 1999). In addition to the thermally reversible hydrogels, 
degradable PEO and PEG hydrogels have been formed by synthesizing block 
copolymers containing hydrolytically degradable poly(lactic acid) (PLA) (Metters 
AT et al., 2000) and enzyme specific cleavage sequences of oligopeptides. 
Another synthetic hydrophilic polymer widely explored for use in space filling 
and drug delivery applications is PVA. It can be physically crosslinked by 
repeated freeze-thawing cycles of aqueous polymer solutions (Cascone MG et al., 
1995) or chemically crosslinked with glutaraldehyde (Nuttelman CR et al., 2001), 
succinyl chloride, adipoyl chloride, and sebacoyl chloride (Orienti I et al., 2001) 
to form hydrogels. It can also be blended with other water-soluble polymers and 
again crosslinked either physically or chemically (Cascone MG et al., 2001; 
Cauich-Rodriguez JV et al., 1996; Cauich-Rodriguez JV et al., 2001). It these 
forms, it is not dissolvable in aqueous solutions. A newer, synthetic hydrogel 
block copolymer, P(PFco- EG) has been created for use as an injectable carrier for 
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bone and blood vessel engineering (Suggs LJ et Mikos AG, 1999). The 
homopolymer poly(propylene fumarate) (PPF) is a hydrophobic, linear polyester 
which undergoes degradation by hydrolysis of the ester linkage. It can form 
hydrogels when synthesized as a block copolymer with hydrophilic PEG and 
crosslinked either chemically (Suggs LJ et al., 1999) or via UV exposure (He S et 
al., 2000). 
 
4.2.2 Naturally derived materials 
Naturally derived hydrogel forming polymers have frequently been used in tissue 
engineering applications because they are either components of or have 
macromolecular properties similar to the natural ECM. For example, collagens are 
the main protein of mammalian tissue ECM and comprise 25% of the total protein 
mass of most mammals (Alberts B et al., 1994; Lee CH et al., 2001) . Similarly, 
HA is found in varying amounts in all tissues of adult animals. Like HA, both 
alginate and chitosan are hydrophilic, linear polysaccharides (SmidsrǾd O et 
Skjak-Bræk G, 1990; Suh J-KF et Matthew HWT, 2000). They have also been 
shown to interact in a favorable manner in vivo and thus have been utilized as 
hydrogel scaffold materials for tissue engineering.  
Collagen is an attractive material for biomedical applications as it is the most 
abundant protein in mammalian tissues and is the main component of natural 
ECM. There are at least 19 different types of collagen, but the basic structure of 
all collagen is composed of three polypeptide chains, which wrap around one 
another to form a three-stranded rope structure. The strands are held together by 
both hydrogen and covalent bonds. Collagen strands can self aggregate to form 
stable fibers. In addition, collagen fibers and scaffolds can be created and their 
mechanical properties enhanced by introducing various chemical crosslinkers (i.e. 
glutaraldehyde, formaldehyde, carbodiimide) (Lee CR et al., 2001; Park S-N et 
al., 2002), by crosslinking with physical treatments (i.e. UV irradiation, freeze-
drying, heating) (Schoof H et al., 2001), and by blending it with other polymers 
(i.e. HA, PLA, poly(glycolic acid) (PGA), poly(lactic-coglycolic acid) (PLGA), 
chitosan, PEO) (Tan W et al., 2001; Chen G et al., 2001; Huang L et al., 2001). 
Collagen is naturally degraded by metalloproteases, specifically collagenase, and 
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serine proteases, allowing for its degradation to be locally controlled by cells 
present in the engineered tissue. HA is the simplest glycosaminolglycan (GAG) 
and is found in nearly every mammalian tissue and fluid. It is especially prevalent 
during wound healing and in the synovial fluid of joints. It is a linear 
polysaccharide composed of a repeating disaccharide of (1–3) and (1–4)-linked b-
d-glucuronic acid and N-acetyl-b-dglucosamine units. Hydrogels of HA are 
formed by covalent crosslinking with hydrazide derivatives (Vercruysse KP et al., 
1997; Prestwich GD et al., 1998; Oerther S et al., 2000), by esterification 
(Mensitieri M et al., 1996, Borzacchiello A et Ambrosio L, 2001; Gamini A et al., 
2002), and by annealing (Fujiwara J et al., 2000). Additionally, HA has been 
combined with both collagen and alginate to form composite hydrogels (Oerther S 
et al., 1999; Miralles G et al., 2001). HA is naturally degraded by hyaluronidase, 
again allowing cells in the body to regulate the clearance of the material in a 
localized manner. Alginate has been used in a variety of medical applications 
including cell encapsulation and drug stabilization and delivery, because it gels 
under gentle conditions, has low toxicity, and is readily available. It is a linear 
polysaccharide copolymer of (1–4)-linked b-d mannuronic acid (M) and a-l-
guluronic acid (G) monomers, and is derived primarily from brown seaweed and 
bacteria (Johnson FA et al., 1997). Within the alginate polymer, the M and G 
monomers are sequentially distributed in either repeating or alternating blocks 
(Draget KI et al., 2000). The amount and distribution of each monomer depends 
on the species, location, and age of seaweed from which the alginate is isolated. 
Gels are formed when divalent cations such as Ca
2+
, Ba
2+
, or Sr
2+
 cooperatively 
interact with blocks of G monomers to form ionic bridges between different 
polymer chains. The crosslinking density and thus mechanical properties and pore 
size of the ionically crosslinked gels can be readily manipulated by varying the M 
to G ratio and molecular weight of the polymer chain. Gels can also be formed by 
covalently crosslinking alginate with adipic hydrazide and PEG using standard 
carbodiimide chemistry (Eiselt P et al., 1999; Lee KY et al., 2000). Ionically 
crosslinked alginate hydrogels do not specifically degrade but undergo slow, 
uncontrolled dissolution. Mass is lost through ion exchange of calcium followed 
by dissociation of individual chains, which results in loss of mechanical stiffness 
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over time (Le Roux MA et al., 1999). Hydrolytically degradable forms of alginate 
have been synthesized by partial oxidation of alginate and an alginate derivative, 
polyguluronate (Bouhadir KH et al., 1999), to form oxidized alginate (Bouhadir 
KH et al., 2001) and poly (aldehyde guluronate) (PAG) (Lee KY et al., 2000), 
respectively.   
Chitosan has been investigated for a variety of tissue engineering applications 
because it is structurally similar to naturally occurring GAGs and is degradable by 
enzymes in humans. It is a linear polysaccharide of (1–4)-linked d-glucosamine 
and N-acetyl-d-glucosamine residues derived from chitin, which is found in 
arthropod exoskeletons (Zhang Y et Zhang M, 2001; VandeVord PJ et al., 2002). 
The degree of N-deacetylation usually varies from 50% to 90% and determines 
the crystallinity, which is greatest for 0% and 100% N-deacetylation. Chitosan is 
soluble in dilute acids which protonate the free amino groups (Chenite A et al., 
2000). Once dissolved, chitosan can be gelled by increasing the pH or extruding 
the solution into a nonsolvent. Chitosan derivatives and blends have also been 
gelled via glutaraldehyde crosslinking (Mi F-L et al., 2000; Shen F et al., 2000), 
UV irradiation (Ono K et al., 2000), and thermal variations. Chitosan is degraded 
by lysozyme; the kinetics of degradation are inversely related to the degree of 
crystallinity (Lee KY et al., 1995; Varum KM et al., 1996; Tomihata K et al., 
1997). 
 
4.2.3 Scaffold design variables 
Selection or synthesis of the appropriate hydrogel scaffold materials is governed 
by the physical property, the mass transport property, and the biological 
interaction requirements of each specific application. These properties or design 
variables are specified by the intended scaffold application and environment into 
which the scaffold will be placed. For example, scaffolds designed to encapsulate 
cells must be capable of being gelled without damaging the cells, must be 
nontoxic to the cells and the surrounding tissue after gelling, must allow 
appropriate diffusion of nutrients and metabolites to and from the encapsulated 
cells and surrounding tissue, and require sufficient mechanical integrity and 
Introduction 
 
50 
 
strength to withstand manipulations associated with implantation and in vivo 
existence (Lim F, 1984). Here, the defined physical properties include mechanical 
strength and gel formation dynamics, while diffusion requirements specify the 
mass transport properties. In addition, the biological properties are designated by 
the required non-toxicity. What follows are definitions and discussions of the 
physical, mass transport, and biological design variables relevant to the design of 
hydrogel scaffolds for tissue engineering. 
 
4.3 Physical properties 
Many scaffolds for tissue engineering initially fill a space otherwise occupied by 
natural tissue, and then provide a framework by which that tissue may be 
regenerated. In this capacity, the physical properties of the material are inherent to 
the success of the scaffold. Specific physical properties include gel formation 
mechanisms and dynamics, mechanical characteristics, and degradation behavior. 
In hydrogels, these properties are prescribed by the intrinsic properties of the main 
chain polymer and the crosslinking characteristics (i.e. amount, type, and size of 
crosslinking molecules), as well as environmental conditions. Gel formation 
mechanisms and dynamics dictate how molecules and cells are incorporated into a 
scaffold and how that scaffold is then delivered. Common fabrication processes 
and reagents such as temperature increases, pH changes, and various solvents can 
denature proteins (Creighton TE,1993) and cause cell damage or death. One 
approach to bypass this issue is to process the material and create a scaffold prior 
to incorporating bioactive molecules and cells. However, an exciting feature of 
many hydrogels is their ability to be mixed with cells and molecules prior to 
injection and in vivo gel formation. Injectable, in vivo gelling forms of alginate 
(Paige KT et al., 1995; Marler JJ et al., 2000; Alsberg E et al., 2001; Lee KY et 
al., 2001), PEO (Elisseeff J et al., 1999), chitosan, and P(PF-co-EG) have all been 
successfully combined with cells and/or bioactive molecules and delivered in a 
minimally invasive manner. The success of this approach depends on the ability to 
control both pre- and post-gel properties including gel formation rates and liquid 
flow properties. Once the scaffold is produced and placed, formation of tissues 
with desirable properties relies on scaffold material mechanical properties on both 
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the macroscopic and the microscopic level. Macroscopically, the scaffold must 
bear loads to provide stability to the tissues as it forms and to fulfill its volume 
maintenance function. On the microscopic level, evidence suggests that cell 
growth and differentiation and ultimate tissue formation are dependent on 
mechanical input to the cells (Kim B-S et al., 1999; Butler DL et al., 2000; Cowin 
SC, 2000; Sikavitsas VI et al., 2001). As a consequence, the scaffold must be able 
to both withstand specific loads and transmit them in an appropriate manner to the 
surrounding cells and tissues. Adequate mechanical performance of a scaffold 
depends on specifying, characterizing, and controlling the material mechanical 
properties including elasticity, compressibility, viscoelastic behavior, tensile 
strength, and failure strain. For hydrogels, these properties are affected by 
polymer and crosslinker characteristics, gelling conditions (e.g. temperature and 
pH), swelling, and degradation (Anseth KS et al., 1996). For example, the 
mechanical strength and compression modulus of alginate hydrogels increase with 
increasing ratios of G to M subunits as well as increasing lengths of G blocks. In 
addition, increasing the volume fraction of alginate from 1% to 3% results in an 
increase in both the compression modulus and equilibrium shear modulus. Similar 
increases in compression modulus were observed for PEG gels when the weight 
fraction of PEG was increased from 10% to 40% (Bryant SJ et Anseth KS, 2002) 
and for PVA hydrogels (Stammen JA et al., 2001). Hydrogel mechanical 
properties are also affected by the crosslinker type and density. The mechanical 
strength of ionically crosslinked alginate hydrogels increases when the ion 
concentration is increased and when divalent ions that have a higher affinity for 
alginate are used for crosslinking. Similarly, the mechanical shear modulus of 
covalently crosslinked alginate is dependent on the crosslinker density. In addition 
to the polymer and crosslinker characteristics, gel swelling usually results in a 
decrease in the mechanical strength of hydrogels. However, the mechanical 
properties and swelling have been independently controlled in covalently 
crosslinked alginate hydrogels by varying both the crosslinker type and density. 
Hydrogel degradation and dissolution usually lead to a weakening of the gels 
unless tissue in growth acts to strengthen them or these properties are decoupled. 
The desired kinetics for scaffold degradation depends on the tissue engineering 
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application. Degradation is essential in many small and large molecule release 
applications and in functional tissue regeneration applications. However, it may 
not be warranted if the application is related to cell encapsulation for 
immunoisolation. Ideally, the rate of scaffold degradation should mirror the rate 
of new tissue formation or be adequate for the controlled release of bioactive 
molecules. Thus, it is important to understand and control both the mechanism 
and the rate by which each material is degraded. For hydrogels, there are three 
basic degradation mechanisms: hydrolysis, enzymatic cleavage, and dissolution. 
Most of the synthetic hydrogels are degraded through hydrolysis of ester linkages 
(Saito N et al., 2001). As hydrolysis occurs at a constant ratein vivo and in vitro, 
the degradation rate of hydrolytically labile gels (e.g. PEG-PLA copolymer) can 
be manipulated by the composition of the material but not the environment. As 
discussed in the materials section above, collagen, HA, and chitosan are all 
degraded by enzymatic action. Synthetic linkages have also been introduced into 
PEO to render it susceptible to enzymatic degradation. The rate of enzymatic 
degradation will depend both on the number of cleavage sites in the polymer and 
the amount of available enzymes in the scaffold environment (West JL et al., 
1999; Mann BK et al., 2001). Ionically crosslinked alginate normally undergoes 
dissolution, but can also undergo controlled hydrolysis after partial oxidization. 
The rate of dissolution of ionically crosslinked alginate depends on the ionic 
environment in which the scaffold is placed (LeRoux MA et al., 1999). 
 
4.4 Mass transport properties 
The success of scaffolds for tissue engineering are typically coupled to the 
appropriate transport of gases, nutrients, proteins, cells, and waste products into, 
out of, and/or within the scaffold. Here, the primary mass transport property of 
interest, at least initially, is diffusion. In a scaffold, the rate and distance a 
molecule diffuses depend on both the material and molecule characteristics and 
interactions. Gel properties such as polymer fraction, polymer size, and 
crosslinker concentration determine the gels nanoporous structure (Lu S et Anseth 
KS Lu S, Anseth KS, 2000). As a consequence, diffusion rates will be affected by 
the molecular weight and size of the diffusion species (defined by Stokes radii) 
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compared to these pores. For example, molecules such as glucose, oxygen, and 
vitamin B12, with molecular weights less than 1300 Da and Stokes radii less than 
1 nm, are able to freely diffuse into and from ionically crosslinked alginate 
microspheres (Tanaka H et al., 1984; Li RH et al., 1996). However, higher 
molecular weight molecules, including myoglobin, albumin, and fibrinogen are 
not able to freely diffuse, and their rate of diffusion is further decreased by 
increases in alginate concentration, in Ca
2+
 concentration, and/or in extent of 
gellation. The diffusion rates of molecules through glutaraldehyde crosslinked 
chitosan gels are also decreased when the crosslinker concentration is increased. 
For PEO hydrogels the size and molecular weight of molecules that are able to 
diffuse and the rate at which they diffuse both increase as functions of increasing 
polymer molecular weight and hydrolysable linkages. Interestingly, for alginate 
and likely other charged polymers, the diffusion rates of charged molecules are 
not solely size-dependent (Stewart WW et Swaisgood HE, 1993). Rather, they are 
also affected by charge interactions with the negatively charged alginate chains. 
Ultimately, diffusion requirements and subsequent material choice depend on the 
scaffold application. In the case of small and large molecule delivery, limiting free 
diffusion out of the scaffold may be a priority. In contrast, enhancing the supply 
of oxygen and nutrients and the removal of waste products is essential to the 
survival of implanted cells. In vivo, most cells exist within 100 mm of a capillary 
(Vander AJ et al., 1990), and diffusion is usually adequate for cell and tissue 
survival over this distance. However, for larger distances, other means of transport 
(e.g. simultaneous angiogenesis) must be incorporated. 
 
4.5 Biological properties 
Materials used to form gels engineered to exist in the body must simultaneously 
promote desirable cellular functions for a specific application (i.e. adherence, 
proliferation, differentiation) and tissue development, while not eliciting a severe 
and chronic inflammatory response. Hydrogel forming polymers are generally 
designed to be non toxic to the cells they are delivering and to the surrounding 
tissue. Both collagen and HA are major components of the native ECM and 
tissues (Alberts B et al., 1994; Lee CH et al., 2001). Both should theoretically 
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interact favorably with the body, provided that they have not been contaminated 
during processing and that there are no cross-species immunological issues (both 
are typically derived from bovine sources). PEO is currently FDA approved for 
many medical applications, while P(PF-co- EG) has been shown to be slightly 
toxic to cultured cells in vitro and to not induce a significant inflammatory 
response in vivo (Suggs LJ et al., 1999). Chitosan has also been shown to be 
nontoxic despite its chemotaxic effect on neutrophils (Lee KY et al., 1995; Ueno 
H et al., 2001). For alginate, it was thought that high M content induced an 
immune response, but recent data suggest that contaminants were the more likely 
cause of the response (Klock G et al., 1997). When purified, alginate is relatively 
immune quiescent; however, the purity of commercially available alginate 
continues to be a problem (Zhang WJ et al., 2001). While many hydrogels are non 
toxic and do not activate a chronic immune response, they also do not readily 
promote cellular adhesion and function. With the exception of collagen, which is a 
natural ECM protein, most cells do not have receptors to hydrogel forming 
polymers and thus cannot adhere. Furthermore, because of the hydrophilic nature 
of hydrogels, ECM proteins such as laminin, fibronectin, and vitronectin typically 
do not readily absorb to the gel surface (West JL et Hubbell JA, 1997). This fact 
has been exploited in the application of post-operative adhesion barriers (West JL 
et al., 1996) and in the design of specific adhesion surfaces (Hubbell JA, 1990). A 
common approach to design a highly specific adhesive surface is to covalently 
couple an entire ECM protein or peptide sequences capable of binding to cellular 
receptors (Rowley JA et al., 1999) to the polymer. The most common peptide 
used in this approach is the amino acid sequence arginine–glycine–aspartic acid 
(abbreviated Arg–Gly–Asp or more commonly, RGD), derived from numerous 
ECM proteins including fibronectin, laminin, vitronectin, and collagen. Other 
common peptides include arginine–glutamic acid–aspartic acid–valine (REDV) 
(from fibronectin), tyrosine–isoleucine–glycine–serine–arginine (YIGSR) (from 
laminin), and isoleucine–lysine–valine–alanine–valine (IKVAV) (from laminin). 
Most cell types are able to bind to RGD, thus both alginate and PEG (Hern DL et 
Hubbell JA, 1998; Mann BK et al., 2001) have been modified with this peptide to 
promote cellular adhesion. In an alternative approach, PVA was modified with the 
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complete fibronectin protein to promote cell adhesion. Growth factor tethering 
and incorporation are other avenues available by which hydrogels can be modified 
to regulate the functions of interacting cells. As with adhesion proteins and 
peptides, growth factors and growth factor derived peptides have been covalently 
attached to hydrogel polymers. For example, transforming growth factor-b (TGF-
b) was tethered to PEG to enhance smooth muscle cell ECM production (Mann 
BK et al., 2001). Alternatively, an oligopeptide derived from bone morphogenetic 
protein-2 (BMP-2) was covalently attached to alginate to promote osteoblast 
migration into gels and subsequent calcification of the scaffolds (Suzuki Y et al., 
2000). Multiple factors may also be incorporated into hydrogels to manipulate 
tissue formation (Elisseeff J et al., 2001). 
 
 
5. In vitro culture of isolated follicles 
 
5.1 Importance of maintaining of follicular architecture  
Folliculogenesis within the ovary is a complex process requiring interaction 
between somatic cell components and the oocyte. At birth the human ovary 
contains 1-2 million primordial follicles, each containing an oocyte in meiotic 
arrest at the prophase stage (Baker TG, 1963). The oocyte is surrounded by a layer 
of somatic granulosa cells. Follicular growth from the primordial to the pre-
ovulatory stage occurs in two distinct stages. The first growth phase occurs very 
slowly and is not directly dependent on gonadotrophin levels (Abir R, 2006). 
There is proliferation of the granaulosa cell layer surrounding the oocyte and an 
increase in both follicle and oocyte diameter. This stage can take weeks in rodents 
and months in larger animal species, including humans. In the human, follicles 
increase in size from 30-50 μm in primordial resting follicles, to 100-200 μm in 
pre-antral follicles (Gosden RG et al., 1993). The second phase of follicular 
growth is far more rapid and culminates with the ovulation of a mature oocyte. 
Follicles are now responsive to follicle stimulating hormone (FSH) and luteinizing 
hormone (LH). The formation of a fluid filled antrum and synthesis of steroid 
hormones marks the transition to the antral phase of follicle development. Human 
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follicles are over 18 mm when they reach the pre-ovulatory or Graafian stage and 
the oocyte is close to its final size, around 120 μM (Griffin J et al., 2006). The 
multi-layer follicle is now surrounded by a basement membrane that separates it 
from the underlying vascularized thecal cell layer. Oocyte growth and cytoplasmic 
meiotic competence are dependent on the gap junctions between the oocyte and 
the granulosa cells (Carabatsos MJ et al., 2000). Knock out mice lacking the gene 
encoding for gap junction protein connexin-37 have impaired folliculogenesis 
(Simon AM et al., 1997). The gap junctions connecting the granulosa cells and the 
oocyte enable sharing of secreted paracrine factors that promote the growth of 
both cell types (Eppig JJ et Schroeder AC, 1989; Herlands RL et Schultz RM, 
1984; Murray A et Spears N, 2000; Diaz FJ et al., 2007) (reviewed in Buccione R 
et al., 1990; Su YQ et al., 2009). Evidence suggests that granulosa cell 
proliferation and certain metabolic processes are controlled by oocyte-derived 
secretions (Eppig JJ et al., 2005). The oocyte is unable to transport certain amino 
acids, carry out glycolysis and cholesterol biosynthesis without the cooperation of 
granulosa cells in providing necessary factors (Eppig JJ, 1991). The oocyte 
overcomes these metabolic deficiencies by stimulating expression of specific 
genes in the cumulus cells that control synthesis of enzymes and amino acids that 
it needs. Severing of the gap junction and intercellular communication during in 
vitro culture triggers premature ovulation and eventual degeneration of the 
released oocyte. Maintenance of the intricate 3-D architecture and granulosa-
oocyte interaction may therefore be critical for successful in vitro maturation of 
follicles. In conventional 2-dimensional (2-D) tissue culture systems, the follicle 
tends to flatten and granulosa cells surrounding and nurturing the growing oocyte, 
migrate away, leaving it naked and unable to complete the maturation process 
(West ER et al., 2007). This is especially true when dealing with human 
primordial follicles, which may need as long as three months in culture (Gougeon 
A, 1986). 
 
5.2 Culture systems for follicle growth 2-D versus 3-D 
The majority of early and ground breaking work on in vitro follicle culture was 
undertaken using conventional 2-D culture methodology. Pre-antral follicle 
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growth in multi-well plates as well as in microdrop culture (Nation A et Selwood 
L, 2009; Cortvrindt R et al., 1996; Adam AA et al., 2004; Mousset-Simeon N et 
al., 2005) yields mature oocytes. Eppig and Schroeder were able to achieve live 
births after in vitro maturation of mouse pre-antral follicles on a collagen 
impregnated gel and in vitro fertilization of the IVM oocytes. By including eight 
days of in situ culture of the intact newborn mouse ovary, the same collagen 
culture methodology could also be used to successfully mature primordial follicles 
and produce live offspring (Eppig JJ et O‟Brien MJ, 1996). Other 2-D systems 
used for follicle culture include membranes coated with extracellular matrix 
proteins (Oktem O et Oktay K, 2007; Hovatta O et al., 1997; Berkholtz CB et al., 
2006; Figueiredo JR et al., 1995). Despite the successes achieved with these 2D 
systems, they have been sub-optimal for sustained culture of cow, sheep and 
human follicles (reviewed in West ER et al., 2007). Culture on treated membranes 
or tissue culture substrata, impedes preservation of the spatial arrangements of 
cells seen in vivo. Follicular flattening due to granulosa cell attachment to the 
tissue culture vessel is problematic making the follicle complex extremely 
vulnerable to disruption of gap junctions. With enzymatic follicle isolation 
techniques, perturbation of the basal lamina surrounding the follicle can lead to 
granulose cell migration away from the oocyte. Establishing an in vitro culture 
model that can more accurately mimic the in vivo ovarian growth environment 
has therefore been the focus of much research. To this end, a tissue 
bioengineering approach has attracted much interest. The recognition of the 
importance of spatial arrangements between cells has spurred research in to 3-D 
culture systems. Data from a variety of different cellular models indicate that 3-D 
culture modulates cell behavior, growth, secretions, response to stimuli and 
communication with surrounding cells. In a landmark study, investigators were 
able to block the cell surface receptor b-1 integrin and completely alter the 
behavior of breast cancer cells grown in 3-D culture, in a manner never observed 
during conventional 2-D culture (Weaver VM et al., 1996; Bissell MJ et al., 
2003). Others have noted that the gene expression profile of cells grown in 3-D 
culture more closely resembles that seen in vivo (Hwa AJ et al., 2007) and 
distinctly differs from that found after conventional 2-D culture. In addition to the 
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spatial arrangement of the cells it is becoming increasingly evident that the 
extracellular matrix support structure (ECM) plays a defining role in organizing 
communication between cells, controlling cell differentiation and modulating 
response to biochemical signals from the cellular microenvironment (reviewed in 
Griffith LG et Swartz MA, 2006). Scaffolding, matrix proteins and 3-D culture 
systems to maintain follicular architecture are avenues of research currently being 
explored by numerous investigators to gain further insight on the growth 
requirements of follicles. These 3-D systems are characterized by their ability to 
maintain the spherical morphology of the ovarian follicle and preserve the critical 
cell-cell and cell-matrix interactions within the surrounding stromal tissue, 
thereby allowing follicles to successfully complete the maturation process. Figure 
4 depicts growth of pre-antral follicles in a 2-D vs 3-D culture system. 
Encapsulation of follicles may protect them from gap junction disruption through 
shear stress (Heise M et al., 2005; Heise MK et al, 2009) and may preserve 
expression of the gene encoding for the gap-junction protein connexin (De Paola 
N et al., 1999). Contiguous assembly of granulosa cells around the oocyte also 
prevents the follicles from undergoing premature ovulation (Xu M et al., 2006). 
Another advantage may be that trophic factors released by granulosa cells remain 
in close proximity to the oocyte exerting a positive effect on oogenesis and 
possibly fostering new local gap junctions. This is an advantage not shared by 2-D 
culture vessels where the volume of medium in culture vessels and polarization of 
granulosa cells towards the culture substrata may result in a more diffuse and less 
uniform exposure to secreted factors. Despite the potential advantages with 3-D 
culture, there is still a good deal of controversy as to how best to achieve such a 
culture system. The questions revolve around the type of biomaterials available, 
their characteristics, permeability, toxicity and ability to be molded and handled 
with ease during follicle loading and harvest. In addition, their biologically 
usefulness ultimately depends on survival of the follicle and maturation of the 
oocyte in vitro. The animal species and the length of time needed for follicular 
culture also warrant consideration in determining whether 3-D culture will be 
beneficial. In humans, in vitro follicle maturation from primary to the antral stage 
can take more than 120 days (Eppig JJ, 1991), in contrast to 30 or so days for 
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follicle maturation in rodent species (reviewed in McGee EA et Hsueh AJ, 2000). 
Moreover, by the early antral stage human follicles measure 2-5 mm in diameter. 
Active perfusion systems may therefore prove necessary to assure sufficient 
nutrient supply to multilayered follicles if cultured in a 3-D environment. 
 
5.3 Design parameters for biomaterials for 3-D culture 
Chemical and physical properties of biomaterials present certain design 
limitations that must be meshed with the physiologic needs of the follicular unit. 
First and foremost, the chemical composition must be non-cytotoxic, allowing 
sustained cell viability for extended culture periods. Growth of follicular diameter 
during the course of in vitro maturation dictates materials with a certain amount of 
elasticity allowing expansion of the granulose cell layers, yet providing enough 
support to retain spherical shape and prevent inadvertent denudation of the oocyte. 
This is especially important in 3-D culture systems that physically encapsulate the 
follicle within a biomaterial. In addition to maintaining structural integrity, this 
biomaterial must allow adequate gas exchange, diffusion of nutrients and removal 
of cellular waste. Within the ovary there is an increase in vascularization as one 
moves deeper in to the ovarian cortex where secondary and pre-antral follicles 
grow (van Wezel IL et Rodgers RJ, 1996). This suggests a stronger need for 
oxygen diffusion during the final stages of follicle maturation. The need for 
oxygenation may also require an active perfusion system when dealing with 
longer in vitro maturation intervals. Diffusion across the biomaterial during 3-D 
culture is controlled by creating specific pore sizes (Eiselt P et al., 2000). The 
mechanical properties of the biomaterial, such as viscosity and its ability to be 
molded also contribute to its usefulness for follicle culture and are dependent on 
molecular weight (Wee S et Gombotz WR, 1998). Another important attribute is 
the biomaterial‟s rigidity, also referred to as shear modulus. The shear modulus of 
a biomaterial is a mathematical description of its elastic properties-that is its 
ability to resist deformation with the application of a force. Biomaterial rigidity 
and its effect on follicle diameter, theca formation, antrum formation, estradiol 
production, and rate of meiotic resumption (GVBD and metaphase II oocyte 
formation) can all be used to compare outcomes with follicle encapsulation in 3-D 
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culture models (Kong HJ et al., 2004; West ER et al., 2007; Xu M et al., 2006). 
The ideal biomaterial for in vitro follicle maturation would also be one that could 
mimic the extracellular matrix (ECM) found within the ovary (Abbott A, 2003). It 
has been suggested that since ovarian stromal composition can vary, the selected 
ECM for follicle culture should ideally share the inherent properties of the 
particular species being cultured (Xu M et al., 2009). A final consideration is 
whether to individually or coculture follicles. Culturing follicles in clusters allows 
sharing of autocrine/paracrine secretions, increasing follicle-to-follicle 
communication and possibly enhancing the culture environment (Hovatta O et al., 
1999). However, some disadvantages of co-culture systems include the potential 
sharing of growth-inhibiting hormones, like AMH (anti-Mullerian hormone), 
amongst follicles (Durlinger AL et al., 1999). Also co-culture can interfere with 
the monitoring, tracking and harvesting of individual follicles during the 
maturation process. 
 
 
5.4 Current 3-D culture models 
 
5.4.1 In situ culture 
In vitro culture of ovarian tissue pieces as a technique for in situ 3-D follicle 
maturation has not been very effective. While primordial follicle growth can be 
supported in this manner, development of follicles past the pre-antral stage is 
inhibited. To obtain complete in vitro maturation of follicles and the release of a 
metaphase II oocyte it is necessary to remove the follicle from the ovarian cortex 
(Abir R et al., 2001; Telfer EE et al., 2008). Two-step culture systems in which 
follicles are first grown from the primordial stage in situ and then mechanically or 
enzymatically isolated and grown in vitro have been investigated with mouse as 
well as human ovarian tissue. Models for human in vitro follicle maturation from 
primordial or even pre-antral stages to a mature oocyte are still in the early phase. 
Recently, Li and colleagues were able to induce maturation of primordial follicles 
in ovarian tissue fragments from cancer patients. Human ovarian tissue fragments 
were treated with PTEN gene inhibitor and transplanted to immunodeficient mice 
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(Li J et al., 2010). The PTEN (phosphatase and tensin homolog) gene plays a 
pivotal role in cell regulation and apoptosis. Interestingly, in this study, inhibition 
of the PTEN gene allowed primordial follicles to advance to the pre-ovulatory 
stage. The ability to activate dormant ovarian follicles may play a pivotal role in 
establishing a successful in vitro culture model for maturing primordial follicles. 
A much deeper understanding of factors regulating human folliculogenesis is still 
needed to successfully mature human follicles to the Graafian stage and to be able 
to assess fertilization potential. Progress in this arena may well depend on 
establishing adequate 3-D culture systems that preserve the normal follicular 
architecture and allow extended in vitro culture intervals. 
 
5.4.2 Matrices for follicle culture 
Synthetic and biologic matrices for the support of follicle growth and maturation 
have been studied in several animal models as well as in humans. Table 4 presents 
various 3-D systems and matrices that have been applied to the culture of rodent 
pre-antral follicles.  
 
Table 4: studies examining matrices for 3D culture of pre-antral ovarian follicles from rodents 
 
Table 5 summarizes 3-D culture models for follicles from larger animals, primates 
and humans. All of the matrices adopted for 3-D culture essentially permit 
spherical growth of the follicle, preserving the physical integrity of granulosa cell 
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and oocyte‟s interaction. Nayadu et al in 1992 accomplished this using a Millicell 
hydrophobic insert.  
 
Table 5: summary of 3D culture studies with follicles from human, primate and large domestic 
animal species 
 
The non-tissue culture treated surface prevented granulosa cell migration that 
could disrupt follicle architecture. A variety of optically clear gels have also been 
applied towards follicle culture in different animal models. Follicles have either 
been completely encapsulated to create a 3-D environment or grown on a gel 
membrane with medium bathing both surfaces to simulate 3-D culture. Gels that 
have been used for tissue engineering include hydrogels like agar/agarose, 
calcium alginate, and hyaluronan, all from naturally derived polymers, as well as 
synthetic polymers such as PEG and PVA (reviewed in Tibbitt MW et al., 2009). 
Gels containing collagen alone as well as compounds containing collagen in 
combination with ECM proteins have also been applied to in vitro follicle growth. 
The physical characteristics of each of these matrices permit physical expansion 
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of the follicular unit during growth. Hydrogels contain polymers that cross-link or 
self assemble into hydrophilic structures. The 3-D crosslinking is what gives the 
gel its stiffness. The temperature and conditions for this cross-linking can be a 
critical factor in determining subsequent development of the follicle. For instance 
agar, derived from seaweed, requires exposure to elevated non-physiologic 
temperatures for melting before the cross-linking or gelling step, potentially 
damaging the follicle (Sawhney AS et al., 1994). Higher rates of atresia were 
observed in follicles grown on agar as compared to those placed in microdrop 
culture or in 3-D culture on a hydrophobic membrane insert. In contrast, Huanmin 
et al. (2000) described active follicular growth and antrum formation with caprine 
follicles embedded within agar (Huanmin Z et Yong Z, 2000). Their data did 
however show that secondary follicles survived better than primary follicles in 
this 3-D agar culture system. Agar embedding has also been applied to human and 
hamster pre-antral follicles (Roy SK et Greenwald GS, 1989; Roy SK et 
Greenwald GS, 1996). Follicles were biologically competent, secreting steroids 
and synthesizing DNA. Low melting point agarose may be a better matrix for 
follicle embedding, permitting encapsulation at temperatures more conducive to 
continued cell growth. Collagen is rich in glycine and proline and can be 
hydrolyzed in to a gel by boiling. This biomaterial has been widely applied to 
follicular culture. Eppig and colleagues used collagen membrane inserts as 
substrata in an attempt to simulate 3-D follicle culture. The membrane inserts with 
follicles were suspended in wells, and follicles were exposed to culture medium 
from below as well as above (Eppig JJ et Telfer EE, 1993). The biomaterial was 
not tissue culture treated. It did however allow follicle attachment but minimized 
granulosa cell migration. In vitro follicle maturation resulted in the formation of 
metaphase II oocytes, with the capability of producing live young after in vitro 
fertilization, growth and transfer to foster mothers. Despite this achievement, 
follicle growth on collagen treated membranes had limited potential in terms of 
maintaining spheroid follicle structure and follicles were susceptible to flattening 
over time in culture and to premature oocyte ovulation. To create a more spatially 
uniform 3-D culture system, follicles have also been embedded in collagen gel 
(Torrance C et al., 1989). Spontaneous follicle disruption as a result of 
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discontinuous or distorted basal lamina and granulose cell migration was 
decreased in the 3-D collagen system compared to control 2-D culture systems 
(Gomes JE et al., 1999). Follicle growth rate has also been reported to be superior 
(Loret de Mola JR et al., 2004). Granulosa-cell oocyte complexes embedded in 
collagen matrix remained rounded and compacted with neuronal- like outgrowths 
towards the oocytes (Combelles CM et al., 2005). Two limitations of the collagen 
gel have however been noted. The collagen gel is susceptible to shrinkage over 
time, affecting the gel‟s natural properties as well as reducing visibility during 
microscopic assessment. Also, follicle extraction from the collagen requires 
enzymatic digestion of the gel, with the potential for subsequent damage to the 
oocyte (Telfer E, 1996). The natural scaffolding upon which cells are organized in 
vivo, known as the extracellular matrix (ECM), is composed of collagen, along 
with laminin and fibronectin. ECM has been shown to play an important role in 
regulating cell behavior, differentiation and secretory activity (reviewed in 
Berkholtz CB et al., 2006). One commercially available ECM tested for follicle 
growth is matrigel (Buyuk E, 2003; Xu M et al., 2009). This ECM product is 
derived from the Engelbreth- Holm-Swarm (EHS) mouse sarcoma. Matrigel is 
composed of collagen IV, laminin, fibronectin, entactin, heparin sulfate 
proteoglycans, and a variety of growth factors such as EGF, FGF, IGF-1, PDGF 
and TGF-b (Martin GR et Timpl R, 1987; Kleinman HK et Martin GR, 2005). 
Murine pre-antral follicles in 3-D culture in matrigel exhibited higher growth and 
survival rates than those in conventional culture. Hovatta et al demonstrated 
higher survival of follicles in frozen-thawed human ovarian tissue placed in 
culture on matrigel coated inserts. Autocrine and paracrine signaling by ECM 
molecules and associated growth factors likely affect folliculogenesis. The 
interactions between ECM proteins and follicles from different animal models 
needs to be further studied. The source and type of ECM could also play a role in 
regulating follicle growth during 3-D culture. The size of ECM molecules can 
present problems and an alternative solution has been to adsorb known sequences 
of matrix peptides, such as RGD (Arg-Gly-Asp) or laminin-derived peptide 
sequences on to synthetic matrices (reviewed in Berkholtz CB et al., 2006). To 
date the most widely applied system for follicle encapsulation and 3-D culture has 
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been alginate (Pangas SA et al., 2003; Kreeger PK et al., 2005; Amorim CA et al., 
2009; Xu M et al., 2009), because of its possibility to form hydrogels in very mild 
conditions. This property facilitates encapsulation of follicles under physiologic 
conditions. Pangas et al. (2003) first applied this system to the 3-D culture of 
granulosa-cell oocyte complexes (GOC) from 12-day old mouse pre-antral 
follicles. GOCs were embedded in alginate beads ranging in size from 0.5 to 1 
mm in diameter. Light microscopic and TEM ultra-structure studies suggested 
that the alginate did not interfere with oocyte or granulose cell growth 
development over a 10 day culture interval. Moreover, oocytes recovered from the 
encapsulated GOCs were able to resume meiosis, undergo fertilization and 
produce viable offspring. This 3-D system has also been applied to secondary 
follicles. Follicles embedded in alginate hydrogels responded to FSH stimulation 
in a dose-dependent fashion, secreting estradiol and progesterone. Alginate matrix 
stiffness and density can affect secondary follicle expansion, hormone production 
and oocyte maturation. Non-human primate follicles have also been successfully 
cultured in calcium alginate gels for up to 30 days. The encapsulated monkey pre-
antral follicles secreted estrogen, progesterone and androstenedione and 
responded to FSH in the culture milieu. Interestingly, follicles cultured in 0.5% 
alginate performed better than those in 0.25% alginate, suggesting that primate 
follicles may require more physical support. One concern however is that denser 
matrices could potentially limit access to hormones and other nutrients. Heise et 
al. (2005) reported inhibited delivery of FSH to microencapsulated follicles. 
Follicle diameters increased with inclusion of FSH in the hydrogel but still did not 
reach that observed in un-encapsulated controls. Clearly, the physical attributes of 
the 3-D matrix selected for follicle culture needs to be tailored towards the species 
and follicle stage being cultured. In humans, pre-antral follicle growth in vitro 
offers an avenue through which cryopreserved ovarian tissue can be utilized 
without the need for transplantation. Human follicles isolated from fresh or 
cryopreserved ovarian tissue have been successfully cultivated in calcium alginate 
hydrogels but functionality needs to be further characterized. Initial data with 
frozen mouse ovarian tissue certainly suggests that meiotically competent oocytes 
can be recovered after in vitro maturation of isolated follicles in this 3-D culture 
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system. To further simulate the in vivo environment, ECM molecules have been 
combined with calcium alginate to construct synthetic ECM matrices for 3D 
culture (Kreeger PK et al., 2003). The adhesion peptide sequence arginine-
glycine-aspartic acid (RGD) common to ECM proteins has been synthetically 
created and coupled to calcium alginate to construct such a synthetic matrix for 
follicle growth. Hormone secretion by follicles was directly related to adhesion 
peptide concentration and a three-fold increase in progesterone and estradiol 
secretion could be induced by adjusting matrix parameters. In a separate study, 
these investigators combined calcium alginate with additional ECM components 
such as collagen I, collagen IV, laminin and fibronectin (Kreeger PK et al., 2006). 
Matrix effect on growth from two-layered to multi-layered follicles as well as 
oocyte maturation to metaphase II was compared. Transition to the multi-layered, 
secondary follicle was enhanced in alginate matrices with RGD or collagen I. 
Final maturation of oocytes and resumption of meiosis was promoted by presence 
of fibronectin, laminin or RGD peptide. 
 
5.4.3 Criteria for biomaterial evaluation 
Increasing follicular diameter is typically used as a measure of follicle maturation. 
During in vitro growth, especially in traditional 2-D culture systems where there 
is granulosa cell expansion, an increase in horizontal diameter of the follicle does 
not necessarily correlate to overall follicular growth. With 3-D culture the 
biomaterial presents equal counter-forces in all directions, minimizing flattening 
and allowing equal growth along all axes. Follicle volume as well as diameter 
should therefore be taken into account when comparing different substrata. 
Another outcome measure indicative of follicle functionality and growth is antrum 
formation. This accumulation of fluid within the follicle complex has been shown 
to vary with 2- versus 3-D culture systems, as well as the biomaterial used for 
follicle encapsulation. The shear elastic modulus and diffusion characteristics of 
the biomaterial must be carefully balanced. Torrance et al. (1989) noted no antrum 
formation in follicles cultured in collagen, despite an apparent increase in 
follicular diameter over the 14 day culture interval. It was suggested that the 
double gelling of the collagen during follicle encapsulation allowed just enough 
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flexibility for some granulosa cell proliferation, but that the overall high shear 
elastic modulus (increased stiffness) inhibited antrum formation. Interestingly, 
this was not observed when follicles were individually cultured in collagen 
microbeads (Sharma GT et al., 2009). A relationship between decreased gel 
stiffness and greater antrum formation was also observed with calcium alginate 
hydrogel when tested at concentrations of 3%, 1.5% and 0.7%. The study of Xu et 
al. (2006) most clearly illustrates the opposing influences of the rigidity of the 
biomaterial at high gel concentration and its interference with diffusion and 
optimal growth. Oocytes obtained from follicles encapsulated in 0.25% alginate 
had a higher developmental capacity than those cultured in 1.5% alginate. In vitro 
maturation and fertilization of oocytes in 0.25% vs 1.5% calcium alginate were 
significantly higher (41% vs 5%, respectively). Moreover oocytes derived from 
the stiffer gel were clearly impaired and unable to undergo in vitro blastulation. 
Interestingly, follicles from primates showed the opposite relationship between 
gel rigidity and follicle growth. Follicle survival and diameter were increased with 
culture in 0.5% calcium alginate as compared to 0.25%. Ovarian stroma of 
primates is more rigid than that found in rodents and it has been suggested that 
perhaps primate as well as human follicles may require a stiffer biomaterial to 
optimize in vitro culture and growth. The 100% survival rate and 75% antrum 
formation observed with human secondary follicles grown in 3-D culture in 0.5% 
calcium alginate matrix further support this supposition. 
 
5.4.4 Non-gel culture systems 
Despite the aforementioned benefits of follicle encapsulation as a model for 3-D 
culture, there are also difficulties. The process of encapsulation as well as the 
removal of follicles from the gel can be problematic, sometimes resulting in loss 
of healthy follicles. Alternatives methods for 3-D culture of follicles that do not 
involve encapsulation have therefore also been explored. Suspension culture of 
follicles in orbiting test tubes, rotating-wall vessels, and roller bottle systems can 
maintain the 3-D morphology of the follicles without encapsulation. 
Unfortunately these systems have not been extremely effective. The rate of 
rotation necessary to keep the follicles from descending to the bottom of the 
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vessels imposes shear stress on the follicles causing follicle degeneration 
(Rowghani NM et al., 2004). Moreover, the only way to negate this effect was to 
encapsulate the follicles before subjecting them to suspension culture with 
rotation. Suspension culture in rotating systems with its accompanying shear 
stress resulted in more follicle loss than that observed with embedding and 
removal of follicles from gels. Follicle survival with culture in a rotating wall 
culture vessel was only 9% as compared to the 15% observed after embedding 
and removal from collagen gel culture. With marsupial follicles, survival rate in 
the roller culture system was higher; nearly 49%, but follicles exhibited no antrum 
formation. Other non-gel approaches have included serial culture of follicles in 
new wells each day to prevent attachment (Boland NI et al., 1993) and flattening, 
or culture in simple microdrop under an oil overlay (Bishonga C et al., 2001). 
Inverted microdrop suspension culture has also been tested as a means to maintain 
the 3-D architecture of follicles (Wycherley G et al., 2004). Follicles are placed in 
microdrops under oil on the bottom of a tissue culture plate and then hung upside 
down during culture. Oil is ideally suited as a biomaterial for microculture 
environments, allowing maintenance of pH and temperature around the follicle 
and free gas exchange (Tae JC et al., 2006). However, its hydrophobic properties 
could potentially allow the escape of lipid soluble follicle secretions and growth 
factors in to the oil layer, ultimately hindering growth (Miller KF et Pursel VG, 
1987). It should however be noted that while inverted suspension culture yielded 
survival rates similar to that observed with alginate gels, the meiotic maturation 
rate was only 10%, far less than that what has been achieved with gel 
encapsulation of follicles. Handling large numbers of follicles in inverted 
suspension culture would also be a delicate and labor intensive process. This 
method would be especially unsuitable for follicles from the human ovary, which 
might require as long as three months of culture. 
 
5.4.5 Microfluidic culture 
The final aspect of follicle culture that needs some attention is the development of 
culture vessels or systems that maximize diffusion of nutrients and gases through 
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the selected biomaterial while allowing retention of the delicate micro-
environment of the follicle and the concentration of essential trophic factors 
around the oocyte. To accurately mimic the in vivo ovarian environment, fluid 
flow across the encapsulated follicle is vital. Also, within the ovarian environment 
follicles are grown in close proximity of each other, allowing sharing and 
concentration of secreted factors. The logistics of co-culturing numerous 
encapsulated follicles can perhaps be aided by the use of microfluidics that allow 
precise control and manipulation of fluids using microchannels. Microchannels 
increase the surface areato-volume (SAV) ratio, implementing laminar fluid flow 
(Beebe D et al., 2002) (reviewed in Suh RS et al., 2003). Diffusion across 
biomaterials has been shown to be influenced by not only the biomaterial and its 
concentration but also by its shape or presentation. Encapsulating in microbeads 
of gel may allow more uniform diffusion across all surfaces as compared to 
culture with follicles embedded in a single continuous layer of gel. Survival and 
antrum formation by cultured pre-antral buffalo follicles was demonstrated to be 
better after culture in collagen microbeads as compared to a continuous layer of 
collagen matrix. Tiny microbeads containing follicles in a biomatrix, combined 
with a system of microchannels could be used to create a network of individual 
follicles sharing nutrients. A dynamic medium exchange could therefore be 
applied to follicle culture in a manner that avoids the shear stress observed with 
rotating culture systems and preserves a “coculture” atmosphere. A variety of 
microfluidic culture systems have been described. Cell immobilization with 
continuous media flow is the common goal. This can be accomplished with 
microposts on the culture surface to entrap cells and create a matrix support while 
still allowing laminar flow of fluid to pass by (Chen X, 2009; Hashimoto, 2008) 
or by entrapping cells between walls of PDMS with continuous flow of culture 
medium above the cells. Microwells can also be used as architectural supports in 
microfluidic systems and act as nests for cells to culture in while fluid is 
exchanged above or below (Khademhosseini A et al., 2005; Moeller HC et al., 
2008). Microfluidics in combination with valves and micro-scale pumps provide 
the option of continuous media flow in ways similar to that seen in vivo (Heo YS 
et al., 2007; Lee PJ et al., 2007). Microfluidics thus permits dynamic culture 
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conditions and medium flow without disturbing the cell itself. Application of 
microfluidics to the field of reproductive biology has gained much attention. It has 
been applied to sperm sorting (Schuster TG et al., 2003; Chung Y et al., 2006), 
oocyte handling and fertilization (Sadani Z et al., 2005; Hogan B et al., 1994; Suh 
RS et al., 2006; Clark SG et al., 2005) and embryo culture (Glasgow IK et al., 
2001; Raty S et al., 2004; Walters EM et al., 2004; Walters E, 2007; Bormann C 
et al., 2008). Follicle culture in microfluidic devices needs to be explored. This 
type of system may be ideal for providing the 3-D environment necessary for 
maintaining follicle architecture over long intervals in culture, allowing adequate 
oxygenation and nutrient exchange and at the same time permitting sequestration 
of autocrine/paracrine factors within the vicinity of the growing follicle. The ideal 
microfluidic model would allow monitoring and harvest of individual follicle but 
also a sharing of the microenvironment to attain the benefit of “coculture”. 
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AIM OF RESEARCH 
 
 
Aim of my PhD research project is development of innovative strategies of 
fertility preservation in cancer women. Currently, different biotechnologies have 
been developed for these patients as oocytes or embryos cryopreservation before 
chemo/radiotherapy dramatically reduces patients fertility. However, oocyte or 
embryo cryopreservation are not an option for pre-pubertal girls and for women 
who do not have enough time before beginning of cancer therapy. In order to give 
these patients the possibility to restore their fertility, I have focused my attention 
on development of two alternative strategies. The first one, more feasible, is 
ovarian tissue cryopreservation: it avoids the delay needed for obtaining mature 
oocytes, but the subsequent potential for establishing pregnancies is unknown 
However, cryopreservation methods have to be still investigated to improve their 
experimental efficiency. The second strategy is isolation of  follicles from ovarian 
tissue and in vitro culture, allowing to avoid also the risk of transmitting  residual 
malignant cells in cryopreserved tissue, but until now this biotechnology is still 
undeveloped and only a few studies have been performed. To this aim in these 
three years of my PhD thesis, I have focused my interest in development of: 
1. new  protocols for  ovarian tissue cryopreservation;   
2. new strategies for  follicle isolation and  in vitro follicle culture.  
 
To improve cryopreservation efficiency the effect of choline chloride as substitute 
of sodium in freezing solutions will be studied. Sodium ion is one of  the major 
cause of electrolyte accumulation within frozen cells, which induces cellular 
damages. Choline ion is, instead, larger and unable to across cell membrane. The 
effect of sodium-depleted choline supplemented cryopreservation protocols will 
be investigated through use of different imaging analysis, such as histological, 
immunohystochemical and ultrastructural analysis.  
A different  biotechnological approach will be used to develop an efficient method 
for follicle isolation and subsequent  in vitro culture. To reproduce in vitro the 
architecture of follicle interactions the effects of alginate matrix on in vitro culture 
Aim of research 
 
72 
 
of isolated follicles will be studied. Follicles will be firstly cultured for up to 10 
days in alginates at different concentration to determine which one best supports 
follicle survival and growth. The efficiency of method will be investigated 
monitoring daily follicular growth through a NIS software imaging analysis and 
viability assays, using fluorescent dies. Since the physical properties of alginate 
hydrogels vary widely depending on their composition (e.g., the proportion of 
guluronic to mannuronic acid residues) and the sequential order of these residues, 
next step will be to investigate which factor could influence the growth 
characteristics of encapsulated follicles. Ovarian follicle culture systems provide 
an ideal tool to study the physical properties of a three-dimensional hydrogel 
matrix in follicle development. The hormonal regulation of folliculogenesis has 
been widely investigated, yet the role of the physical properties of the follicle 
microenvironment has not. Understanding the role of the physical environment on 
follicle development will be useful for the development of biomimetic matrices 
for the in vitro culture of follicles and other hydrogel-encapsulated cell culture 
systems. To this end, the following biomaterials will be tested: alginate SLG 20 
1.5% (69% guluronic acid, 75kDa), alginate SLG 100 1.5% (68% guluronic acid, 
200kDa), alginate 1.5% (50% guluronic acid, 50% mannuronic acid); As 
extracellular matrix (ECM) is essential for follicular development, to further 
simulate the in vivo environment, ECM molecules will be combined with calcium 
alginate to build synthetic ECM matrices for 3D culture. To this end, alginate 
1.5% will be combined with collagen type IV 0.3mg/mL, as the latter is the main 
ECM component present during follicologenesis. Similarly, the efficiency of 
method will be studied through viability assays, growth monitoring and analysis at 
confocal microscope.  
After, the development of follicles and their ability to survive to cryopreservation 
will be analysed. Particularly, two different protocols will be tested and validity of 
vitrification will be studied analyzing morphologically follicles after thawing. 
Moreover, viability assays will be applied.  
Finally, to understand whether frozen thawed isolated follicles were able to 
undergo growth and development after transplantation, in the present study, in 
collaboration with the Research Laboratory on Human Reproduction in Brussels, 
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after in vitro culture and vitrification/thawing alginate encapsulated follicles will 
be xenografted to the kidney capsule or the back muscle in immunodeficient mice. 
Grafts will be removed after 3 months and analysed by histological assay in order 
to evaluate the physiological status of xenografted follicles. 
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MATERIALS AND METHODS 
 
Tissue collection and dissection 
Ovarian tissue has been collected as small biopsy pieces from 20 women donors 
with a median age of 31 years (range 22–40 years). All women have been 
informed about the ongoing project, and they signed an informed consent form. 
Ovarian tissue has been transferred in sterile 50 ml Falcon Tube containing 20 ml 
of pre-warmed gamete buffer (Cook Italy) and immediately transported at 37°C to 
the laboratory. The ovarian cortical tissue has been manually dissected from 
medullar tissue and divided into strips of about 1 mm
3
. Two small pieces of fresh 
tissue have been fixed directly and subsequently used as non-frozen controls for 
light microscopy and transmission electron microscopic evaluation. The others 
have been randomly distributed into vitrification and slow-freezing groups.  
 
 
 
 
Fig. 6: ovarian dissection 
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Tissue cryopreservation 
Freezing and thawing solutions have been dissolved in two different basal media: 
the first one was conventional Dulbecco Phosphate Buffered Saline (DPBS), the 
second one consisted of modified phosphate buffered saline in which chloride 
sodium has been replaced by choline chloride on an equimolar basis (CPBS). 
 
Vitrification and warming 
Basal media have been supplemented with 10 mg/ml human serum albumin 
(HSA). 
The first vitrification protocol (VH and VHC) consisted of three incubation steps 
in solutions with increasing concentrations of DMSO (Sigma-Aldrich, Sweden), 
1,2-propanediol (PrOH) and ethylene glycol (EG) dissolved in basal mediums. 
After washing for 5 min in basal media, pieces of ovarian cortex have been 
transferred for 5 min sequentially to 1 ml of vitrification incubation solutions VS1 
(0.35 M DMSO, 0.38 M PrOH, 0.38 M EG), VS2 (0.7 M DMSO, 0.75 M PrOH, 
0.75 M EG) at room temperature and VS3 (1.4 M DMSO, 1.5 M PrOH, 1.5 M 
EG) at 4°C. At the third step, VS3 has been supplemented (10% w/v) with 
polyvinylpyrrolidone (PVP; Sigma-Aldrich, Sweden) (Keros et al., 2009). The 
samples have been directly plunged into liquid nitrogen (-196°C) and placed in a 
pre-cooled 5.0 ml Nunc cryotube (Nunclon, Roskilde, Denmark), closed and 
stored in liquid nitrogen.  
In the second vitrification protocol (VYB and VYBC) the strips have been 
dehydrated by using a two-step regimen: (1) 2.0 mol/L dimethyl sulfoxide 
(DMSO) + 0.1 mol/L sucrose for 5 minutes; (2) 2.0 mol/L DMSO + 2.0 mol/L 
propanediol (PROH) + 0.2 mol/L sucrose for 5 minutes. The samples have been 
directly plunged into liquid nitrogen as reported before (LI Yu Bin et al., 2007).   
For warming, the vitrified pieces have been taken out of the cryovials in a 
container filled with liquid nitrogen, quickly immersed into a 38°C water bath, 
and gently agitated until the ice melted nearly completely. Afterwards, the tissues 
have been moved quickly into 0.5 mol/L sucrose in basal media for 5 minutes at 
room temperature, and then taken through 0.25 mol/L and 0.125 mol/L sucrose in 
basal media each for 5 minutes at room temperature. Finally, the warmed strips 
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have been rinsed three times in basal media and put into a 37°C, 5 % CO2 
humidified incubator for 15 minutes for following procedures.  
 
Slow freezing and warming 
Basal media have been supplemented with 25 mg/ml human serum albumin 
(HSA). 
The first slow freezing cryopreservation protocol (Hovatta et al., 1996) (CLH and 
CLHC) consisted of three steps of incubation in cryopreservation solutions with 
PrOH as a permeating cryoprotectant and sucrose as non-permeating 
cryoprotectant. The tissue pieces have been first incubated for 5 min in 1 ml of 
basal media, then for 10 min in the first slow cooling solution (SC1) containing 
1.5 M PrOH, and finally for 15 min in SC2 which contained 1.5 M PrOH and 0.1 
M sucrose. The third incubation step has been performed in 1.8 ml Nunc cryovials 
(Nunclon, Roskilde, Denmark), which have been placed in a programmable 
freezer. Subsequently, the samples have been cooled from room temperature to -
6.5°C at a rate of 2°C/min. Seeding has been performed by means of forceps pre-
cooled in liquid nitrogen. After a 10-min holding period, the samples have been 
cooled to -35°C at a rate of -0.3°C/min, and after holding for 10 min they have 
been plunged directly into liquid nitrogen. For thawing, the cryovials have been 
first taken from liquid nitrogen and exposed for 30 s to room temperature. They 
have been then plunged for 2 min into a warm (37°C) water bath until the ice has 
been melted. Then pieces have been transferred to different thawing solutions 
(TS) in basal mediums. The first step has been 5 min in TS1 which contained 1.0 
M PrOH and 0.2 M sucrose, then 5 min in TS2 containing 0.5 M PrOH and 0.2 M 
sucrose, then 10 min in TS3 with 0.2 M sucrose and finally 10 min in TS4 which 
consisted in pre-warmed basal media in 37°C, 5 % CO2 air.  
The second slow freezing cryopreservation protocol (CLYB and CLYBC) 
consisted of two incubation steps respectively in SC1 supplemented with 1.5 M 
DMSO for 5 min and in SC2 supplemented with 1.5 M DMSO and 0.1 M sucrose. 
This one has been performed in 1.8 ml Nunc cryovials (Nunclon, Roskilde, 
Denmark), which have been placed in a programmable freezer. The samples have 
been cooled as follows: from 4°C to -8°C at -2°C/min; soaked for 10 minutes at    
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-8°C, then seeded manually with prechilled forceps, continually held for 10 
minutes; cooled to -40°C at -0.3°C/min and to -150°C at -50°C/min; finally 
samples have been plunged immediately into liquid nitrogen and stored until 
thawing. For warming, the pieces have been taken out of the cryovials in a 
container filled with liquid nitrogen, quickly immersed into a 38°C water bath, 
and gently agitated until the ice melted nearly completely. Afterwards, the tissues 
have been moved quickly into 0.5 mol/L sucrose in basal media for 5 minutes at 
room temperature, and then taken through 0.25 mol/L and 0.125 mol/L sucrose in 
basal media each for 5 minutes at room temperature. Finally, the warmed strips 
have been rinsed three times in basal media and put into a 37°C, 5 % CO2 
humidified incubator for 15 minutes for following procedures. 
 
 
 
Histological analysis  
For histological investigation, all tissue pieces have been fixed for 4h in Bouin’s 
solution (15% picric acid, 5% formaldehyde, 1% acetic acid glacial) (Sigma). 
Next, pieces have been repeatedly washed in current water, in order to remove the 
exceeded fixative, and dehydrated through sequential passages in ethanol at 
increasing concentrations. Particularly pieces have been sequentially transferred in 
ethanole 75% for 24h, ethanole 95% for 24h and finally three times in ethanole 
100%, 10’ each one. Pieces have been then clarified by two sequential passages, 
of 30’ each one, in Hystolemon, transferred in Hystolemon-paraffin 1:1 at 46°C 
for 45’ and finally embedded in paraffin wax for 24h at 60°C. Embedded pieces 
have been serially sectioned at 5 μm. 
Sections have been then stained with hematoxylin/eosin, and analyzed under a 
microscope. For staining, sections have been deparaffinized, by two passages of 
5’ each one in Xylene (blot excess xylene before going into ethanol), rehydrated 
through sequential passages, of 2’ each one, in ethanole 100%, 95%, 75% and 
50% and then transferred in deionised water (blot excess water before going into 
hematoxylin). At this point, sections have been stained for 7’ in hemalum, rinsed 
in tap water, stained for 7” in eosin 0.5%, dehydrated and mounted with 
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Hystovitrex (Carlo Erba).  Hemalum is a complex formed from aluminium ions 
and oxidized haematoxylin. This colors nuclei of cells (and a few other objects, 
such as keratohyalin granules) blue. Instead, eosin colors eosinophilic structures 
in various shades of red, pink and orange. 
The staining of nuclei by hemalum does not require the presence of DNA and is 
probably due to binding of the dye-metal complex to arginine-rich basic 
nucleoproteins such as histones. The mechanism is different from that of nuclear 
staining by basic (cationic) dyes such as thionine or toluidine blue. Staining by 
basic dyes is prevented by chemical or enzymatic extraction of nucleic acids. Such 
extractions do not prevent staining of nuclei by hemalum. The eosinophilic 
structures are generally composed of intracellular or extracellular protein. Most of 
the cytoplasm is eosinophilic.  
The number of follicles of different developmental stages has been evaluated. 
Follicles with an oocyte surrounded by a single layer of flat granulosa cells have 
been defined as primordial. Follicles with the oocyte surrounded by one layer of 
only cuboidal granulosa cells have been defined as primary. Follicles with the 
oocyte surrounded by two or more layers of cuboidal granulosa cells have been 
classified as secondary. Eosinophilia of the ooplasm, contraction and clumping of 
the chromatin material, and wrinkling of nuclear membrane of the oocytes have 
been regarded as the signs of atresia (Gougeon A., 1986). The qualities of follicles 
have been graded from one to three. A follicle of grade 1 is spherical and is 
randomly distributed around oocytes granulosa cells, with homogenous cytoplasm 
and slightly granulated nucleus, in the center of which condensed chromatin in the 
form of dense spherical structure is detected. A follicle of grade 2 has the same 
peculiarities, but the granulosa cells cover irregular oocytes; these cells can be flat 
and condensed chromatin is not detected in cytoplasm. A follicle of grade 3 has 
partly or fully disrupted granulosa or cytoplasm and picnotic nucleus. Follicles of 
grades 1 and 2 have been denoted as normal and those of grade 3 have been 
denoted as degenerated. To illustrate the changes caused by different 
cryopreservation protocols, also oocyte germinative vescicle diameter and 
undamaged and pyknotic stromal cells have been considered.  
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Transmission electron microscopic analysis  
For TEM, small pieces of all samples were fixed in 2.5% glutharaldehyde (SIC, 
Rome, Italy) in 0.1 M sodium cacodylate at pH 7.3 for 1.5 hour, washed three 
times for 10 minutes in the same buffer, postfixed in 1% osmium tetroxide (SIC) 
in 0.1 M sodium cacodylate at pH 7.3 on ice and washed three times for 10 
minutes in the same buffer. Glutharaldehyde kills cells quickly by crosslinking 
their proteins and is usually employed alone or mixed with formaldehyde as the 
first of two fixative processes to stabilize specimens such as bacteria, plant 
material, and human cells. Osmium tetroxide is used in order to crosslink and 
stabilize cell and organelle membrane lipids.  Samples were then treated in 0.1% 
tannic acid in cacodylate for 10 minutes and dehydrated in ascending series of 
ethanol (Carlo Erba Reagenti, Milan, Italy) on ice. All samples were treated twice 
for 5 minutes with propylene oxide (FLUKA, Milan, Italy), infiltrated in 1:1 
propylene oxide/Epon 812 (Agar Scientific, Stansted, United Kingdom) 
overnight, and individually embedded in fresh resin. Thick (0.5–1 mm) and thin 
sections (60–80 nm) were cut with a diamond knife (Diatome, Biel, Switzerland) 
at a Reichert-Jung Ultracut E ultramicrotome and collected on glass slides or 200-
mesh thin bar copper grids (SIC). Thick sections were stained with 0.1% toluidine 
blue in sodium borax, examined by light microscopy (LM) and photographed 
using a Nikon DS-cooled camera head DS-5Mc connected to a Nikon DS camera 
control unit DS-L1. Thin sections were stained with saturated uranyl acetate in 
methanol and Reynold’s lead citrate and observed and photographed with a 
Philips (Eindhoven, The Netherlands) EM 208 S electron microscope (EM) at 80 
KV. Uranyl acetate is the acetate salt of uranium and is a yellow crystalline solid 
made up of yellow rhombic crystals and has a slight acetic odor. Uranyl acetate is 
slightly radioactive, the precise radioactivity depends on the isotopes of uranium 
present. This compound is a nuclear fuel derivative, and its use and possession are 
sanctioned by international law. Uranyl acetate is used as a positive stain for 
TEM. Uranyl ions react strongly with phosphate and amino groups, staining DNA 
and some proteins. Organelles composed of membranes are not stained well. Note 
that the starting material is radioactive. Lead citrate may also be employed as a 
positive stain. Reynolds lead citrate stain binds lead ions to negative ions, 
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producing a general increase in contrast. Lead is a cumulative toxin, so skin 
contact must be avoided.  
In the oocytes we studied the chromatin structures, the integrity of nuclear 
membranes, the density and integrity of the mitochondrial cristae, density of the 
cytoplasm, the size and numbers of vesicles in the cytoplasm, integrity of the 
cytoplasmic membrane and attachment of the oocyte to the granulosa cells. The 
same parameters were evaluated for assessment of granulosa cells. The nuclear 
and cytoplasmic membranes, nuclear chromatin of stromal cells, the attachment 
between granulosa cells and attachment to the basement membrane were also 
evaluated.  
 
 
Immunohistochemical analysis  
For immunohistochemical investigation, all procedures were carried out at room 
temperature unless otherwise stated. The paraffin-embedded ovary sections of all 
samples were deparaffinizated, rehydrated and then incubated for 5 minutes with 
3% hydrogen peroxide in methanol (Sigma Aldrich), in order to inhibit the 
activity of endogen peroxidases. Samples are washed three times for 10 minutes 
in PBS supplemented with 0.1 % TRITON X100 (TPBS), incubated for 1 hour in 
blocking solution, containing 0.5% normal goat serum in TPBS and then washed 
three times for 10 minutes in TPBS. Triton X100 is used to permeabilize 
eukaryotic cell membranes and reduce the surface tension of aqueous solutions 
during immunostaining. Ovary sections were incubated with the following 
primary antibodies at 37 °C for 1 hour: mouse monoclonal p53 and p63 (8μg/mL); 
rabbit polyclonal p21 (8μg/mL) and rabbit polyclonal Apaf-1 (5μg/mL) (Santa 
Cruz Biotechnology). P53 plays a role in apoptosis, genomic stability, and 
inhibition of angiogenesis. In its anti-cancer role, p53 works through several 
mechanisms: 1) It can activate DNA repair proteins when DNA has sustained 
damage; 2) It can induce growth arrest by holding the cell cycle at the G1/S 
regulation point on DNA damage recognition (if it holds the cell here for long 
enough, the DNA repair proteins will have time to fix the damage and the cell will 
be allowed to continue the cell cycle); 3) It can initiate apoptosis, the programmed 
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cell death, if DNA damage proves to be irreparable. Activated p53 binds DNA 
and activates expression of several genes including WAF1/CIP1 encoding for 
p21. p21 (WAF1) binds to the G1-S/CDK (CDK2) and S/CDK complexes 
(molecules important for the G1/S transition in the cell cycle) inhibiting their 
activity. When p21(WAF1) is complexed with CDK2 the cell cannot continue to 
the next stage of cell division. Apaf 1 is an apoptotic protease activating factor 1. 
This gene encodes a cytoplasmic protein that forms one the central hubs in the 
apoptosis regulatory network.  
Control sample was incubated with TBS alone. All sections are then washed three 
times for 10 minutes in TPBS. Bound antibodies were detected by incubating the 
sections with horseradish peroxidase-labeled secondary antibodies at 37°C for 2 
hours. Sections are then washed three times for 10 minutes in TPBS and for 5 
minutes in TRIS HCl 50mM pH7.4; reaction was then revealed with 0.7 mg/mL 
of 3,3’ –diaminobenzidine tetrahydrocloride in TRIS HCl 50mM pH 7.4 for 20 
seconds. After color development, the sections were washed three times in water, 
dehydrated and finally mounted for light microscopy. Sections were then 
dehydrated and mounted with Hystovitrex. 
 
 
Ovarian follicle isolation 
Ovary was transported to the lab in 0.9% NaCl solution at 4°C. Medullar tissue 
was removed  using sterile blades and cortical portion was dissected in small 
pieces of about 1mm
3
. Ovarian fragments obtained were transferred to 50 ml 
conical tubes containing 10 ml of Leibovitz medium L15 (Sigma) supplemented 
with 1% fetal calf serum (Sigma) (FBS), 1 mg/ml collagenase type IA (Sigma), 
0.25mg/ml Dnase I (Roche) and incubated in a water bath at 37°C for 30 min with 
gentle agitation. The ovarian digest was periodically (every 15 min) shaken with a 
pipette to mechanically disrupt the digested tissue. Digestion was completed by 
the addition of an equal volume of L15 medium supplemented with 10% FBS. 
The solution was transferred to Petri dishes and investigated for follicles under a 
stereomicroscope (Leica, Van Hopplynus Instruments, Brussels, Belgium). The 
follicles were picked up using a 135-μm-diameter flexipet (COOK) and washed 
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three times in L15 medium supplemented with 10% FBS in order to avoid 
introduction of stromal cells into the alginate matrix. Follicles were then 
transferred in culture medium, consisting of α- MEM supplemented with 20% 
FBS, 0.47mM pyruvic acid (Sigma), 1% insulin-transferrin-selenium (GIBCO) 
and 1% penicillin-streptomicin (Sigma), for 30’ at 38°C. Follicle diameter was 
measured using NIS elements advanced software (Nikon). Two to five follicles 
were subsequently processed for live/dead assays in order to evaluate follicular 
viability after isolation. The remaining follicles were embedded in an alginate 
matrix (2-3 follicles/group).  
 
 
Follicle viability 
Follicles were incubated in 0.5ml of culture medium containing 50μg/ml 
propidium iodide (Sigma) for 30’ at 38°C in the dark. Propidium iodide enters 
cells with damaged membranes and then binds to DNA with high affinity, 
resulting in a red fluorescence in dead cells. After exposure to propidium iodide 
(Excitation at 488 nm, emission at 617 nm), 10μg/ml Hoechst 33342 was added to 
the same medium and follicles were incubated for other 10’ in the dark. Hoechst 
33342 nucleic acid stain (excitation/ emission maxima ~350/461 nm) is a popular 
cell-permeant nuclear counterstain that emits blue fluorescence when bound to 
dsDNA.  
At the end of incubation with fluorescent dyes, follicles were washed in fresh 
culture medium for three times, of 10’ each one and observed under an inverted 
fluorescence microscope (Nikon).  
 
 
3D confocal staining and imaging 
Follicles for confocal microscopy studies were fixed in 4% PFA at 37°C for 1 h, 
followed by 1 h in wash buffer, consisted in PBS supplemented with 2% normal 
goat serum, 1% BSA, 0.1 M glycine, and 0.1% Triton X-100 (Xu et al., 2009; 
Barrett and Albertini, 2007). They were then stained overnight at 4°C with 
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Rhodamine-Phalloidin (1:50 Molecular Probes, Invitrogen, Eugene, Oregon), that 
labels F-actin in connections between somatic cells and the oocyte called 
transzonal projections (TZPs), and 1 μg/ml Hoechst 33342 (Sigma) for 
chromatin/DNA. Follicles were mounted in 5–10 ml of a 50% glycerol/PBS 
solution. The coverglass was placed on glass shards, to prevent the compression 
of the follicle. Follicles were imaged at a Leica TCS SP5 laser scanning confocal 
microscope, using a 40x or 63x oil objective. Overlapping 1–3 μm sections were 
taken throughout each follicle imaged. 
 
 
Follicle Encapsulation  
 
Materials 
Alginate is a linear polysaccharide consisting of (1,4)-linked b-D-mannuronate 
(M) and its C-5 epimer α-L-guluronate (G). The monomers can appear in 
homopolymeric blocks of consecutive G-residues (G-blocks), consecutive M-
residues (M-blocks), alternating M and G-residues (MG-blocks) or randomly 
organized blocks. Chemical composition, primary structure and average block 
lengths are conveniently determined by NMR spectroscopy. Commercial alginates 
are extracted from brown algae, and the relative amount of each block type varies 
with the origin of the alginate. Physical-chemical and biological properties of 
alginate vary widely with chemical composition. G-blocks form stable cross-
linked junctions with divalent cations (e.g. Ca2+, Ba2+, Sr2+, among others) 
leading to a three-dimensional gel network. Alginate can also form gels under 
acidic conditions without cross-linking agents. Thickening properties are mainly 
dependent upon the average molecular weight, which can be determined by size 
exclusion chromatography combined with light scattering detection (Fig. 7) 
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Fig. 7: chemical structure of alginate 
 
 
Encapsulation  
Morphologically normal follicles with centrally located spherical oocytes 
surrounded by a layer of granulose cells were used for further in vitro culture. The 
isolated follicles were transferred into 1.5% of sodium alginate solution. Droplets 
of alginate (~2–3 μL) were suspended on a cover of a 6 cm Petri dish. 2-3 follicles 
were pipetted into each droplet in a minimal amount of media, using a flexipet 
(Cook). Different types of alginate were used. Particularly, four different matrices 
were tested: 
1. Alginic acid sodium salt from brown algae (Sigma), viscosity 4-12 cP 
(ALG). It is a straight-chain, hydrophilic, colloidal, polyuronic acid 
composed of 50 % glucuronic and 50% mannuronic acid residues. 
Alginate is an anionic polysaccharide distributed widely in the cell walls 
of brown algae. Alginate is biocompatible and gels making it useful for 
cell encapsulation and immobilization. A 3% (w/v) solution of sodium 
alginate was stripped using activated charcoal (0.5 g charcoal/g alginate) 
to remove organic impurities, sterile filtered using 0.22 μm filters. Sodium 
alginate was reconstituted to 1%, 2% (w/v) alginate in PBS1x for use. 
Alginate solutions were stored at 4°C. 
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2. ALG modified with collagen type IV (Sigma) (ALG-COLL). Particularly, 
collagen type IV was choose because it is the only component of 
extracellular matrix to be preserved during follicular development (RJ 
Rodgers et al., 2003). Lyophilized human placental collagen type IV 
(5mg) (Sigma) was dissolved in 1mL of glacial acetic acid (0.5%) and 
stored at -20°C. Aliquots of charcoal-stripped and sterilized sodium 
alginate were diluted to either 1% in 0.3 mg/mL collagen type IV solution, 
and vortexed well to mix. ALG-COLL solution was stored at 4°C.  
3. Alginate SLG 100 (PRONOVA FMC Biopolymer) is made from an 
alginate where over 60% of the monomer units are guluronate and is a 
highly purified and well-characterized sodium alginate. One of the 
functional properties of alginate is viscosity. The viscosity of an alginate 
solution can be manipulated by changing the concentration of the alginate 
or by using materials with varying chain length (i.e. molecular weight). 
Typically, the molecular weight for PRONOVA SLG100 is in the 200000 
– 300000 g/mol range. The ultra low levels of endotoxins, proteins and 
product sterility allows for a big variety of in vitro and in vivo 
applications. PRONOVA sterile alginate products are manufactured and 
documented in compliance with ISO 9001:2008 and ISO 13485:2003 
(medical device directive) and in accordance with ICH Q7 guidelines. The 
products are characterized using validated analytical methods. 
4. Alginate SLG20 (PRONOVA FMC Biopolymer) is also made from an 
alginate where over 60% of the monomer units are guluronate but in this 
case the molecular weight for PRONOVA SLG20 is in the 75000 – 
220000 g/mol range.  
 
After, all droplets had been filled, the cover was immersed in a 6 cm Petri dish, 
containing sterile 50 mM CaCl2 and 140 mM NaCl encapsulation solution for 2 
minutes to cross-link the alginate, and then rinsed in culture media. The 
composition of medium is reported before. The beads were transferred into four-
well multidish for 10 days at 38°C in 5% CO2. Every two days, half of the media 
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volume was exchanged and follicles were examined for survival and size 
measurements.  
 
 
Follicle Vitrification And Thawing  
At day 2 of culture period, encapsulated follicles were vitrified as follows: 
 
Protocol 1 
Encapsulated follicles were vitrified using a modified ethylene glycol (EG)-
sucrose-based protocol, as reported by Desay et al. 2011. The basal media for the 
preparation of equilibration and vitrification solutions was L15 + 20% FCS. 
Follicles were equilibrated for 5 min in 2M EG followed by a 30–60-s incubation 
in vitrification solution containing 6M EG + 0.3M sucrose. All equilibration and 
vitrification steps were performed at room temperature. Follicles were then 
pipetted on the surface of a cryoleaf, held for 2 min in the vapor phase, just above 
the surface of the LN2, before immersion into LN2. Vitrified follicles were 
warmed by immersion in basal medium containing 1M sucrose. Follicles were left 
in the warming solution for 10 min at room temperature and then washed at 37°C. 
After 5 min, follicles were pipetted into fresh basal medium at 37°C for another 
5–10 min before processing for viability assays, as reported before. 
 
 
 
Protocol 2 
Second vitrification and thawing protocol was modified from the method 
described by Xing et al., 2010. Briefly, encapsulated follicles were initially 
exposed to the first vitrification solution (4% EG in DPBS + 10% FBS) for 15 
min. Subsequently, they were rinsed three times in the second vitrification 
solution (35% EG and 0.5 M sucrose in DPBS + 10% FBS) and equilibrated at 
room temperature for 20-30 sec. Then follicles were directly dropped onto the 
surface of a cryoleaf. Droplets containing the vitrification solution and follicles 
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were instantaneously vitrified into transparent spherical droplets, by direct 
immersion in LN2. Cryoleafs were closed and stored in LN2. 
Warming was achieved by direct transfer into warming solution containing 0.25 
M sucrose and 10% FBS in DPBS at 37°C for 5-10 min followed by three washes 
in DPBS. Then, follicles were transferred in 0.5 mL of culture medium and 
incubated for 15-20’, before processing for follicular viability, as reported before.  
 
 
Xenotransplantation of alginate beads into SCID mice 
Xenotransplantation of encapsulated follicles was performed in collaboration with 
the Lab of Research in Human Reproduction, in Brussels (ULB: universitè libre 
de Bruxelles). 
 
Animals 
All animals were obtained by Harlan laboratories. The scid (severe combined 
immunodeficiency) mutation was discovered in a C.B-17/Icr congenic strain in 
1980 by Dr. M.J. Bosma at the Fox Chase Cancer Center (Philadelphia, PA). 
Harlan SCID® models are licensed under agreement with the Fox Chase Cancer 
Center, produced within flexible-film isolators and monitored for microbiologic 
integrity. SCID mice accept xenografts, making them a useful model for 
oncology, immunology, HIV pathology, and other fields of biomedical research. 
A total of ? nude 6-week-old female mice were used. The animals were housed in 
ventilation cabinets at a positive pressure of 6 cm H2O. They had unlimited access 
to gamma-irradiated food pellets and sterile water, and were inspected daily. The 
oophorectomy and transplantation procedure were executed in a laminar flow 
cabinet to provide a sterile environment for the immunocompromised animals. 
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Fig. 8: SCID mouse 
 
 
Subcutaneous grafting 
The recipient animals were anesthetized by intraperitoneal (IP) injection of 
ketamine (75 mg/kg; ketamine 1000; CEVA Sant e Animale, Brussels, Belgium) 
and xylazine HCl (10 mg/kg; Rompun; Bayer Animal Health, Brussels, Belgium). 
Analgesia was obtained by IP administration of buprenorphine (0.1 mg/kg; 
Temgesic; Schering Plough, Brussels, Belgium). A single dorsal transverse skin 
incision of 0.5 cm was made, allowing sufficient access to both left and right 
abdominal cavity, and the abdominal wall was incised in the lumbar fossa. Before 
the actual transplantation procedure, the animals were bilaterally 
oophorectomized. Each ovary was exteriorized, the top of the cornus uteri was 
ligated with polyglactin (Vicryl 6/0, Ethicon, Somerville, 
NJ), and the ovary was excised. The transplantation procedure was performed 
with the aid of a binocular microscope (Motic SMZ168; Motic China Group Co. 
Ltd., Xiamen, People’s Republic of China) at ×7.5 magnification. The left kidney 
was exteriorized, and a small slit was made in the kidney capsule with a 27-gauge 
needle. Encapsulated follicles were pipetted under the kidney capsule. The kidney 
was returned to its normal anatomical position, the abdominal wall was sutured 
with polyglactin (Vicryl 6/0), and the skin defect closed with polypropylene 
(Prolene 6/0). Similarly, encapsulated follicles were grafted under the back 
muscle. All the procedure was performed at 37°C. Recovery was unproblematic, 
and no signs of abdominal discomfort or infection were noted. After 3 months 
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from xenografting, mice were sacrified and xenografts were collected and 
analysed by histological assays, as reported before. 
 
 
Fig. 9: xenografting 
 
 
Statistical analysis 
The data are presented as mean±SD. Overall analysis was performed by the 
estimate model of analysis of variance (ANOVA) followed by the Tukey’s 
honestly significant difference test for pairwise comparisons when overall 
significance was detected. Percentage data were compared by χ2 or Fisher’s exact 
test. Statistical significance was defined as P<.05. 
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RESULTS  
 
Light microscopy 
A total of 892 follicles was analysed by LM to evaluate the viability and the 
developmental stages in non-frozen, slowly cryopreserved and vitrified tissues. 
Particularly, 406 follicles were slow cooled and 247 were vitrified. Most of the 
follicles were at primordial, intermediary and primary stages in all samples. 
Difference between the total numbers of follicles in different samples is not 
attributed to different protocols, since large variation in the distribution of the 
follicles between patients and pieces from the same ovary were observed (table-
graph 6).  
 
K 34.9±7.3 
SCH 28.7±14.7 
SCHC 48.8±19.5 
SCYB 50.5±2.1 
SCYBC 54,5±14.8 
VH 33±11.3 
VHC 24.5±3.5 
VYB 9.5±0.7 
VYBC 13±0.6 
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Table-graph 6: total number of analyzed follicles in different samples 
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As reported previously, eosinophilia of the ooplasm, contraction and clumping of 
the chromatin material, and wrinkling of nuclear membrane of the oocytes were 
regarded as the signs of atresia (Gougeon A., 1986). The qualities of follicles were 
graded from one to three. A follicle of grade 1 is spherical and is randomly 
distributed around oocytes granulosa cells, with homogenous cytoplasm and 
slightly granulated nucleus, in the center of which condensed chromatin in the 
form of dense spherical structure is detected (Fig. 10). A follicle of grade 2 has 
the same peculiarities, but the granulosa cells cover irregular oocytes; these cells 
can be flat and condensed chromatin is not detected in cytoplasm (Fig. 11A). A 
follicle of grade 3 has partly or fully disrupted granulosa or cytoplasm and 
picnotic nucleus (Fig. 11B).  Follicles of grades 1 and 2 were denoted as normal 
and those of grade 3 were denoted as degenerated.  
 
 
Fig. 10: follicle of grade 1 
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Fig. 11: (A) follicle of grade 2; (B) follicle of grade 3 
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Microscopic visualization of haematoxylin/eosin-stained sections reveal clear 
differences in the structures of the follicles cryopreserved using the different 
protocols. Particularly, in SCYB follicles oocyte is separated from surrounding 
picnotic granulosa cells, and ooplasm is highly eosinophile; in contrast, SCYBC 
follicles are better preserved. However, germinative vescicle is not well 
condensed. SCH and SCHC follicles show a more regular morphology, 
characterised by a more homogeneous cytoplasm and follicular cells well 
distributed around the oocyte, but only in SCHC follicles, no intercellular spaces 
are present in stromal tissue and germinative vescicle shows a well condensed 
chromatine (Fig. 12).  
 
                    
 
                    
 
Fig. 12: frozen/thawed follicles. Different superscripts indicate slow freezing protocol 
 
The percentages of different grade follicles in slowly cooled samples are showed 
in table 7. In fresh tissue, 51.86±12.85 of total follicles were of grade1. In slow 
freezing groups percentage of morphologically normal follicles were significantly 
higher in choline modified protocols than in conventional ones (graph. 7) 
Particularly, for both first and second slow cooling protocols, percentages of 
SCYB SCYBC 
SCH SCHC 20 µm 20 µm 
20 µm 20 µm 
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follicles of grade 1 were 50.5±13.43 and 51.3±12.75 vs 21.17±15.69 and 
30.25±14.72.  
 
 % follicles of grade 1 % follicles of grade 2 % follicles of grade 3 
K 51.86±12.85 30±15.95 18.14±13.51 
SCH 21.17±15.69** (vs K) 26.67±1.63 50.33±16.44* (vs K) 
SCHC 50.5±13.43** (vs SCH) 17.5±5.2 32±16.06 
SCYB 30.25±14.72* (vs K) 15.05±2.56* (vs K) 54.7±15.52* (vs K) 
SCYBC 51.3±12.75 15.35±6.33* (vs K) 33.35±14.56 
* p<0.05 
** p<0.01 
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Table-graph 7: percentages of follicles of different grade in all slowly cooled samples 
 
In vitrification groups percentage of morphologically normal follicles were also 
higher in choline modified protocols than in conventional ones, but follicular 
morphology is not well preserved (Fig. 13). In fact, all follicle are characterised 
by vacuolization and intercellular spaces. Moreover, nuclei of granulosa cells are 
picnotic and germinative vescicle is highly damaged. 
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Fig. 12: frozen/thawed follicles. Different superscripts indicate vitrification protocol 
 
 
Particularly as showed in table 8, percentages of follicles of grade 1 were 
3.5±4.95 and 24±9.26 vs 28±7.07 and 29.95±5.52. After thawing, the proportion 
of the morphologically intact follicles were significantly reduced in the two 
vitrification groups. 
 
 % follicoles of grade 1 % follicles of grade2 % follicles of grade3 
K 61±11.31 15±9.9 24±1.41 
HV 3.5±2.95** (vs K) 26±8.49 70.5±3.54** (vs K) 
HVC 28±7.07* (vs K) 23.5±12.02 48.5±4.95 
YBV 24±9.26** (vs K) 23.6±1.98 42.4±7.28* (vs HV) 
YBVC 29.95±5.52* (vs K) 15.4±2.55 49.2±12.44 
* p<0.05 
** p<0.01 
VH VHC 
VYB VYBC 
20 µm 20 µm 
20 µm 20 µm 
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Table-graph 8: percentages of follicles of different grade in all vitrified samples
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Moreover, diameter of fresh and cryopreserved follicles germinative vescicle was 
measured and there are no significative differences between all samples, as shown 
in Table 9.  
 
K 22.7±2.6 
SCH 20.4±2.4 
SCHC 20.5±2.6 
SCYB 21.3±2.8 
SCYBC 21±3.1 
VH 17.9±2.9 
VHC 18.3±2.7 
VYB 17.1±2.8 
VYBC 18.5±1.4 
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Table-graph 9: diameter of germinative vescicle in all samples
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Immunohistochemical analysis 
 
In an immunohistochemical study, three different situations were retrieved.  
Follicles of grade 1 are negative for p53, p21 and Apaf1 (Fig. 14).    
 
     
Fig. 14: Immunohistochemistry of follicles of grade 1 
 
Follicles of grade 2 are immunoreactive for p53, and p21 but staining for Apaf-1 
is revealed only in 50±24.04% of them (Fig. 15).  
 
     
     
Fig. 15: Immunohistochemistry of follicles of grade 2 
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Follicles of grade 3 are immunoreactive for all tested markers (Fig. 16).  
 
     
Fig. 16: Immunohistochemistry of follicles of grade 3 
 
In the control sections, replacing the primary antibody with only phosphate 
buffered saline, resultes in the complete inhibition of staining in oocyte and 
follicular cells, indicating the specificity of immunoreaction.  
 
Ultrastructural analysis  
 
All follicles analyzed by TEM are at a primordial stage. Follicles at a different 
developmental stage are not revealed.  
In fresh human ovarian biopsies, the oocyte and the follicular structures generally 
are well preserved. Follicles are characterised by an intact and well defined 
oolemma, an homogeneous cytoplasm and nucleus with well condensed 
chromatine. There are no lipid droplets, vesicles or lysosomes found in these 
follicles (Fig. 17). Particularly, mitochondria had the typical morphological 
features described in human oocytes (Sathananthan AH et al., 2000; Motta PM et 
al., 2000). They occur as spherical/oval elements, approximately 0.5 mm in 
diameter, and typically contain a few short cristae rarely crossing a highly electron 
dense matrix 
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Fig. 17: Control follicle 
 
Compared to fresh follicles, in cryopreserved follicles, mitochondria have a 
decreased electron density of the matrix or irregular shape. However, choline 
slowly freezed follicles, for both protocols, are characterised by a more 
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homogeneous cytoplasm both in oocyte and in follicular cells, well defined 
oolemma and nuclear membrane, mitochondria of regular shape and at a 
cytoplasmatic level typical structures called anulatae lamellae are well preserved 
(Fig. 18).  
 
 
          
 
Fig. 18A : SCYB follicle 
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Fig. 18B : SCYBC follicle 
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Fig. 18C : SCH follicle 
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Fig. 18D : SCHC follicle 
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Follicles from vitrified tissue are characterised by lipid droplets, vesicles or 
lysosomes not revealed in control samples. However, choline vitrified follicles 
have no intercellular spaces between follicular cells, mitochondria are better 
preserved and at a cytoplasmatic level typical structures called anulatae lamellae 
are well visible (Fig. 19).   
 
 
 
 
  
Fig. 19A : VYB follicle 
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Fig. 19B : VYBC follicle 
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Fig. 19C : VH follicle 
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Fig. 19D : VHC follicle 
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Mitochondrial analysis 
 
Density of mitochondria has been evaluated by counting number of mitochondria 
inside an area of 50µm
2
. Results demonstrated no significant difference between 
control and slowly cooled samples. Instead, in all vitrified a significant decrease 
of mitochondrial density has been reported. (Table-Graph 10) 
 
K 72±3.5 
SCH 52±13.2 
SCHC 58±9.3 
SCYB 54±12.5 
SCYBC 53±8.2 
VH 32±10.3 
VHC 35±7.5 
VYB 49±7.2 
VYBC 36±5.6 
 
 
 
 
Table-Graph 10: Number of mitochondria / µm2 in all samples 
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Mitochondrial areas have been classified in two categories: 
1. Elongated mitochondria, characterised by an extended shape and 
numerous mitochondrial cristae; 
2. Round mitochondria, characterised by a circular shape and few 
mitochondrial cristae. 
 
Results demonstrated that, in all analysed follicles, no significant differences 
between elongated mitochondria areas have been found, except for SCYB 
follicles, in which case an increase has been recovered. However, round 
mitochondria areas have been significantly decreased after vitrification/thawing, 
for both protocols. (Graph 11)  
 
 
Graph 11: mitochondria areas in all samples. * p<0.05 
 
 
 
 
 
 
 
 
 
* * * 
* 
* 
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Isolation of ovarian follicles 
 
In order to assess the ability of ovarian follicles to grow in 3D matrices, I isolated 
follicles from 30 different ovarian tissues The mean number of isolated follicles is 
200±35 (Fig. 20).  
 
      
 
Fig. 20: Isolated follicles 
 
The initial mean diameter was 41.9±5.20µm and fluorescent assays through 
staining with propidium iodide and Hoechst 33342 show that viable follicles are 
87.7±5.4% (Fig. 21).  
 
    
Fig. 21: Imaging of a viable follicle 
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Effect of Alginate Rigidity on Follicle Survival and Growth 
 
Follicles were firstly cultured for up to 10 days in alginates at different 
concentration to determine which one best supports follicle survival and growth. 
Particularly follicles were encapsulated in alginate 1%, 2% and 3%. At the end of 
the culture, mean follicular growths are 33.2±6.5% for ALG1%, 20±3.4% for 
ALG2% and 10±2% for ALG3% (Graph 12). Furthermore, at day 10 of culture, 
fluorescent assays show that viable follicles are 83.2±6% after encapsulation in 
ALG1%, 75±3% for follicles encapsulated in ALG2% and 58±4% after 
encapsulation in ALG3% (Graph 13). 
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Graph 12: follicular growth at day 10 of culture in alginates at different concentration 
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Graph 13: follicular viability at day 10 of culture in alginates at different concentration 
 
 
 
 
 
Effect of Alginate Physical properties on Follicle Survival and Growth 
 
Next step was to study the effects of physical properties of alginate matrix on in 
vitro culture of isolated follicles. In order to improve the efficiency of culture 
system, four matrices were tested, which differ for percentage of guluronic acid, 
molecular weight, viscosity and combination with ECM molecules. Particularly, 
as reported previously, follicles were encapsulated in: SLG20 1%, SLG100 1%, 
ALG 1% and ALG-COLL 1%. All matrices were able to support follicular growth 
and able to preserve tridimensional structure of follicles. In fact, at day 10 of 
culture, follicles observed by brightfield microscopy significantly increase their 
initial diameter (Fig. 22-23). However, no antral cavity is revealed.  
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Fig. 22: follicle at day 0 
 
    
Fig. 23: follicle at day 10 of culture 
 
 
 
Similarly, follicular growths and viabilities in different culture conditions were 
investigated.  Results demonstrated that at the end of culture period, mean 
follicular growths were 49.7±2.8% for SLG 20 1.5%, 52.7±6.2% for SLG 100 
1.5%, 33.2±6.8% for ALG 1.5% and 103.8±9.3% for ALG-COLL (graph 14).  
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Graph 14: follicular growths at day 10 of culture in different alginates. Different superscripts 
denote significant differences among treatment groups 
 
Moreover, follicular viabilities, at day 10, were respectively 73.7±3.2% for SLG 
20 1.5%, 72.3±10.1% for SLG 100 1.5%, 52.2±10.81% for ALG 1.5% and 
85.7±6.2% for ALG-COLL (graph 15). 
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Graph 15: follicular viabilities at day 10 of culture in different alginates. Different superscripts 
denote significant differences among treatment groups 
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Analysis at confocal microscope 
Follicles were also stained for F-actin with rhodamine-phalloidin and Hoechst 
33342 for analysis at confocal microscope. Results demonstrated a marked and 
significant increase of follicular diameter, due to the presence, at the end of the 
culture period, of  multilayered granulosa cells. In fact, after isolation, follicles 
display at most two cell layers of granulosa cells (Fig. 24). Oocyte is centred and 
show a clear germinative vescicle. Nuclei of granulosa cells are well visible and 
regularly distributed around the oocyte.   
 
 
 
 
 
Fig. 24: follicles at day 0. In blue nuclei (Hoechst 33342); in red actin (Rhodaminate Phalloidin) 
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At day 10 of culture, follicles increase their size and a multilayered granulosa 
cells is well visible. Moreover, the oocyte size also increases in culture as the 
follicle grow three-dimensionally and preserve e regular morphology (Fig. 25).  
 
 
 
 
Fig. 25: follicle at day 10. In blue nuclei (Hoechst 33342); in red actin (Rhodaminate Phalloidin) 
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Vitrification of follicles 
 
A total of 285 encapsulated follicles were vitrified. Particularly, 140 follicles were 
vitrified immediately after enzymatic digestion and 145 follicles were vitrified 
after 2 days of in vitro culture in ALG-COLL matrix. Morphological features and 
viability of follicles before (control) and after vitrification were investigated. 
At day 0, after thawing, no viable follicles were recovered and 91.2±3.5% of 
follicles extruded their oocytes, with both vitrification protocols (Fig. 26-27). 
 
 
Fig. 26: frozen/thawed follicle after vitrification as reported by Xing et al. Oocyte has been 
extruded.  
 
        
Fig. 26: frozen/thawed follicle after vitrification as reported by Xing et al. In blue Hoecsht 33342; 
in red propidium iodide. 
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At day 2 of in vitro culture, in the control group, 87.7±5.4% of encapsulated 
follicles were morphologically normal and viable. After thawing, there was a 
significative difference in terms of morphologically normal and viable follicles 
relative to the control in the two different tested protocols (Fig. 28). 
 
          
 
              
Fig. 28: frozen/thawed follicle after vitrification as reported by Desai et al. In blue Hoecsht 33342; 
in red propidium iodide. 
 
 
 
Particularly, follicles vitrified as reported by Desai et al. 2011 show, after 
thawing, a viability of 84.53±3.51% and 80±2.4% of them are morphologically 
normal. Instead, there was a significantly lower proportion of morphologically 
normal follicles after vitrification as reported by Xing et al. 2010. Moreover, in 
this case viable follicles are 20±7.2% (Graph 15). Furthermore, follicles, after 
thawing, were able to restore their growth ability. In fact, thawed follicles, after 5 
days of in vitro culture, show a growth of 10%.  
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Graph 15:follicular viabilities after vitrification/thawing. * p<0.01; ** p<0.05 
 
 
 
Xenotransplantation of encapsulated follicles in immunodeficient mice 
 
In collaboration with Research Laboratory on Human Reproduction in Brussels, at 
day 2 of in vitro culture, after monitoring viability and growth of encapsulated 
follicles, four different alginate beads (ten follicles/bead) were xenotransplanted 
to the kidney capsule or the back muscle of two immunodeficient mice. After 
three months, grafts were readily identifiable and removed. No follicles could be 
identified after histological analysis of kidney and back muscle. 
 
 
 
** 
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DISCUSSION AND CONCLUSIONS 
 
 
In recent years cancer incidence is constantly increasing as a result of population 
aging and growth as well as, increasingly, an adoption of cancer-associated 
lifestyle choices including smoking, physical inactivity, and ‘‘westernized’’ diets. 
(World Health Organization Databank WHO Statistical Information System, 
2010). Moreover, recent data coming from AIRTUM Working group about 
children cancer incidence (Epidemiol Prev 2008; 32(2) Suppl 2: 1-112) indicate 
that there is a growth trend of both all new cases of cancer and mean tumor sites 
at 0-14 years. In contrast, early detection of cancer and progresses in diagnosis 
and enhanced effectiveness of chemotherapy and radiotherapy has increased the 
survival rate of young female cancer patients (von Wolff et al., 2009). 
Unfortunately these growing population of adolescent and adult long-term cancer 
survivors may experience infertility problems due to induced premature ovarian 
failure (POF) caused by cancer therapies, in a manner dependent on the age of the 
patient at the time of diagnosis and dependent on the type and  quantity of drugs 
used for therapies. In fact, the ovaries, containing a definite number of follicles 
from the birth, are very sensitive to cytotoxic treatment, especially to alkylating 
agents, which are classified as high risk for gonadal dysfunction (e.g. 
cyclophosphamide, busulfan, melphalan, chlorambucil, dacarbazine, procarbazine, 
ifosfamide, thiotepa and nitrogen mustard) (Warne et al., 1973; Koyama et al., 
1977; Fisher et al., 1979; Viviani et al., 1985; Mackie et al., 1996; Teinturier et 
al., 1998; Legault and Bonny, 1999; Meirow et al., 1999; Blumenfeld et al., 2000; 
Kenney et al., 2001; Tauchmanova et al., 2002). The follicular destruction 
following these treatments generally results in the loss of both endocrine and 
reproductive functions. Enthusiasm has therefore generated for young female 
patients, in which case the improvement of cancer therapies allows that young 
cancer patients can survive and undergo a normal reproductive life. In order to 
preserve their fertility, advances on biology of reproduction and Assisted 
Reproductive Technologies have opened a wide range of options. There are a few 
options available to preserve fertility in these patients. These include 
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cryopreservation of embryos, oocytes (Yang et al., 2007; Porcu et al., 2008) or 
ovarian tissue (Hovatta et al., 1996; Nugent et al., 1997; Donnez et al., 2000; Kim, 
2006). Embryo cryopreservation is the most mature technology available for 
fertility preservation and it is the most effective strategy to date. Human embryos 
can survive the freezing and thawing process up to 95% of the time, and 
cumulative pregnancy rates can be greater than 60% if multiple embryos are 
available (Oktay et al., 2003, 2005; Rao et al., 2004; Juretzka et al., 2005; Lee et 
al., 2006; Seli et al., 2005). Recently, oocyte cryopreservation has improved 
significantly allowing better survival and fertilization rate (Fabbri et al., 2001; 
Oktay et al., 2006). However, clinical pregnancy and live birth rates are lower 
than those observed with unfrozen oocytes. On the other hand, both methods 
require a delay in cancer treatment and hormonal stimulation. Furthermore, there 
are ethical problems for embryos cryopreservation. Thus, these methods are not 
an option for patients who need to start immediately cytotoxic treatments, for 
patients who have an estrogen sensitive cancer, such as breast cancer and for pre-
pubertal patients. Moreover, embryo cryopreservation couldn’t be performed for 
single women. In order to preserve fertility in these patients, ovarian tissue 
cryopreservation followed by transplant is a promising fertility preservation 
approach. The advantages of the ovarian tissue cryopreservation are the possibility 
to: preserve a large number of primordial follicles present in the cortex of the 
ovarian tissue, preserve  both steroidogenic and gametogenic functions, avoid 
postponement of cancer treatment, collect ovarian tissue independently of the 
stage of the menstrual cycle and in a non invasive manner, through laparoscopy, 
and finally restore the natural state, when the  graft is transplanted in fully remised 
patients allowing conception in vivo with their own germ cells. 
Autotransplantation of ovarian cortical strips has resulted in viable offspring in 
animal models (Bordes et al. 2005) and human. Worldwide, 14 live births have 
been reported as a result of autotransplanting frozen/thawed ovarian tissues 
(Donnez et al., 2004, 2011; Meirow et al., 2005; Demeestere et al., 2007; 
Andersen et al., 2008; Silber et al., 2008; von Wolff et al., 2009; Piver P et al., 
2009; Ernst et al., 2010; Sanchez-Serrano et al., 2010; Roux et al., 2010). Despite 
these promising findings, transplantation of cryopreserved tissue carries the risk 
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of re-introducing cancer cells into the patient (Shaw and Trounson, 1997; Meirow 
et al., 1998, 2008). In order to avoid this risk, the only possibility to preserve 
fertility is represented by the in vitro growth of the oocytes from the primordial 
stage. However, until now, only in a murine model, isolated follicle culture using 
a 3-dimensional alginate matrix has yielded mature oocytes capable of 
fertilization and delivery of healthy mouse pups (Abir et al., 2006). Thus, even 
though the risks of transmitting disease in grafted tissue carrying malignant cells 
related to ovarian tissue cryopreservation is still an open question up to now, and 
even if only a few studies about in vitro culture of human isolated follicle have 
been performed, these ones represent the only suitable technology for fertility 
preservation for pre-pubertal girls and women who cannot delay the start of 
chemotherapy. In this scientific contest, aim of my PhD research was 
improvement of these two alternative strategies. In fact, cryopreservation methods 
have to be still investigated in order to improve their experimental efficiency, and, 
to date, isolation of  follicles from ovarian tissue and in vitro culture is still 
undeveloped.  
As first step, in the present study I studied the development of new protocols for 
ovarian tissue cryopreservation in order to improve the efficiency of the method. 
Main results demonstrated a beneficial effect of replacement of sodium with 
choline in freezing media. Two studies have already reported the efficacy of 
sodium-depleted slow freezing for cryopreservation of human oocytes. In a series 
of 12 patients, a total of 144 oocytes were cryopreserved and thawed (Quintans C 
et al., 2002). The median survival was 63%. Nonetheless, based on the surviving 
oocytes, a fertilization rate of 59%, an implantation rate of 25%, six clinical 
pregnancies, and two live births were obtained. Boldt et al. (Boldt J et al., 2003) 
compared two slow freezing protocols: oocytes cryopreserved in the sodium-
depleted freezing medium resulted in a significantly higher survival rate than 
oocytes in the sodium-based freezing group after thawing. In the sodium-depleted 
group, 59% fertilization rate was obtained, and out of 11 women who received 
embryo transfer four pregnancies and five live births were reported. Two potential 
explanations have been proposed (Stachecki et al., 1998, 2000, 2002, 2006). The 
first theory relates to the ‘‘solute effect’’, involving the transport of a large 
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quantity of sodium ions cross the cell membrane through the plasma membrane–
associated sodium-potassium (Na-K) pump. During equilibration in PBS-based 
freezing media which contains a relative high concentration of Na, an excess Na 
may be pumped into the ooplasm. However, the functions of Na-K pumps may be 
impaired during freezing and thawing, resulting in an intracellular accumulation 
of Na and ultimately in cell death. An alternative explanation is that the choline 
may have a direct cryoprotective effect by stabilizing the cell membrane (Toner et 
al., 1993). Unlike the sodium ion, choline is thought not to cross the cell 
membrane and therefore would not be expected to contribute to the intracellular 
solute load.  
In the present study, the improvement of ovarian tissue cryopreservation after 
replacing of sodium with choline has been demonstrated by histological, 
immunohystochemical and ultrastructural analysis. The ovarian cortex contains 
follicles mainly at primordial and primary stages, which are particularly resistant 
to cryopreservation procedures (Hovatta, 2005). At these stages, the follicles 
possess certain characteristics that make them less sensitive to cryoinjury, such as 
a low metabolic rate and number of granulosa cells, absence of a ZP and 
peripheral cortical granules, and a small immature oocyte (arrested in the 
prophase of the first meiotic division) with low amounts of intracytoplasmic 
lipids. In the present study, microscopic visualization of haematoxylin/eosin-
stained sections revealed clear differences between non frozen, slowly cooled and 
vitrified follicles. Results demonstrated that in slow freezing groups percentage of 
morphologically normal follicles were higher in choline modified protocols than 
in conventional ones, according to criteria reported by Gougeon A in 1986. In 
vitrification groups percentage of morphologically normal follicles were also 
higher in choline modified protocols than in conventional ones, but follicular 
morphology is not well preserved and the proportion of the morphologically intact 
follicles were significantly reduced in the two vitrification groups.  
To deepen these data, an ultrustructural study has been performed. Different 
studies have demonstrated that cryopreservation of ovarian tissue may injure 
follicular structure (Cortvrindt et al., 1996; Oktay et al., 1997; Gook et al., 1999; 
Nisolle et al., 2000; Abir et al., 2001; Hreinsson et al., 2003; Eyden et al., 2004; 
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Imhof et al., 2004; Lucci et al., 2004; Martinez-Madrid et al., 2004a; Rodrigues et 
al., 2004a,b; Camboni et al., 2005; Fabbri et al., 2006a,b; Santos et al., 2006; 
Nottola et al., 2007b; Fauque et al., 2007). In fact, the structure and functionality 
of the follicles present in the ovarian cortex might be altered by inadequate 
cryopreservation procedures. Microorganelles responsible for a specific biological 
event has a different susceptibility to be damaged from freezing, and follicles 
cryodamaged may be responsible of retard follicle growth and oocyte maturation 
after transplantation. Particularly, alterations in mitochondrial morphology, as 
well as in the association between mitochondria and smooth endoplasmic 
reticulum (SER) elements (membranes and vesicles), may influence the 
developmental competence of human oocytes (Van Blerkom, 2004). Decrease in 
temperature appears to have an influence on oocytes. Chilling has been implicated 
in the modification of membranes (Ghetler et al., 2005), which may affect their 
integrity, while freezing has been shown to cause mitochondrial enlargement and 
alterations in the relationship of SER elements with mitochondria in bovine 
oocytes (Schmidt et al., 1995). Sathananthan et al. (1988) also observed 
mitochondrial swelling and SER element damage after cooling human oocytes to 
0°C. In the present study, electron microscopy investigations showed that, 
compared to fresh follicles, in cryopreserved follicles, mitochondria have a 
decreased electron density of the matrix or irregular shape. Particularly, 
mitochondrial area and number of mitochondria/µm
2
 have been analyzed. 
Moreover, two categories of mitochondria have been investigated: elongated and 
round mitochondria, different for shape and respectively more or less 
mitochondrial cristae. Results demonstrated that all slowly freezed follicles, for 
both protocols, have been characterised by a similar density of mitochondria, if 
compared with non frozen samples, but elongated mitochondria areas significantly 
decreased in conventional freezing, while these ones have been well preserved in 
sodium depleted choline-supplemented slow freezing techniques. Furthermore, at 
an ultrastructural level, follicles slowly cooled with both choline modified 
protocols, have been characterised also by a more homogeneous cytoplasm both 
in oocyte and in follicular cells, well defined oolemma and nuclear membrane 
and, at a cytoplasmatic level, only in choline cryopreserved follicles, typical 
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structures called anulatae lamellae are well preserved. Instead, all follicles from 
vitrified tissue have been characterised by an inferior mitochondrial density and 
increased round mitochondria areas if compared with non frozen samples. 
Similarly, follicles vitrified with choline modified protocols, if compared with 
follicles vitrified with conventional protocols, have no intercellular spaces 
between follicular cells and at a cytoplasmatic level, also in this case, anulatae 
lamellae are well visible. However,  in vitrified follicles, different injuries have 
been found, not revealed in control samples, such as lipid droplets, vesicles or 
lysosomes. Finally, I further investigated whether cryopreservation affects 
primordial follicle physiology and functionality, specifically the p53-p21-Apaf1 
pathway, which has been shown to play an important role in regulating ovarian 
apoptosis. Several studies demonstrated that p53 expression was not altered after 
slow-freezing (Hussein et al. 2006) and no significant difference between the p53 
mRNA level in vitrified and non-vitrified tissue (Mazoochi et al., 2009). 
However, expression of p53 is the result of DNA damage (Lu X and Lane DP, 
1993) and the expression of p53 protein in the apoptotic granulosa cells of atretic 
follicles suggests its possible role in atresia (Kim et al., 1999). p21 is an important 
p53 target, which gene product associates with and inhibits cyclin-Cdk complex 
kinase and thereby blocks the transition from G1 to S in the cell cycle (EI-Deiry 
WS et al., 1993; Harper JW et al. 1993). Moreover, in the mitochondrial 
signalling pathway, it is generally believed that when the cells receive a stressful 
stimulus which leads to mitochondrial damage, cytochrome c is released from the 
mitochondria (Green and Reed, 1998; Wang, 2001) and binds with Apaf1 (Zou et 
al., 1997; Robles et al., 1999), and then the Apaf1–cytochrome c complex binds 
with procaspase- 9 (Cecconi et al., 1998; Qin et al., 1999). The Apaf1– 
cytochrome c–procaspase-9 complex plays a key role in mitochondrion-dependent 
apoptosis (Cecconi, 1999; Grutter, 2000;Wang, 2001). In this project research, 
expression of p53, p21 and Apaf1 have been investigated by 
immunohistochemical approach. Results showed that three different situations 
have been observed. Follicles of grade 1 are negative for p53, p21 and Apaf1. 
Follicles of grade 2 are immunoreactive for p53, and p21 but staining for Apaf-1 
is revealed only in part of them. Finally, follicles of grade 3 are immunoreactive 
127 
 
for all tested markers. Thus, immunohistochemical analysis confirms histological 
and ultrustructural ones and demonstrated that morphology of follicles is highly 
related to their functionality. Overall, data herein indicated that sodium-depleted 
choline-supplemented cryopreservation preserves ovarian tissue better than 
conventional sodium based one.   
A new biotechnological approach has been used to develop an efficient method 
for follicle isolation and subsequent  in vitro culture. Conventional culture, as 
reported by different studies, is unable to support follicular growth and hormone 
production. In conventional 2-dimensional (2-D) tissue culture systems, the 
follicle tends to flatten and granulosa cells surrounding and nurturing the growing 
oocyte, migrate away, leaving it naked and unable to complete the maturation 
process (West ER et al., 2007). In the first stages of follicologenesis, interactions 
between oocyte and granulosa cells are necessary (Carabatsos MJ et al., 2000) and 
only a tridimensional culture system can preserve this condition. Encapsulation of 
follicles may protect them from gap junction disruption through shear stress 
(Heise M et al., 2005; Heise MK et al, 2009) and may preserve expression of the 
gene encoding for the gap-junction protein connexin (De Paola N et al., 1999). 
Contiguous assembly of granulosa cells around the oocyte also prevents the 
follicles from undergoing premature ovulation (Xu M et al., 2006). Another 
advantage may be that trophic factors released by granulosa cells remain in close 
proximity to the oocyte exerting a positive effect on oogenesis and possibly 
fostering new local gap junctions. To reproduce in vitro the architecture of follicle 
interactions, in this research project, the effects of  alginate matrix on in vitro 
culture of isolated follicles has been studied. In the alginate system, follicles have 
been able to grow (Pangas et al., 2003), produce fluid-filled antral cavities (Xu et 
al., 2006), and produce meiotically competent oocytes (Kreeger et al., 2006; 
2005), which were successfully fertilized and implanted to yield multiple live 
births of healthy mouse pups (Xu et al., 2006). Moreover, alginate is one of the 
most used biomaterials for microencapsulation, for its biocompatibility, high 
affinity to water and ability to form hydrogels in very mild conditions (Pangas SA 
et al., 2003; Kreeger PK et al., 2005; Amorim CA et al., 2009; Xu M et al., 2009). 
The properties of alginate hydrogels vary widely depending on different physical 
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and mechanical properties. Ovarian follicle culture systems provide an ideal tool 
to study the properties of a three-dimensional hydrogel matrix in follicle 
development. The hormonal regulation of folliculogenesis has been widely 
investigated, yet the role of the physical properties of the follicle 
microenvironment has not. Understanding the role of the environment on follicle 
development will be useful for the development of biomimetic matrices for the in 
vitro culture of follicles and other hydrogel-encapsulated cell culture systems. 
The mechanical properties of alginate are dependent on several factors, such as 
the mass of polymer and the extent of cross-linking (Anseth KS et al., 1996). 
Decreasing the percentage of alginate reduces the extent of cross-linking within 
the gel, thereby decreasing the modulus for the material (Kong HJ et al., 2004). 
Less rigid hydrogels deform more readily, which would create space as the 
follicle increases in size. The other mechanism by which the alginate percentage 
may affect follicle growth is the extracellular transport of macromolecules (Wee S 
et al., 1998; Peters MC et al., 1998). The culture media contains macromolecules 
necessary for follicle growth, and cells within the follicle are producing and 
secreting factors that affect the maturation process. Decreasing the percentage of 
alginate increases the mean mesh size within the hydrogel, which may enhance 
macromolecular transport through the hydrogel. However, natural and synthetic 
matrices, such as the negative-charged polysaccharide alginate, can also bind 
macromolecules to serve as reservoirs for growth factors (Peters MC et al., 1998). 
Decreasing the percentage of alginate would reduce binding sites for these 
macromolecules and increase transport. Therefore, factors added to the culture 
media would be transported through the gel more easily with a reduction in the 
alginate percentage. In addition, factors produced by the follicle, which may affect 
growth positively and negatively, would more effectively escape from the follicle.  
In this contest, different studies show that the strength of the alginate gel network 
is an important factor that influences the growth characteristics of encapsulated 
cells. Xu et al. in 2006 reported that follicles encapsulated in 0.5% and 0.25% 
alginate had increased to more than 300μm, significantly larger than those 
cultured in 1.5% alginate. Also, follicles encapsulated in 1.5% alginate were less 
likely to develop an antrum, did not develop laminar-like teca cells, and produced 
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lower androstenedione levels. Thus, alginate concentration not only affected theca 
cell proliferation and differentiation but also regulated granulosa cell proliferation 
and differentiation. Interestingly, different studies demonstrated, instead, that 
follicles cultured in 0.5% alginate performed better than those in 0.25% alginate, 
suggesting that primate follicles may require more physical support. One concern 
however is that denser matrices could potentially limit access to hormones and 
other nutrients. Heise et al. (2005) reported inhibited delivery of FSH to 
microencapsulated follicles. 
Three different concentrations of alginate were chosen for the present study: 
primordial and primary follicles have been enzimatically isolated and cultured for 
up to 10 days in alginates 1%, 2% and 3% to determine which one best supports 
follicle survival and growth. Viability of follicles has been detected using a 
double staining with Hoechst 33342 and propidium iodide; follicular growth has 
been instead monitored daily through a NIS element imaging software. All 
alginates were able to support in vitro follicular culture. However, results 
demonstrated opposing influences of the rigidity of the biomaterial at high gel 
concentration and its interference with diffusion and optimal growth. In fact, best 
results have been obtained with encapsulation of follicles in ALG1%. At the end 
of the culture, mean follicular growths and follicular viability are higher for 
follicles encapsulated in ALG1% and they decrease at increasing of alginate 
concentration. 
Next step, in this research project, has been studying the effects of physical 
properties of alginate matrix on in vitro culture of isolated follicles. The physical 
properties of alginate hydrogels vary widely depending on their composition (e.g., 
the proportion of guluronic to mannuronic acid residues) and the sequential order 
of these residues. Briefly, alginates possessing a high guluronic acid content 
develop stiffer, more porous gels which maintain their integrity for longer periods 
of time. During cationic cross-linking, they do not undergo excessive swelling and 
subsequent shrinking, thus they better maintain their form. Conversely, alginates 
rich in mannuronic acid residues develop softer, less porous gels that tend to 
disintegrate with time. Alginates with a high mannuronic acid content are also 
plagued by a high degree of swelling and shrinking during cationic crosslinking. 
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In the present study, different matrices have been tested, which differ for 
percentage of guluronic acid, molecular weight and viscosity. To date the most 
widely applied system for follicle encapsulation and 3-D culture has been alginate 
produced by brown algae (Xu M  et al., 2006; West ER et al., 2007; Xu M et al., 
2006, 2009a,b,c; Pangas SA et al., 2003; Kreeger PK et al., 2005; Amorim CA et 
al., 2009). To further simulate the in vivo environment, ECM molecules have 
been combined with calcium alginate to construct synthetic ECM matrices for 3D 
culture (Kreeger PK et al., 2003). In a separate study, these investigators 
combined calcium alginate with additional ECM components such as collagen I, 
collagen IV, laminin and fibronectin (Kreeger PK et al., 2006). Transition to the 
multi-layered, secondary follicle was enhanced in alginate matrices with RGD or 
collagen I and final maturation of oocytes and resumption of meiosis was 
promoted by presence of fibronectin, laminin or RGD peptide. 
In the present study, the following biomaterials have been tested: alginate SLG 20 
1% (69% guluronic acid, 75kDa), alginate SLG 100 1% (68% guluronic acid, 
200kDa), alginate 1% (50% guluronic acid, 50% mannuronic acid). Moreover, 
alginate 1% has been combined with collagen type IV 0.3mg/mL, as the latter is 
the main ECM component present during follicologenesis. At day 10 of culture, 
all follicles observed by brightfield microscopy increase significantly their initial 
diameter but no antral cavity is revealed. However, at the end of culture period, 
improvement of mean follicular growths and viability were obtained for SLG 20 
1% and for SLG 100 1%, showing a beneficial effect of a major percentage of 
guluronic acid in alginate molecule and, moreover, follicular growth and viability 
percentages have been significantly improved after encapsulation in ALG-COLL. 
In fact, although all follicles are able to grown, only follicles encapsulated in 
alginate combined to collagen IV double their initial diameter and viability is 
better preserved during culture period. Follicles were also stained for F-actin with 
rhodamine-phalloidin and Hoechst 33342 for analysis at confocal microscope. 
Results demonstrated a marked and significant increase of follicular diameter, due 
to the presence, at the end of the culture period, of multilayered granulosa cells. 
Under these conditions oocytes retained a normal morphology. Thus, although all 
matrices were able to support follicular growth, the presence of components of 
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ECM, such as collagen, improves the efficiency of in vitro culture of isolated 
follicles, better preserving follicular growth and viability. As a result, new 
prospectives in fertility preservation in cancer women could be opened, because 
follicles cultured in vitro could be cryopreserved and re-implanted at the 
pathology remission, in order to avoid also the risk of re-introduction of malignant 
cells associated to ovarian tissue cryopreservation. Isolated follicles can be 
cryopreserved by slow-freezing or by vitrification. Vitrification is a method with a 
high concentration cryoprotectant combined with a fast cooling rate, which avoids 
ice crystal formation during the cryopreservation process (Fahy GM et al., 1984). 
The recent advance of ultrarapid vitrification procedures has been attributed to 
new devices which enabled high cooling rates, such as electron microscopic 
copper grids (Martino A et al., 1996), OPS (Vajta G et al., 1997), cryoloop (Lane 
M et al., 1999), microdrops (Papis K et al., 2000), SSV (Dinnyes A  et al., 2000) 
and nylon mesh (Matsumoto H et al., 2001). Xing et al. (2010) demonstrated, in 
rat, that the rate of totally viable follicles of the SSV group was slightly higher 
than that of the OPS group and significantly higher than that of the slow-rate 
freezing group. Moreover, after in vitro culture, the increase of follicle diameter of 
SSV group was significantly higher than that of the slow-rate freezing group. 
Desai et al. 2011 reported that EG-raffinose vitrification protocol resulted in 
excellent post-warming survival. About 95% of mouse follicles were 
morphologically intact immediately post warming and 65% survived to the end of 
the in vitro culture interval period, with 41% of oocytes maturing to the MII stage. 
However, after collection, isolated follicles could be stressed by the enzymatic 
digestion and 2-3 days of in vitro culture after encapsulation in a tridimensional 
matrix could allow the recovery of follicle physiological functions after enzymatic 
digestion. In this study, follicles were vitrified immediately after enzymatic 
digestion and after 2 days of in vitro culture in ALG-COLL matrix and their 
ability to survive to cryopreservation has been analysed by fluorescent assays. 
Particularly, two different vitrification methods have been tested (Desai et al. 
2011; Xing et sl. 2010) and thawed follicles have been stained and imaged at the 
fluorescence microscope to detect eventual damages induced by the 
cryopreservation. At day 0, after thawing, no viable follicles have been recovered 
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and the most part of follicles extruded their oocytes, with both vitrification 
protocols. At day 2 of in vitro culture, after thawing, a significative difference in 
terms of morphologically normal and viable follicles relative to the control have 
been retrieved in the two different tested protocols. Results demonstrated that, 
after thawing, follicles vitrified according to Desai et al had a higher viability 
compared to the protocol of Xing et al. Morphological analysis of follicles 
confirmed these data. Furthermore, follicles, after thawing, have been able to 
restore their growth ability. In fact, thawed follicles, after 5 days of in vitro 
culture, showed a growth of 10%.  
Thereafter, to understand whether frozen thawed isolated follicles were able to 
undergo growth and development after transplantation three potential possibilities 
exist: heterotopic autografting, orthotopic autografting and xenografting. In 
transplantation experiments with isolated follicles to the ovarian bursa of mice, 
Gosden (1990) had resorted to the plasma clot procedure to retain follicles in situ. 
Also, Dolmans et al. (2007) reported 58.3% recovery rate for isolated follicles 
xenografted to the murine ovarian bursa in a plasma clot. Ovarian tissue is 
commonly grafted to the kidney capsule or the back muscle of immunodeficient 
mice because these sites favour rapid revascularization due to its rich capillary 
bed. Recently (Aerts et al., 2010) a novel transplantation technique, consisted in 
microinjecting follicles underneath the kidney capsule to prevent follicle extrusion 
from the renal membrane into the abdomen, thus avoiding the need for a plasma 
clot as a vehicle for transplantation, resulted in 100% of grafted follicles 
recovered from the kidney capsule, indicating that the microinjection technique 
successfully retains the transplants in situ. 
In the present study, after in vitro culture and vitrification/thawing alginate 
encapsulated follicles have been xenografted in immunodeficient mice. Thus, in 
collaboration with Research Laboratory on Human Reproduction in Brussels, after 
monitoring viability and growth of encapsulated follicles, four different alginate 
beads (ten follicles/bead) have been xenotransplanted to the kidney capsule or the 
back muscle of two immunodeficient mice. After three months, grafts were 
readily identifiable. The grafts have been removed after 3 months and analysed by 
light microscopy. Unfortunately, until now, no follicles could be identified after 
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histological analysis of kidney and back muscle. However, observations on the 
physiological status of xenografted follicles are currently under way. Thus, data 
obtained in this PhD thesis encourage the development of new strategies to 
preserve fertility in cancer women. Improvements to in vitro follicle culture 
systems, along with improved cryopreservation and follicle isolation techniques, 
may provide a viable avenue for the maturation of cryopreserved immature 
ovarian follicles in vitro for subsequent fertilization and implantation to preserve 
reproductive options for female cancer patients. In addition to germline 
preservation, follicle culture techniques may also revolutionize approaches to treat 
female infertility. In addition, ovulation induction requested for actual fertility 
preservation methods produces a limited number of oocytes, many of which may 
not produce viable embryos. In vitro culture systems may allow for the maturation 
of immature follicles for subsequent oocyte collection and fertilization. If a viable 
human in vitro follicle culture system is developed, a small portion of the ovary 
could be removed by laparoscopy, and follicles could be cultured and observed to 
yield fertilizable germ cells. This approach may also potentially allow women to 
delay childbearing until later in life due to lifestyle or other reasons. In vitro 
follicle culture systems have many potential clinical and research applications, but 
improvements to current technologies are needed to make these applications a 
reality. The application of tissue engineering techniques to follicle culture have 
already led to improvements to culture system technologies, and further 
improvements may one day produce culture systems capable of producing 
successfully maturing human ovarian follicles. 
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